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The acute respiratory distress syndrome (ARDS) is a catastrophic form of acute lung
inflammation. Patients with ARDS require support on the intensive care unit (ICU) and
the associated mortality approaches 50%. ARDS represents the severe end of a spectrum
of lung injury that evolves over a period of hours or days in a subgroup of patients
following a major insult such as multiple trauma, sepsis or aspiration. Professor Haslett's
group in Edinburgh have undertaken clinical studies in patients in the very early at-risk
period of ARDS, soon after the initiating insult. We have shown that in patients with
multiple trauma, raised levels of intrapulmonary interleukin-8 (IL-8), but not other
inflammatory cytokines, are associated with subsequent progression to ARDS (n=56,
P<0.001). IL-8 is a potent chemoattractant and activator of neutrophils, considered to be
the primary injurious cell in ARDS. The high IL-8 levels were detected within a few
hours (range 0.75 - 4 hr) of the trauma incident. Immunohistochemical analysis
implicated the alveolar macrophage as a potent source of intrapulmonary IL-8. The
mechanisms by which IL-8 may be rapidly generated in this clinical setting are unknown.
Our clinical observations suggest that events occurring in the immediate aftermath of a
trauma incident contribute to the generation of IL-8 in macrophages. I hypothesised that
clinically relevant physiological events may include:
1) A neuro-endocrine 'stress' response to major trauma. This would result in the rapid
intrapulmonary and systemic release of clinically relevant stress mediators including
catecholamines and neuropeptides that may stimulate the macrophage to generate IL-
8.
2) Acute tissue hypoxia and hyperoxia. By the time of sampling, the trauma victims
were likely to have undergone a period of sustained tissue hypoxia secondary to head-
injury, atelectasis and lung contusion and subsequent resuscitation with delivery of
high flow oxygen. I hypothesised that hypoxia / hyperoxia was as direct multiple-
stimuli or 'hits' to generate IL-8 in macrophages.
I aimed to test these hypotheses in studies of cultured human monocyte-derived
macrophages and in a novel animal model of acute lung injury.
In human-monocyte derived macrophages, I have shown that the stress mediators
adrenalin, substance P and macrophage migration inhibitory factor (MIF) do not increase
IL-8 production at an early time-point (2 hr). Compared to normoxic controls, acute
hypoxia (PO2 ~ 3.5 KPa) increased IL-8 protein release by 1.8-fold by 2 hours and
steady-state IL-8 111RNA expression by 30 mins. The multiple hit of hypoxia / hyperoxia
was found to be a more potent stimulus for IL-8 generation than hypoxia or hyperoxia
alone.
The effects of hypoxia / hyperoxia on IL-8 generation were studied in a rabbit model of
acute lung injury. Localised bronchoscopic instillation of HC1 into the left lower lobe of
an anaesthetised ventilated rabbit resulted in significantly increased IL-8 mRNA and
protein expression, neutrophil infiltration into alveolar airspaces and lung in the directly
injured lung but not the contralateral 'indirectly' injured lung. Systemic hypoxaemia was
induced by reduction in the inspiratory oxygen fraction. Compared to normoxic controls
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(arterial PaC>2 ~ 11 KPa), acute hypoxia (Pa02 ~ 5 KPa) for up to 2 hours increased
intrapulmonary IL-8 mRNA but not protein expression in the acid-injured lung. Delivery
of 100% oxygen for 2 hours (PaC>2 ~ 60 KPa) following acute hypoxia (a multiple-hit),
increased both intrapulmonary IL-8 mRNA and IL-8 protein levels. The increase in IL-8
protein was attenuated if the reoxygenation phase was controlled to return arterial PO2 to
normoxic levels (-11 KPa).
The mechanisms by which hypoxia may rapidly increase IL-8 mRNA expression in
monocyte-derived macrophages was further studied in vitro. The rapidity of the response
(30 mins) suggested an increase in gene transcription. Electromobility gel-shift assay
revealed that hypoxia increased nuclear levels of the IL-8 promoter-binding transcription
factors AP-1 and CEBP-P, but not NF-kB, by 15 min exposure. Hypoxia induced
macrophage expression of HIF-la, a critical regulator of hypoxic adaptive responses.
However cobalt chloride and desferrioxamine, HIF-la-inducing hypoxia mimics, did not
upregulate IL-8, suggesting that IL-8 transcription may be HIF-1 independent. Finally it
was demonstrated that in contrast to IL-8, hypoxia inhibited expression of a panel of
chemokines and cytokines including MCP-1, MlP-la, MIP-ip and TNF-a. Both the
pattern of chemokine expression and transcription factor activation with hypoxia differed
from that induced by bacterial lipopolysaccharide (LPS), which potently activated NF-kB
and upregulated several inflammatory genes.
These data support the hypothesis that acute hypoxia / hyperoxia act as multiple-hits in
the generation of macrophage-derived IL-8 in vitro and intrapulmonary IL-8 in vivo,
representing a potential mechanism for our observation of elevated alveolar IL-8 levels
patients with multiple trauma that progress to ARDS. The observation that hypoxia alone
rapidly and selectively increased IL-8 mRNA expression suggests that hypoxia may
represent a 'priming' stimulus in macrophages, 'arming' the cell for a subsequent second
hit such as hyperoxia. Furthermore, the specific chemokine response to hypoxia differs
markedly with that observed with LPS implying potentially distinct adaptive responses to
hypoxia and infection in the macrophage.
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1.1. THE ACUTE INFLAMMATORY RESPONSE
The classical localised response to injury or infection has been recognised for at least
2000 years. Redness and swelling with heat and pain (rubor et tumor cum calore et dolor)
were described in the writings of Celsus (30 B.C. to 38 A.D.) and together with loss of
function (functio laesa), comprise the cardinal features of acute inflammation. Isolating
the injured site, destroying the injurious agent and initiating healing are processes which,
in evolutionary terms, must clearly be aimed at enhancing the hosts prospects of survival.
Unless tightly regulated however, these processes are themselves liable to cause host
injury. Indeed, it is this potential conflict that is believed to be central to the pathogenesis
of inflammatory disease (Gallin et al., 1992)
Whilst the cardinal features of localised inflammation have long been recognised, the
concept of a systemic inflammatory response to a significant injury or insult is
comparatively new. In his writings in the 1850's, Claude Bernard had recognised that in
order to sustain life, the constancy of the 'milieu interieur' must be maintained (Selye,
1956). This fundamentally important concept was termed homeostasis by Walter Cannon
in the 1930's. Throughout the first half of the 20th Century, numerous terms were coined
to embody a stereotypical response to a major insult, manifested by a disturbance of
homeostatsis: 'Maladie postoperatoire', 'hemoclastic crisis', 'syndrome chimque
d'histolse massive', and 7e syndrome malin de maladies infectueuses'' were all
characterised by changes in blood pressure, heart rate, respiratory function,
thermoregulation, and immune and metabolic activity in response to surgery, blood loss,
trauma, burns and infection (Selye, 1956).
In the last 50 years, our understanding of this acute systemic response has advanced on
two fronts. Firstly, there are now widely accepted definitions and classifications for the
systemic inflammatory response and its complications, greatly aiding clinical studies.
Secondly, the nature and function of many neuro-endocrine and immune mediators, and
their cellular sources, is becoming clearer.
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1.1.1 The syndromes associated with systemic inflammation
The term 'systemic inflammatory response syndrome' (SIRS) was introduced following a
consensus conference of the American College of Chest Physicians and Society of
Critical Care Medicine (ACCP/SCCM) a decade ago (Bone et al., 1992). It is defined as
the response to a severe clinical insult and manifested by the presence of two or more
conditions from a list of criteria relating to temperature, heart rate, respiratory rate and
white blood cell (WBC) count (Appendix 1A). The term 'sepsis' is used to describe an
identical syndrome, but in which infection can be identified as a cause.
Figure 1.1.1
Figure 1.1.1 Relationship between major clinical insults and SIRS. Sepsis is
infection complicated by SIRS. Adapted from Bone et al., 1995
Although the criteria used to define SIRS were based on consensus and not on cited
clinical or experimental data, subsequent prospective studies have demonstrated that the
early presence of SIRS and the presence of >2 criteria does confer an increase in patient
mortality on the intensive care unit (ICU) (Rangel-Frausto et al., 1995; Malone et al.,
2001). Virtually all patients that die in an ICU setting exhibit dysfunction or failure of
one or more major organs. Indeed there is a virtually linear relationship between mortality
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and number of organs failed (Moreno et al., 1999). Hence, SIRS may be viewed as a
phase within a continuum, with the potential to progress from a heightened inflammatory
state to an overwhelming inflammatory cascade, precipitating dysfunction in major
organs such as the lung, kidney and liver. The ACCP/SCCM consensus committee of
1991 termed this state of altered organ function (or failure of homeostasis) the multi-
organ dysfunction syndrome (MODS). No attempt was made to define or categorise
'organ dysfunction' specifically, though several scoring systems have subsequently been
suggested (Nathens and Marshall, 1996). In the context of a severe systemic
inflammatory response, the lung appears to be particularly susceptible to injury (Vincent
et al., 1998). In its most catastrophic form, this is termed the acute respiratory distress
syndrome (ARDS).
1.1.2 The acute respiratory distress syndrome
In 1967, Ashbaugh and colleagues described twelve patients on the intensive care unit
with respiratory failure in whom i) the chest radiograph revealed bilateral diffuse alveolar
shadowing, ii) hypoxaemia was refractory to oxygen therapy, iii) lung compliance was
markedly reduced and iv) pulmonary oedema and hyaline membrane formation was
prominent in the necropsy specimens of the seven that died (Ashbaugh et al., 1967). Soon
after, this constellation of abnormal findings was termed the adult respiratory distress
syndrome, to distinguish it from a similar pathological condition in neonates (Petty and
Ashbaugh, 1971).
1.1.2.1. Definition of ARDS
The diagnostic criteria for diagnosing ARDS have evolved since Ashbaugh's original
description. The central clinical features of respiratory failure with refractory
hypoxaemia, pulmonary infiltrates secondary to leakage of proteinaceous fluid and 'stiff
lungs still apply, but have been both refined and clearly defined - a process critical for the
purposes of epidemiological and therapeutic studies. It is recognised that ARDS
represents the severe end of a spectrum of acute lung injury (ALI) and the attempts at
diagnostic criteria reflect this. In 1988 Murray and colleagues proposed an expanded
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definition of ARDS that allocated a lung injury score to individual cases based upon;
chest radiograph, degree of hypoxaemia, PEEP (peak end-expiratory pressure - an
indirect measure of lung compliance) and compliance itself if available. A score of 0
indicated no lung injury, 0.1-2.25 indicated mild to moderate injury and >2.5 indicated
severe lung injury (ARDS). This scoring system has been widely used in studies of ALI /
ARDS.
More recently the key features of this scoring system have been incorporated into a
potentially simpler definition; The North American / European Concensus Criteria
(Bernard et al., 1994)(Appendix IB). This acknowledged that lung injury was a
continuum from mild to severe and distinguished ARDS from acute lung injury on the
basis of severity of impaired oxygenation alone. Furthermore, it emphasised that lung
injury was associated with a precipitating or predisposing event.
1.1.2.2 Pathological features of ARDS
The various predisposing events associated with ARDS may be broadly separated into
two main categories; in one, the lungs are injured directly by a disease process and in the




Aspiration of gastric contents Sepsis
Pneumonia Multiple Trauma
Smoke Inhalation Acute Pancreatitis
Near Drowning Burns
Pulmonary Emboli Massive Transfusion
Pulmonary contusion Reperfusion Injury
Table 1.1. Major insults or events predisposing to the development of ALI / ARDS
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In the early stages of ARDS, there may be histological features that reflect the underlying
precipitating event. For example, microthrombi may be observed where ARDS is
associated with disseminated intravascular coagulation (DIC), or there may be
histological evidence of aspiration or atypical pneumonia (Hasleton, 1996). Most of the
early ultrastructural pulmonary changes are however similar regardless of the cause.
Injury to the type 1 alveolar epithelial cell, characterised by cytoplasmic swelling,
membrane fragmentation and exposure of the underlying basement membrane, is
considered an important, relatively early event in ARDS (Baclofen and Weible, 1977).
The alveolar wall capillary endothelial cells also show evidence of swelling, vacuolation
and focal necrosis (Baclofen and Weible, 1982). The relative importance of endothelial
versus epithelial injury in the pathogenesis of ARDS is unresolved (Schnells et al., 1980).
This may reflect the variety in the initiating insults that give rise to lung injury.
Widespread and prominent oedema of the alveolar walls and airspaces (lung leak) is a
feature of established ARDS. This fibrin-rich oedema fluid forms 'hyaline membranes',
possibly at sites of type 1 epithelial cell injury (Sevitt, 1974). Neutrophil infiltration is a
prominent feature of established disease and there is compelling evidence that the
neutrophil, through release of multiple histotoxic agents, is injurious to the lung
parenchyma (Downey et ah, 1999; Haslett et ah, 2000). Both experimental and clinical
studies have, however, demonstrated that neutrophil recruitment alone may occur without
alteration in lung endothelial or epithelial permeability to protein (Wiener-Kronish et ah,
1991; Martin et ah, 1989).
1.1.2.3 The natural history of ARDS
The mechanisms by which an initially severe but potentially limited insult leads to
catastrophic lung injury are not clearly defined. There are however characteristic features
in the natural history that may provide insight into the pathogenesis of ARDS. Firstly,
lung injury evolves over time and is not clinically apparent until several hours or days
following the initiating insult. This 'latent period', during which most patients will
exhibit SIRS, is particularly evident when ARDS follows an indirect insult such as
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multiple trauma or sepsis. Secondly, not all patients with a predisposing disease will
develop severe lung injury. The percentage of those at risk that progress to ARDS
depends upon the cause; approximately 40-60% of patients with sepsis, 20-35% of
trauma patients and 10-20% of patients with gastric aspiration (Fowler et al., 1983)
progress to ARDS.
Finally, established ARDS is associated with a high mortality and to date no
pharmacological therapy has convincingly been shown to reduce mortality (reviewed by
Ware and Matthay, 2000). In the early 1980's figures of 65% or higher were frequently
quoted (Milberg et ah, 1995), and whilst this figure has fallen a little over the last 20
years, it remains over 50% in most centres. The majority of deaths are a consequence of
MODS and sepsis, with less than a fifth attributable directly to respiratory failure
(Montgomery et ah, 1985). These characteristics of the disease have led some
investigators to focus on the at-risk period ofARDS, offering the potential for identifying
key mediators that may play a role in the development of severe lung injury. The at-risk
period begins immediately after the onset of the initiating insult and as such the acute
systemic response may be highly relevant to subsequent disease progression.
1.1.3. The systemic response to a major insult
A severe insult such as major trauma, infection or other conditions predisposing to
ARDS, leads to a systemic co-ordinated host response. The principle aim is preservation
of critical organ function achieved through maintenance of blood pressure, perfusion and
energy supply. Known as the 'stress response' (Selye, 1936) or the 'fight or flight'
reaction (a term used by physiologists such as Walter Canon in the 1930's), the
physiological effects may be very rapid if in response to an acute, perceived injurious
insult. This early response is orchestrated through the sympathetic nervous system (SNS)
and the hypothalamic-pituitary-adrenal (HPA) axis.
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1.1.3.1. Interaction between the SNS and HPA following a major insult
The complex interaction or cross-talk between the HPA and the SNS is mediated via a
range of neuro-endocrine and inflammatory cell mediators, and occurs at multiple levels
both centrally and in peripheral tissues (Figure.1.1.2). For example, the SNS originates in
the brainstem and included in its extensive network of innervation is lymphoid tissue and
the adrenal glands. Activation of the SNS results in increased catecholamine expression,
both localised release of noradrenalin from the sympathetic nerve fibres and systemic
release of adrenalin from the adrenal medulla. Catecholamines are the principle end-
products of the SNS and mediate tachycardia, vasoconstriction and critical rapid
metabolic adaptations to severe injury. In addition, catecholamines have been shown to
have a role in immunoregulation. In general, both adrenalin and noradrenalin are
considered anti-inflammatory in nature, downregulating a range of proinflammatory
cytokines and stimulating anti-inflammatory cytokines from antigen presenting cells and
lymphocytes (reviewed in Elenkov et ah, 2000).
A corresponding 'central' mediator in the HPA axis is corticotropin-releasing hormone
(CRH), principally secreted in the paraventricular nucleus (PVN) of the hypothalamus.
Corticotrophic cells in the anterior pituitary respond to CRH stimulation by releasing
adrenocorticotropic hormone (ACTH) into the circulation which, in turn, stimulates
Cortisol synthesis in the adrenal cortex. Cortisol, the principle end-products of the HPA, is
a critical mediator of the stress response. As with the catecholamines, Cortisol
predominantly exhibits anti-inflammatory properties.
There is a direct two-way communication between the HPA axis and the SNS at a central
level, with CRH-secreting neurons projecting from the PVN into the brainstem-origin of
the SNS and noradrenergic neurons projecting from the brainstem into the PVN. Hence,











Figure 1.1.2 The interaction between the Hypothalamic Pituitary Adrenal axis
(HPA) and the sympathetic nervous system (SNS) following a major insult.
Endotoxin, trauma and hypoxia have direct effects both on the brainstem and
hypothalamus, and on peripheral tissue. In this figure, the cellular component in the
tissues is represented by the macrophage. Tissue generated cytokines TNF-a, IL-1 and
IL-6 stimulate the hypothalamus, which has bi-directional innervation with the brainstem
origin of the SNS, resulting in dual activation. The neuro-endocrine mediators released
following activation of the HPA / SNS, in addition to having widespread physiological
effects (see text), also influence macrophage function. Finally, there is evidence that the
macrophage is able to release a number of neuro-endocrine mediators (broken arrows),
indicating potential autocrine activity.
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1.1.3.2 Substance P
Although catecholamines and Cortisol represent the major peripheral effectors of the
stress response, there are a host of other candidates that may also play a regulatory role.
Substance P (SP) is a neuropeptide stored in peripheral sensory nerve endings throughout
the body. In sympathetic ganglia, SP is found co-localised with noradrenalin (Kessler,
1985) and may be essential to the maintenance of adrenal catecholamine secretion in
response to stress (Livett et al., 1990). In contrast to the immunoregulatory activities of
catecholamines and Cortisol, SP is regarded as possessing proinflammatory properties
(Payan, 1989) and these may be particularly relevant in the lung (Bozic et al., 1996;
Kaltreider et al., 1997).
1.1.3.3 Macrophage migration inhibitory factor
Macrophage migration inhibitory factor (MIF) was first described 35 years ago as a
substance produced by activated T cells which inhibited the random migration of
macrophages (Bloom and Bennett, 1966; David, 1966). It has subsequently been
'rediscovered' and amongst its varied activities, it is now viewed as a critical regulator in
the stress response (Bucala, 1996; Donnelly et al., 2000). Pre-formed MIF granules have
been identified co-localised to the same cells that release ACTH in the rat anterior
pituitary and stimulation with CRF results in a dose-dependent release ofMEF (Nishino et
al., 1995). MIF is also released from activated inflammatory cells, including the
macrophage (Calandra et al., 1994) and eosinophils (Rossi et al., 1998).
The potential importance ofMIF in the stress response is demonstrated by the finding that
it is able to directly counter-regulate the anti-inflammatory effects of glucocorticoids both
in vitro and in a mouse model of endotoxaemia (Calandra et al., 1995). In clinical studies,
raised circulating levels ofMIF have been found in patients with sepsis (Lehmann et al.,
2001) and trauma (Joshi et al., 2000). With regard to lung inflammation, intrapulmonary
MIF levels are raised in patients with ARDS (Donnelly et al., 1996) and asthma (Rossi et
al., 1998).
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1.1.4. The classical early inflammatory mediators
At a tissue level, it is believed that a major insult such as infection, direct trauma or
ischaemia causes localised cytokine release, which may then be amplified in a 'cytokine
cascade' to generate high circulating levels of inflammatory mediators. Bacterial
endotoxin or lipopolysaccharide (LPS) is a major component of the Gram-negative
bacterial cell wall and is widely considered to be a principal mediator in the pathogenesis
of SIRS and sepsis following in gram-negative infection (Morrison and Ryan, 1987;
Gutierrez-Ramos and Bluethmann, 1997; Horn et ah, 2000). Tumour necrosis factor
(TNF) -a, interleukin (IL)-l and IL-6 are the archetypal early inflammatory cytokines.
The pleiotropic autocrine and paracrine activity of TNF-a and IL-1 place these cytokines
at the summit of the perceived cytokine cascade (Tracey et ah, 1986; Tracey and Cerami,
1994; Dinarello, 1992). Both cytokines are able to stimulate production of each other, IL-
6 and multiple other inflammatory mediators, thus amplifying the inflammatory response.
Independently, TNF-a, IL-1 and IL-6 are able to directly stimulate the hypothalamus and
activate the HPA axis (Figure 1.1.2) (Chrousos, 1995; Imura, et ah, 1991; Sapolsky et ah,
1987).
Endotoxin is also able to activate the HPA axis, though this effect may be mediated
through cytokines, particularly IL-6 (Perlstein RS et ah, 1993). Finally, although TNF-a,
IL-1 p and IL-6 are considered the classical early inflammatory cytokines for the reasons
described, this pattern of cytokine generation may not be relevant to all tissues. Within
the lung, there is evidence that the chemokine interleukin-8 (IL-8) may be one of the
earliest generated proinflammatory mediators. This is discussed in Chapter 1.2.
1.1.4.1 Tumour necrosis factor-a
TNF-a is a pleiotropic trimeric peptide and binds to 2 receptors; a 55 kD protein (TNFRI
or CD120a) and a 75 kD protein (TNFRII or CD120b). Signalling occurs through these
membrane bound receptors, but TNFRI and TNFRII are also expressed in an extracellular
('soluble') form, capable of binding TNF-a and limiting bioavailability. Human
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monocytes and macrophages express both receptor types in soluble and membrane bound
form, though the relative expression is stimulus dependent. In resting monocytes for
example, membrane bound TNFRII is predominantly expressed and stimulation with
LPS results in downregulated expression both in vitro and in circulating cells (Hart et al.,
1996; Van der Poll et al., 1997).
In patients with pancreatitis and sepsis, serum TNF-a levels are characteristically raised,
often within 30 mins of onset and peaking by 2 hours (DeGroot et al., 1989; Exley et al.,
1992; Parsons and Moss, 1996). Multiple trauma appears to have a less consistent effect
on circulating TNF-a (Ayala et al., 1990; Hoch et al., 1993). The 'toxic' effects of TNF-
a include hypotension, fever, metabolic acidosis, coagulopathy and capillary leak
(Natanson et al., 1989; Van der Poll et al., 1991), all phenomena associated with SIRS
and the genesis ofMODS.
1.1.4.2 Interleukin-1
There are two well characterised IL-1 proteins, termed IL-la and IL-ip. Although
products of two distinct genes, both cytokines possess a similar wide spectrum of activity.
IL-1 binds several cell surface receptors, the two most prominent being IL-lRtI (p80,
CDw 121a) and IL-lRtH (p68, CDw 121b) (Dinarello, 1992). Monocytes express both
receptors, though signalling only occurs through IL-lRtI (Uhl et al., 1989; Granowitz et
al., 1992). IL-lRtll has a regulatory function, inhibiting cell responses to IL-1 (Neumann
et al., 2000). IL-1 converting enzyme (ICE), or caspase-1, is an enzyme required for the
post-translational modification of inactive IL-ip (30 KDa) to active IL-ip (17 KDa).
The proinflammatory properties of IL-1 are akin to those ofTNF-a and elevated systemic
IL-1 is frequently detected in sepsis, though classically highest levels are reached after
the TNF-a peak. In other conditions associated with SIRS such as trauma and / or
haemorrhage however, systemic IL-1 is frequently undetectable for several hours or days
following the insult (Rodrick et al., 1986; Hoch et al., 1993).
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1.1.4.3 Interleukin-6
A characteristic feature of the response to a major inflammatory stimulus is the systemic
elevation of a large number of serum proteins, broadly termed the acute phase proteins
(Gabay and Kushner; 1999). The precise function of many of these upregulated proteins
remains uncertain, though some, for example C-reactive protein, are known to play
important regulatory roles in the inflammatory process (Xia et al., 1997; Heuertz et al.,
1997). EL-6 is considered the chief stimulator of acute phase protein production (Gauldie
et al., 1987), in addition to its functions as a pyrogen and inducer of IL-1 and TNF-a.
Peak serum levels of IL-6 following an inflammatory insult occur several hours after
peak TNF-a and IL-1 expression. High levels have been consistently detected following
sepsis, pancreatitis and trauma and of the three classical cytokines, circulating IL-6
correlates most closely with severity of illness and outcome in both trauma and sepsis
(Gabay and Kushner, 1999).
1.1.4.4 Endotoxin
Endotoxin or LPS consists of a structurally conserved core lipid component, glycolipid A,
and an outer component of O- and R-polysaccharide antigens (Wardle, 1997). It is the
glycolipid A portion which fonns the toxic moiety of the LPS macromolecule.
Intravenous injection of low-dose endotoxin in humans results in most of the
haemodynamic, metabolic and immune responses associated with SIRS (Martich et al.,
1991; Dinarello 1991; van der Poll and Deventer, 2000). In patients in whom there is a
clearly identifiable source, such as perforated bowel or renal or pulmonary infection,
endotoxin is generally accepted as playing a central role in the development of SIRS,
septic shock and potentially MODS (Morrison and Ryan, 1987; Bone, 1996).
Depending upon the nature of the insult and the injured organ, a variety of cells may
respond to cytokine or endotoxin stimulation and contribute to the generation
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of inflammatory mediators. However, the macrophage may have a central role, and this
is discussed in Chapter 1.3.
1.1.5. Mediators in patients at-risk of ARDS
Based on current understanding of the development of SIRS and progression to lung
injury, a number of investigators have attempted to identify mediators of potential
pathological or prognostic significance both in the blood or alveolar airspaces of patients
at-risk of ARDS (Pittet et ah, 1997; Hirani and Donnelly, 1997). Interpretation of data
from such studies requires an awareness of their potential limitations, in particular
limitations which relate to practical obstacles that hinder studies of critically-ill patients
at-risk of ARDS.
Ideally, at-risk patients should be identified as early as possible following the initiating
insult. This would provide the widest 'window of opportunity' in which to measure
potentially important mediators before the onset of ARDS. Furthermore, since ARDS is
regarded as the severe end of a continuum of lung injury, targeting patients early would
tend to recruit a more homogenous population with relatively mild injury. Finally, the
perception of an inflammatory cascade suggests that the pathways involved become
progressively more complex and divergent 'downstream' of the initiating insult. The
search for key regulatory mediators may be more rewarding early in the disease process.
In a clinical setting however, targeting patients early is fraught with logistical difficulties.
Defining the 'at-risk' period is relatively simple if the initiating insult is major trauma or
surgery, but not in conditions in which the time of onset is likely to be imprecise as in
sepsis or pancreatitis. Recruiting acutely critically-ill patients, in whom the priority is
resuscitation and supportive care, may raise important issues of consent. In a number of
studies, patients have been recruited after admission to the intensive care unit and
requiring ventilatory support. Amongst these patients, there already exists a spectrum of
lung injury, though not yet severe enough to satisfy diagnostic criteria for ARDS. A
further dilemma, and one which may explain many of the apparent discrepancies in
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results between studies, is that the risk factors for ARDS are heterogenous and the
pathogenesis ofARDS may reflect this.
Patients with multiple trauma may represent a group particularly salient to studies in the
pathogenesis of ARDS. The onset of the initiating insult is sudden and easily defined.
Patients are frequently immediately intubated in order to maintain a patent airway. This
allows relatively easy access for bronchoalveolar lavage (BAL) sampling very soon after
the trauma episode. Table 1.1.2 summarises studies ofbiological mediators in patients at-
risk of ARDS following major trauma. Included is data from our own studies of ARDS,
in which a particular focus was placed in targeting patients early in the disease process. In
an initial study of 29 patients at-risk of ARDS, BAL levels of the chemokine interleukin-
8 (IL-8) were significantly higher in the 7 patients who progressed to ARDS compared to
the 22 that did not (Donnelly et al., 1993). There was no significant association with
plasma IL-8 levels. Immunostaining studies of BAL cells revealed that the alveolar
macrophage was a significant source of the rapidly elevated IL-8 detected. The at-risk
population in this study however, represented a heterogeneous group of patients with
major trauma, pancreatitis or perforated bowel.
With this in mind, we studied 56 consecutive patients (median age 48 years, range 18-89)
presenting to the Edinburgh Royal Infirmary with major trauma and requiring intubation
in the Accident and Emergency Department (Hirani et al., 2001). The median injury
severity score (ISS, Baker and O'Neill, 1976) was 25 (range 16-66). A chest radiograph
was taken and reviewed within 4 hours of admission for all patients. No patients had
radiographic evidence of ARDS at this time. BAL sampling was performed at a median
time of 95 mins (range 30-240) after the trauma event. Subsequent development of
ARDS was defined using the European / American Consensus criteria (Bernard et al.,
1994). Endotoxin levels and a range of chemokines and cytokines were measured in BAL
fluid and plasma. Total BAL protein levels and BAL differential cell counts were
determined. Seventeen of the 56 trauma patients subsequently progressed to ARDS and
the mean BAL IL-8 level was significantly higher in these patients compared to those
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Elastase Blood + Donnelly et ah,
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E / P- selectins Blood + Donnelly et ah,
1994;
L-selectin Blood + Stengel et ah, 2001
vWf-Ag Blood - Moss et ah, 1996
CD1 lb / CD18 Blood + Simms et ah, 1991
Protein leak Albumin Urine + Gosling et ah, 1994;
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Surfactant
proteins
SP-A Blood + Pison et ah, 1992
Iron
metabolism
Ferritin Blood + Sharkey et ah, 1999
Table 1.2 Biological mediators measured in patients with major trauma at-risk of
ARDS. Studies included are those in which the entire study population comprised trauma
patients, or in which analysis of a subgroup of trauma patients was performed. Although
several studies have demonstrated association with the development of ARDS, there have
been no large prospective studies.
16
In contrast there was no significant difference in BAL levels of TNF-a (P=0.37), IL-ip
(P=0.13), MlP-la (P=0.49), MIP-lp (P=0.7) and MCP-1 (P=0.08) between the two
groups. BAL endotoxin levels were also not significantly different between groups
(P=0.80) and in 7 of the 17 patients who progressed to ARDS, endotoxin levels were at
the lower limit of detection (2.5 pg/ml). Plasma endotoxin levels in patients who did and
did not progress to ARDS were also not significantly different (5.6+3.1 v 4.7±3.2,
P=0.65). A correlation was observed between degree of patient hypoxia at admission to
casualty, as manifested by reduced PaCL/FiC^, and raised BAL IL-8 levels (r= -0.56,
PO.OOl).
Thus, our original observation that IL-8 was associated with the development of ARDS
was confirmed in a larger population of at-risk trauma patients. Importantly, this
association was not observed with a range of other cytokines, chemokines or endotoxin.
Interleukin-8 is a potent neutrophil chemokine, and its properties are discussed in
Chapter 1.2.. A correlation was observed between degree of patient hypoxia at




1.2.1 Classification of chemokines
The chemokines (chemotactic cytokines) are group of small proteins (8-12 kDa) that play
a role in attracting leukocytes and regulating recruitment to tissues during inflammation
(reviewed by Luster, 1998; Keane and Strieter, 2000). Over 40 members of the
chemokine family have been identified to date, exhibiting 20-70% homology in amino
acid sequence. They are classified based on the relative position of two highly conserved
NH2-terminal cysteine residues. In the CXC or a-family, the two cysteines are separated
by one non-conserved amino acid residue and in the CC or P-family the two cysteines are
in juxtapostion. These two families are by far the most extensively characterised. The
only representatives outside of the a and p-families are lymphotactin (a C chemokine)




CXC Chemokines CC Chemokines
Interleukin-8 (IL-8) Monocyte chemotactic protein (MCP)-1,2,3,4,5
Epithelial-derived neutrophil activating protein (ENA-78) 1-309
Growth-related oncogene (GRO)-a, p, y Macrophage inhibitory protein (MIP)-la,ip,15,3a,3p
Granulocyte chemotactic protein (GCP)-2 Regulated on activation normal T cell expressed and
secreted (RANTES)
Beta-thromboglobulin (P-TG) Eotaxin
Neutrophil activating protein (NAP)-2 Macrophage-derived chemokine (MDC)
Platelet factor 4 (PF4) Haemofiltrate CC chemokine (HCC)-1,2,4
Interferon-y-inducible protein 10 (IP-10) Thymus and activation-regulated chemokine (TARC)
Monokine induced by interferon-y (MIG) Thymus-expressed chemokine (TECK)
Stromal cell-derived factor-1 (SDF-1) 6-cysteine chemokine (6Ckine)
Interferon inducible T cell alpha chemoattractant (ITAC) Dendritic cell chemokine-1 (DC-CK1)
B cell-attracting chemokine-1 (BCA-1) Pulmonary and activation-regulated chemokine (PARC)
Lipopolysaccahride-induced CXC chemokine (LIX) Secondary lymphoid-tissue chemokine (SLC)
C Chemokines CXXXC Chemokine
Lymphotactin-a,P Fraktalkine
Table 1.3. The classification of chemokines
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The CXC chemokines are further subdivided on the basis of the presence or absence of a
structure/function domain near the N-terminal: CXC chemokines harbouring the
sequence glutamic acid-leucine-arginine ("ELR" motif) are chemoattractants for
neutrophils and possess angiogenic activity whilst those that do not are mononuclear cell
chemoattractants and inhibit angiogenesis (Strieter et al., 1995).
1.2.2. Chemokine Receptors
Chemokine activity is mediated through specific G-protein-coupled receptors (GPCR).
The functional unit of this family of cell-surface receptors comprises a seven
transmembrane receptor coupled to the heterotrimeric G proteins. Currently at least five
human CXC chemokine receptors (CXCR1 through CXCR5), ten CC chemokine
receptors (CCR1 through CCR10), a C chemokine receptor (CR1) and a CXXXC
chemokine receptor (CXXXCR1) have been cloned and characterised (Murphy, 1994;
Premack and Schall, 1996; Keane and Strieter, 2000). In recent years, the biology of
chemokine receptors has attracted tremendous interest, fuelled by the seminal observation
that CCR5 represented a cofactor mediating HIV-1 entry into CD4+ cells (Feng et ah,
1996; Dragic et ah, 1996; Deng et ah, 1996).
The varied expression of chemokine receptors both between and within cell types adds a
further level of complexity to the inflammatory pathway. For example, the CXCR1
receptor is restricted to neutrophils and appears to mediate IL-8 signalling alone. In
contrast, CCR3 is expressed on eosinophils, basophils and dendritic cells and binds
RANTES, eotaxin, MCP-3, MCP-4 and MlP-la.
1.2.3. Interleukin-8 - An archetypal CXC chemokine
In 1987, Yoshimura and Matsushima isolated a 10 kD polypeptide from LPS-stimulated
human monocyte supernatants. The protein exhibited potent neutrophil chemotactic
activity, hence the original term monocyte-derived neutrophil chemotactic factor
(MDNCF). The cDNA was subsequently cloned independently by several investigators
(Schmid and Weismann, 1987; Matsushima et ah, 1988) and the protein was
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subsequently renamed IL-8 (Balkwill and Burke, 1989). Thereafter this chemokine has
become the most extensively studied in human disease.
1.2.3.1. Structural characterisation of IL-8
IL-8 is generated in a precursor form, consisting of 99 amino acids with a signal peptide
in the hydrophobic N-terminal region (Matsushima et al., 1988). Subsequent cleavage
results in a 72-amino acid (IL-872-aa) or a 77-amino acid (IL-877.aa) non-glycosylated
protein. The fonner is the predominant active form released from stimulated monocytes,
macrophages and neutrophils. IL-877-aa is the predominant form secreted from endothelial
cells (Hebert et al., 1990). There is evidence that the functional characteristics between
the two forms differ: In contrast to IL-872-aa the 77-aa peptide exhibits comparatively
weak neutrophil chemoactivity (Nourshargh et al., 1992), is pro-apoptotic in leukaemic
cells (Terui et al., 1998) and may indeed have anti-inflammatory properties (Gimbrone et
al., 1989). However, the in-vivo relevance of these differences is not clear. Thrombin and
plasmin have been shown to cleave 77-aa IL-8 to the 72-aa form (Hebert et al., 1990;
Nakagawa et al., 1991). The proteolytic processing of IL-8 may be relevant to the in vivo
activity of IL-8.
The three dimensional structure of IL-8 represents a short N-terminus followed by three
anti-parallel p sheets linked together with loops and by a p turn to the a helix which
constitutes the carboxyl terminal (Clore et al., 1990). The sites susceptible to cleavage by
neutrophil elastase, cathepsin G and proteinase 3 reside in the region of the P sheets and
in the folded molecule are inaccessible to proteinases (Pardrines et al., 1994). In the
micromolar range, IL-8 is a functionally active dimer. However it has been shown that at
physiological concentrations (pico- and nanomolar range), IL-8 is found in a functionally
active monomelic form (Burrows et al., 1994; Rajarathnam et al., 1994)
1.2.3.2. Cellular sources of IL-8
A wide variety of cells have the capacity to secrete IL-8 (Mukaida et al., 1998).
Monocytes and macrophages are potent sources, particularly in response to
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proinflammatory mediators such as TNF-a, IL-1 and LPS (Yoshimura et al., 1987;
Metinko et al., 1992; Peveri et al., 1988). IL-8 responsive-cells, notably neutrophils, also
generate IL-8, leading to potential autocrine activity (Bazzoni et al., 1991; Siddiqui et al.,
1999).
1.2.3.3. IL-8 and cell surface receptor binding
IL-8 has been shown to bind to three distinct families of receptor: (i) The CXC receptors;
(ii) the Duffy antigen receptor for chemokines (DARC); (iii) the heparan sulphate
proteoglycans. The CXC receptors exhibit restricted expression and transduce
intracellular signalling upon binding. In contrast, DARC and proteoglycan receptors are
ubiquitously expressed and bind IL-8 without associated signalling.
(i) CXC Receptors
IL-8 binds to two members of the CXC family of receptors: CXCR1 (IL-8RA) is
relatively selective for IL-8, known only to bind GCP-2 of the other chemokines; CXCR2
(IL-8RB) in addition to IL-8 also binds GCP-2, GRO-a,P and y, NAP-2, ENA-78 and
LIX (Luster, 1998). Whilst IL-8 receptors have been reported on a variety of
inflammatory cells, it is overwhelmingly the neutrophil that exhibits activation in
response to IL-8. Approximately 20,000 high affinity (K<i 8x10~8 M) IL-8 receptors are
expressed per neutrophil (Oppenheim et al., 1991). Interaction with IL-8 occurs via two
distinct domains, with subsequent binding and signalling proceeding in two distinct
phases (Wu et al., 1996).
(ii) Duffy antigen receptor for chemokines (DARC)
The Duffy antigen is a transmembrane spanning protein present on red blood cells
(RBCs) that exhibits high binding affinity for the malarial parasite Plasmodium vivax
(Miller et al., 1976). The role of DARC expression on RBCs is uncertain, but one
suggestion is that these cells serve as a 'sink', mopping up excess chemokines. In support
of this, DARC knockout mice have been shown to exhibit an exaggerated inflammatory
response to endotoxin (Dawson et al., 2000). In 1993, Horuk et al. demonstrated that this
receptor also bound a range of CXC and CC chemokines including IL-8. Subsequently
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DARC was also detected on postcapillary venule endothelial cells and found to bind to a
number of chemokines (Hadley et al., 1994).
(iii) Heparan proteoglycans
Heparan and heparan sulphate are negatively charged proteoglycan constituents of cell
surfaces and extracellular matrix. As with DARC, heparan sulphate proteogycans have
been shown to bind several chemokines including MIP-ip (Tanaka et al., 1993), platelet
factor (PF)-4 (Stringer and Gallagher, 1997) and IL-8 (Baggiolini et al., 1994; Ramdin et
al., 1998; Dunzendorfer et al., 2001).
It has been postulated that endothelial-expressed DARC and heparan sulphate
proteoglycans serve to capture chemokines in the extracellular matrix, raising local
concentrations. In the case of IL-8, expression on endothelial surfaces may play a critical
role in recruiting neutrophils to the inflammatory site. (Rot et al., 1996; Middleton et al.,
1997).
1.2.3.4. The role of IL-8 in inflammatory cell recruitment
Neutrophil extravasation from the bloodstream, across intact endothelium and into the
inflammatory site is a tightly regulated process, evolving through a series of coordinated
events (Nourshargh and Williams, 1995). These include: 1) phenotypic changes in the
neutrophil and / or endothelium resulting in altered expression of adhesion molecules, 2)
tethering and rolling of the neutrophil along the endothelium, 3) firm adherence of the
progressively flattened neutrophil to the cell surface and 4) regulated passage of the
neutrophil through interendothelial cell junctions, across the perivascular basement
membrane and into the interstitium (Butcher, 1991; Springer, 1994).
In vitro IL-8 induces directed neutrophil migration along a concentration gradient
(chemotaxis) and upregulation of neutrophil integrins (Detmers et al., 1990; Divietro et
al., 2001). Human studies have revealed that the entire process of neutrophil recruitment
can be emulated by injection of IL-8 into tissue (Colditz et al., 1990; Swensson et al.,
1991; Leonard et al., 1991). Animal studies of IL-8 are partially restricted in that rodents
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do not appear to express this chemokine. Mice do, however, express an IL-8 receptor
homologue, genetic deletion of which severely impairs neutrophil transmigration
following intraperitoneal thioglycollate injection (Cacalano et al., 1994). In transgenic
mice engineered to over-express IL-8, circulating levels of the chemokine are
constitutively raised and neutrophils accumulate in the pulmonary, splenic and hepatic
vascular beds. Neutrophil extravasation following an inflammatory stimulus such
intraperitoneal thioglycollate instillation is impaired due, it is postulated, to the absence
of a significant IL-8 gradient (Simonet et al., 1994).
In contrast to rodents, the pattern and array of chemokine expression in rabbits is thought
to be similar to that of humans (Fox-Dewhurst et al., 1997; Wuyts et al., 2000). The
rabbit expresses IL-8 (82% homology with human IL-8) and both IL-8 receptor
homologues (Beaubien et al., 1990; Prado et al., 1994). Numerous rabbit models of
disease have clearly implicated IL-8 in the pathogenesis of neutrophil-associated tissue
injury (Wada et al., 1994; Folkesson et al., 1995; Harada et al., 1996; Matsumoto et al.,
1997; Nakamura et al., 2000).
There is therefore considerable evidence to support central role for IL-8 in neutrophil
recruitment. Chemotaxis is, however, conceptually difficult to conceive in an in vivo
setting. Constant blood flow would prevent the establishment of a persistent soluble
chemoattractant gradient at the blood-endothelial cell interface (Colditz et al., 1985;
Tanaka et al., 1993). Rot and colleagues have performed a series of elegant studies in
which radiolabelled IL-8 was injected intradermally in rabbits and into viable human skin
in vitro, and its 'journey' monitored. It was observed that within 30 min the IL-8 had
been transported from the extravascular tissue across the venular endothelium and was
present on the luminal surface of endothelial cells (Middleton et al., 1997). This process
involved internalisation of the IL-8 into the endothelial cell, incorporation into smooth
membrane-bound plasmalemmal vesicles and immobilisation on the luminal surface. This
latter event is thought to occur through the interaction of the non-signalling C-terminus of
the IL-8 molecule with endothelial heparan sulphate or possibly DARC (Rot et al., 1996).
These studies suggest a mechanism for coordinated IL-8 - neutrophil interactions at the
endothelial surface. The validity of this concept in neutrophil recruitment to the lung is
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unproven. There is evidence that some of the cellular and molecular mechanisms
proposed for neutrophil migration in the systemic vasculature may not applicable to the
pulmonary circulation (recently reviewed by Wagner and Roth, 2000)
Finally, whilst it is accepted that IL-8 is predominantly associated with neutrophil
recruitment, recent studies have revealed a role for IL-8 in the adhesion of eosinophils
(Ulfman et al., 2001) and monocytes (Gerszten et al., 1999) to endothelium. Hence, IL-8
may play be an important mediator in a wide range of inflammatory diseases.
1.2.3.5. Role of IL-8 in angiogenesis
Angiogenesis, the growth of new blood vessels from existing vessels and capillaries, is a
process critical to normal physiological development, growth and repair. Dysregulated
angiogenesis, however, can result in catastrophic host damage and is implicated in the
pathogenesis of fibroproliferative disease, tumour growth and chronic inflammation
(Folkmann and Brem, 1992; Folkmann, 1995; Jackson et al., 1997; Majno, 1998).
An array of important angiogenic regulators has been described (comprehensively
reviewed by Griffioen and Molema, 2000). In the chemokine superfamily, CXC
chemokines containing the ELR motif (IL-8, ENA-78, GRO-a,p.y) in general exhibit
angiogenic activity, whilst those without the ELR motif (PF4, IP-10, MIG) are angiostatic
(Moore et al., 1998). IL-8 mediates endothelial cell chemotactic and proliferative activity
(Strieter et al., 1992) and neovascularisation in vivo, independent of its neutrophil
recruitment properties. Human non-small cell lung cancer (NSCLC) growth is
significantly attenuated by a neutralising anti-IL-8 antibody treatment strategy in a
murine model (Arenberg et al., 1996). It has been postulated however that it is the net
balance between angiogenic versus angiostatic CXC chemokines that may determine
disease activity and progression (Arenberg et al., 1996A; Keane et al., 1997; Moore et al.,
1998).
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1.2.3.6. IL-8 in human disease
Since its initial description, IL-8 has been implicated in the pathology of a number of
diseases. The vast majority of these are primarily disorders of inflammation. (Table
1.2.1)
1.2.3.7. IL-8 in sepsis and MODS
Intravenous administration of LPS in primates or healthy human volunteers results in a
rise in circulating IL-8 by 1 hour, peaking at 2 hours (Van Zee et ah, 1991; Martich et ah,
1991). Studies of patients with sepsis have consistently shown high serum IL-8 levels,
that either independently or in combination with other markers of inflammation, have
predictive value for progression to multi-organ failure or death (Marty et ah, 1994;
Fujishima et ah, 1996; Takala et ah, 1999; Lin et ah, 2000; Slotman, 2000). In a rabbit
model of septic shock, pre-treatment with an anti-IL-8 antibody improved survival
(Carvalho et ah, 1997; Yokoi et ah, 1997). However there have been no published studies
to date of anti-IL-8 therapy in sepsis or MODS in humans.
1.2.3.8 IL-8 in inflammatory lung diseases
It is in lung inflammation, and in particular pulmonary diseases in which the neutrophil is
a prominent feature that IL-8 is most strongly associated (Table 1.2.1). Whilst it is
possible that IL-8 represents a marker of intrapulmonary inflammation, the known
biological properties of IL-8 and the data from animal studies suggest a causal association
between IL-8, neutrophil recruitment and hence the potential for lung injury. Several lines
of evidence from clinical studies further support this notion.
Our own clinical studies have identified an association between raised intrapulmonary IL-
8 levels and the progression to ARDS (Donnelly et ah, 1993; Hirani et ah, 2001). Other
investigators have also identified this chemokine as an early marker of inflammation, and
have demonstrated raised intrapulmonary levels present before the onset of neutrophil
influx in neonatal lung disease (McColm and Mcintosh, 1994; Munshi et ah, 1997;
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Ghezzi et al., 1998) and in cystic fibrosis (Khan et al., 1995). In a recent study of lung
transplant patients, our group reported that raised intrapulmonary IL-8 levels in donor
lungs were significantly associated with subsequent development of graft dysfunction in
the recipients (Fisher et al., 2001). Studies have revealed that persistently raised alveolar
IL-8 levels are associated with non-resolution of ARDS and death (Miller et al., 1992;
Baughman et al., 1996). Although the related CXC chemokines, particularly ENA-78 and
the Gro-family, have neutrophil chemotactic properties, IL-8 is generally regarded as
being the more potent and biologically relevant in acute lung injury. Neither ENA-78 nor
Gro-a were found to be associated with the development of ARDS (Donnelly,
unpublished data) or graft dysfunction following transplant (Fisher et al., 2001).
Goodman et al., (1996) have demonstrated that interleukin-8 may be responsible for over
50% of the neutrophil chemotactic activity of BAL fluid in patients with established
ARDS, with comparatively little contribution from other CXC chemokines. Clearly
therefore factors other than IL-8 also play a role in pulmonary neutrophil chemotaxis.
Leukotiene B4 (LTB4), a myeloid-cell product derived from arachadomic acid, is
chemotactic for neutrophils (Ford-Hutchinson et al., 1980) and macrophages (Hubbard et
al., 1991). In chronic inflammatory lung disease, namely COPD and bronchiectasis,
LTB4, together with IL-8, is regarded as a major neutrophil chemoattractant (reviewed in
Hill et al., 2000). The complement protein C5a, a product of classical complement
cascade activation, is also potent neutrophil chemoattractant (Strunk et al., 1988). In
patients at-risk of ARDS, plasma and BAL levels of LTB4 have been found to be higher
than in controls (Stephenson et al., 1988; Antonelli et al., 1994). Similarly, raised plasma
levels of C5a have been reported in at-risk patients (Weinberg et al., 1984; Duchateau et





ARDS Jorens et al, 1992; Miller et al., 1992; Chollet-
Martin et al., 1993, Donnelly et al., 1993; Torre et
al., 1993; Hirani et al., 2001
Asthma Marini et al., 1992; Folkard et al., 1997; Gibson et
al., 1997
Chronic brochitis and emphysema Richman-Eisenstat et al., 1993; Hill et al., 1999;
Crooks et al., 2000
Bronchiectasis Mikami et al., 1998
Idiopathic pulmonary fibrosis Lynch et al., 1992; Southcott et al., 1995; Keane et
al., 1997; Panteladis et al., 1997
Cystic fibrosis Khan et al., 1995
Bacterial pneumonia Rodriguez et al., 1992; Bohnet et al., 1997
Post-transplant lung injury Fisher et al., 2001
Neonatal bronchopulmonary dysplasia McColm and Mcintosh, 1994; Groneck et al., 1994;
Tullus et al., 1996; Munshi et al., 1997; Ghezzi et
al., 1998
Acute chest syndrome in sickle cell disease Abboud et al., 2000
High Altitude Pulmonary Oedema Kubo et al., 1996
Lung cancer Strieter et al., 1995; Arenberg et al., 1996A and
1996B; Yatsunami et al., 1997; Yuan et al., 2000
Sepsis Hack et al., 1992, Marty et al., 1994; Endo et al.,
1995; Fujishima et al., 1996; Takala et al., 1999; Lin
et al., 2000
Multi-organ dysfimction syndrome Hamano et al., 1998; Slotman et al., 2000;
Holzheimer et al., 2000
Glomerulonephritis Wada et al., 1994; Lai et al., 1996; Ralston et al.,
1997; Sekikawa et al., 1998
Cerebral infarction or head injury Kostulas et al., 1998; Whalen et al., 2000
Inflammatory bowel disease Mahida et al., 1992; Gibson and Rosella, 1995
Pancreatitis Gross et al., 1992; Chen et al., 1999
Rheumatoid arthritis Brennan et al., 1990; Deleuran et al., 1994; Woods
et al., 2000
Psoriasis NickoloffBJ etal., 1991;Biasi etal., 1998
Table 1.2.1 Human diseases in which IL-8 has been implicated
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1.3. THE MACROPHAGE
The term 'macrophage' was proposed by Metchnikoff in the late 19th century to describe
a large cell, present in connective tissues and fluids throughout the body, with a
propensity to phagocytosis (Metchinkoff, 1905). Macrophages are remarkably ubiquitous
and have been identified in all animal species studied. The functional repertoire of the
macrophage extends beyond phagocytosis to include antigen presentation, anti-bacterial
activity, anti-tumour activity and secretion of an array of biologically active peptides and
proteins (Nathan et al., 1980; Auger and Ross, 1993; Seljelid and Eskeland, 1993). This
supports the view that the macrophage is fundamentally important to the integrity of the
multicellular organism.
1.3.1 Origins and tissue distribution ofmacrophages
The macrophage often exhibits a tissue-specific phenotype, such as the histiocyte in
connective tissue, the Kupffer cell in the liver and the alveolar macrophage in the lung.
The origin of these cells remained an area of controversy for many years. A series of
elegant studies in mice revealed that the resident Kupffer cell (Crofton et ah, 1978),
alveolar macrophage (Bowden and Adamson, 1980; Blusse van Oud Alblas and van
Furth, 1983) and splenic macrophage (van Furth and Diesselhoff-den Dulk, 1984) were
all principally derived from the circulating monocyte. It is now accepted that in the steady
state, the majority of tissue macrophages derive from the circulating monocyte, itself
derived from precursor cells in the bone marrow.
During an acute inflammatory process, neutrophils are the first of the blood leukocytes to
be recruited, often within 2 hours of onset. The arrival of circulating monocytes is
relatively delayed but, in contrast to neutrophils, monocytes continue to accumulate
beyond the first 24 hours (Adams, 1992; Bellingan et ah, 1996). Thus, depending upon
the stimulus, the monocyte is frequently the predominant inflammatory cell by 48 hours.
Once recruited to the inflammatory site, the monocyte differentiates into a macrophage
phenotype. Whether recruitment of blood monocytes is the predominant source of
increased tissue macrophages during inflammation remains an area of contention.
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Although van Furth and colleagues provide compelling evidence that this is indeed the
case in a variety of organs (Thomas et ah, 1976; Blusse van Oud Alblas et ah, 1981;
Blusse van Oud Alblas et ah, 1983; Diesselhoff-den Dulk and van Furth; 1979), other
investigators have demonstrated extensive local proliferation of monocytes and
macrophages (De Bakker et ah, 1985; Bouwens et ah, 1986).
1.3.2 Pulmonary Macrophages
Based on their localisation, it has been proposed that pulmonary macrophages may be
characterised into four different types; i) the alveolar macrophage, ii) the interstitial
macrophage, iii) the intravascular macrophage and iv) the dendritic cell (Lohmann-
Matthes et ah, 1994). Alveolar macrophages are located at the interface between air and
lung tissue, bathed in surfactant (a protein and phospholipid-rich lining fluid secreted by
type II alveolar epithelial cells). In healthy humans and most animals, over 90% of cells
retrieved following bronchoalveolar lavage (BAL) are alveolar macrophages (Reynolds,
1987). These mature cells remain prevalent in the lavage fluid after several washes, and
since they are the most accessible population of pulmonary macrophages, they are the
most studied. There is compelling evidence that the alveolar macrophage predominantly
derives from the circulating monocyte (Thomas et ah, 1976; Bowden and Adamson,
1980; Blusse van Oud Alblas and van Furth, 1983). The contribution from dividing
interstitial cells is relatively small under normal conditions.
1.3.3 Macrophage function in acute inflammation
The macrophage is a functionally complex cell. Many of its multiple roles are manifest in
the acute inflammatory response in which, whilst attempting to fulfil a critical role in host
defence, the macrophage has the potential to cause tissue injury (Adams and Hamilton,
1992).
1.3.3.1 Macrophage response to bacterial endotoxin
The macrophage plays a major role in the recognition, engulfment and killing of
microbial organisms. The response to bacterial invasion is triggered by interaction
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between macrophage cell surface receptors and secreted products or bacterial wall
components (Noursadeghi and Cohen, 2000), the most important of which is bacterial
endotoxin or lipopolysaccharide (LPS). At least 3 cloned macrophage cell surface
molecules are known to bind lipid A, the toxic moiety of LPS; CD14, the CD11/18 P2
leukocyte integrin family and the macrophage scavenger receptor (SR). The latter does
not possess signalling properties, but is involved in LPS processing and host defence
(Haworth R et ah, 1997). The CD11/18 integrins are capable of inducing signalling
events and macrophage activation (Ingalls and Golenbock, 1995; Ingalls et al., 1997;
Ingalls et al., 1998), but the major LPS receptor for macrophages and monocytes is
CD14.
1.3.3.2 The CD14 receptor
CD 14 is a glycophosphatidylinositol (GPI)-linked protein (Fenton and Golenbock, 1998;
Lien et al., 2000 in Update in ITU pi64). LPS in the circulation binds lipopolysaccharide-
binding protein (LBP) and the resulting complex is able to cross-link CD 14 on the cell
(Tobias et al., 1993). Soluble CD14 receptor also binds LBP, and this complex can confer
endotoxin responsiveness in CD 14 deficient cells such as endothelial cells (Tapping and
Tobias, 1997). Genetically engineered CD14 deficient mice are completely resistant to
endotoxin induced death (Haziot et al., 1996). Deletion of murine LBP greatly diminishes
LPS responsiveness ex-vivo, but the in-vivo effects of endotoxaemia are similar to wild-
type mice (Jack et al., 1997; Wurfel et al., 1997). LBP is an acute phase protein and is
likely to play a complex role in host defence; its function depends on its concentration
which in turn varies in response to systemic inflammation (Lien et al., 2000).
CD 14 protein lacks transmembrane and intracellular domains and contains no known
signalling motifs. It has subsequently been demonstrated that CD 14 acts by associating
with a distinct transmembrane signal transducing protein of the Toll family (Yang et al.,
1998; Kirschning et al., 1998). The Toll and Toll-related proteins are a widely conserved
family of innate immune recognition receptors. To date at least 8 mammalian Toll-like
receptors (TLR) have been recognised (reviewed in Means et al., 2000). It was initially
believed that TLR2 was the primary signalling receptor in human cells, but this
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observation may require reinterpretation following the report that commercial
preparations of LPS typically contain highly bioreactive contaminants generically mis-
termed endotoxin proteins (Hirschfeld et al., 2000).
1.3.4 Macrophage and inflammatory cytokines
The cytokine superfamily of low molecular weight proteins includes interleukins, growth
factors, colony stimulating factors, tumour necrosis factor (TNF) and chemokines. The
tremendous range of activity demonstrated by these proteins implicates cytokines as
having potential roles in the initiation, maintenance and resolution of inflammation.
Depending upon state of activation and stimulus, the macrophage has the capacity to
generate a plethora of cytokines and express complementary receptors, demonstrating
potential autocrine regulation. The cytokines TNF-a, IL-1, IL-6 are discussed in
Chapters 1.1.5 and the chemokine IL-8 is discussed in Chapter 1.2.3.
1.3.5. Role of the macrophage in inflammatory diseases
The proposition that the macrophage plays a central role in the inflammatory process is
supported by studies in macrophage-depleted animals. Several techniques for selective
macrophage depletion, including delivery of liposome-encapsulated toxic agents that are
preferentially taken up by macrophages, have been described (van Rooijen et al., 1997).
Macrophage depletion studies have highlighted the double-edged nature of macrophages
in both host defence and in tissue injury. Acute inflammation in the lung (Sone et al.,
1999; Ofulue and Ko, 1999; Zhang-Hoover et al., 2000), kidney (D'Souza et al., 1999),
joints (Richards et al., 1999, Barrera et al., 2000), brain (Zito et al., 2001) has been shown
to be attenuated by selective macrophage depletion. In contrast, studies of endotoxaemia,
for example, have revealed enhanced tissue injury and lethality following macrophage
depletion (Groeneveld et al., 1988; Nieuwenhuijzen et al., 1993).
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1.3.6 Macrophage studies in vitro
In vitro studies of human macrophages are limited by the relatively difficulties in
efficiently extracting tissue macrophages. Whilst alveolar macrophages are relatively
accessible, bronchoalveolar lavage still represents an invasive procedure. Peripheral
blood monocytes are in contrast relatively accessible. In the presence of serum, adherent
cultured monocytes undergo maturation changes consistent with differentiation into
macrophages (Johnson et al., 1977)
Since the macrophage is intimately associated with the inflammatory process, studying its
adaptation and response to the local micro-environment is a salient area of research.
Hyperthermia, acidosis and glucose deprivation are all relevant to inflamed tissue. Tissue
oxygenation may however be particularly relevant to a variety of human diseases.
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1.4.TISSUE OXYGENATION
1.4.1. Oxygenation in Health
1.4.1.2. Ventilation, perfusion and gas exchange
The percentage of oxygen in inspired air (Fi02) is constant at 21%. At normal
atmospheric pressure the PO2 of dry air is 21.3 KPa. However as oxygen is transported
into the lungs through to the alveolar capillary interface the PO2 progressively falls. These
initial step-wise reductions in PO2 (Figure 1.4.1) represent the effects of humidification,
and more importantly, the effect of constant oxygen uptake and of CO2 addition. Hence,
the 'normal' alveolar PO2 is approximately 13.6 KPa. This figure represents a mean
value, as it should be emphasised that even in a healthy lung there are regions of
comparatively high and low ventilation and high and low perfusion. This implies
significant ventilation / perfusion (V/Q) mismatch resulting in alveolar units that are
relatively hypoxic, and hyperoxic compared to the mean. Although actual measurements
of PO2 within individual units is not technically feasible, indirect methods have shown
that the mean alveolar P02 is greater than 17.5 KPa near the lung apex but less than 12
KPa at the base (West, 1985). This V/Q mismatch is the major cause of a further stepwise
reduction in PO2, such that the mean systemic arterial blood P02 is around 11.5 KPa. The
diffusion of oxygen across the alveolar / capillary membrane is a passive process.
However since the diffusion distance is small (<0.5 pM) and the diffusion gradient high
(8 KPa on average), oxygen floods into the bloodstream. Equilibrium between capillary
and alveolar oxygen is attained within 0.25 seconds of the average 0.75 seconds that a red
blood cell is in transit through the gas exchange portion of a capillary.
1.4.1.3. Oxygen Transport in Blood
Oxygen is principally transported bound to haemoglobin (Hb), a complex four
polypeptide protein. Oxygen dissolved in plasma when breathing 21 % oxygen is
normally negligible compared to that carried by haemoglobin. One gram of Hb is able to













Legend for Figure 1.4.1 Oxygen tension from atmosphere to mitochondria.
There is a progressive reduction in P02 from air to the to site of oxidative
phosphorylation, the mitochondria.
even when exposed to relatively low oxygen tensions, Hb is over 95% oxygen-saturated.
It is only as PO2 falls below 7.5 KPa that Hb becomes rapidly desaturated, such that P50
(defined as the oxygen concentration at which 50 % of the Hb is saturated) is 3.5 KPa.
Oxygen content of the blood can be calculated as follows:
Oxygen content = 1.39 x Hb concentration x percentage saturation + 0.003 x PO2
Hence a healthy individual with normal Hb level of 15 g / 100 ml blood, is potentially
able to carry 20.8 ml oxygen per 100 ml of blood (1.39 x 15x1 + [0.0003 x 11.5]).
1.4.1.4. Tissue Oxygenation
The primary site of oxygen utilisation is at the tissue level, wherein the generation of
high-energy phosphate bonds (ATP) via the mitochondrial electron transport chain is
O2 dissolved in plasma
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fundamental to normal cell function and survival. Constant oxygen utilisation by tissues
results in a gradient favouring release of oxygen from Hb. This chemical release is further
enhanced by the effects of raised temperature, increased PCO2 and lowered pH and
increased 2,3 diphosphoglycerate concentration, all features of metabolically active
tissue. The released oxygen passively diffuses through the endothelium and surrounding
tissue to mitochondria. Potential diffusion distances vary between tissues. In the left
ventricle, each capillary serves a cellular zone of approximately 12.5 pm. The
corresponding figure is 20 pm in the brain and 200 pm in skeletal muscle. In poorly
vascularised tissue such as fat and cartilage diffusion distances are greater still. Hence,
the PO2 at the mitochondrial level is considered to be 0.7-1.3 KPa. (Gayeski and Honig,
1986; Leach and Treacher 1998). Although incompletely understood, perfusion and
diffusion distances are part of the explanation for the observation that in healthy resting
adults only about 25 % of delivered oxygen is extracted by tissues.
1.4.1.5. Mitochondria - the site of oxidative phosphorylation
The mitochondrial electron transport chain (Figure 1.5.2) is the site of ATP production
under normal conditions. Virtually all cellular processes are driven by the energy released
when ATP undergoes hydrolysis to form adenosine diphosphate (ADP) and inorganic
phosphate (Pi). The generation of ATP occurs through a series of redox reactions, in
which electrons are transferred step-wise from nicotine adenine dinucleotide (NADH)
and flavin adenonine dinucleotide (FADH2), to the terminal electron quencher, oxygen.
The transfer occurs through a series of intermediate complexes (I, III and IV) of
progressively lower reducing potential. Each complex contains redox-active electron
carriers, several of which are located in the inner mitochondrial membrane. As each
electron is accepted, the energy released is used to actively pump protons (H+) from the
miochondrial matrix into the intermembrane space. An electrochemical gradient is thus
created across the inner membrane. The presence of this gradient drives hydrogen ions
through a mitochondrial enzyme, the F0FiATPase, that in turn catalyse the formation of
ATP from ADP and Pi.
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1.4.2. Causes of hypoxia
In 1920, Barcroft proposed a form of classification for the causes of hypoxia. With minor
modifications over time, this classification is still widely applied: (1) hypoxic hypoxia, in
which the PO2 of the arterial blood is reduced (termed hypoxaemia); (2) anaemic
hypoxia, in which arterial PO2 is normal but reduced haemoglobin lowers oxygen
carrying capacity in blood; (3) ischaemic or stagnant hypoxia, a consequence of impaired
blood flow to tissues; (4) histotoxic or cytopathic hypoxia, in which despite adequate
oxygen delivery, the tissue is unable to take up or utilise oxygen.
1.4.2.1. Hypoxic Hypoxia
Maintenance of adequate systemic arterial PO2 is dependent upon normal pulmonary
function. Physiologically, there are five primary mechanisms that may result in
hypoxaemia (a reduction in arterial PO2):
i. A reduction in inspiratory oxygen fraction (Fi02). This is most commonly a
consequence of increasing altitude. Atmospheric pressure decreases with distance
above sea-level in an approximately exponential manner. The pressure at 5500
meters is 50% of the sea-level value, resulting in a FiC>2 of approximately 10 KPa.
This results in a corresponding fall in alveolar PO2 to around 5.5 KPa and as a
consequence the 'driving' pressure gradient across the alveolar / capillary membrane
is reduced leading to hypoxaemia.
ii. Hypoventilation. Alveolar PO2 is a balance between rate of oxygen removal by
blood and replenishment through alveolar ventilation. Hypoventilation secondary to
reduced central drive to breath, weakness of respiratory muscles or injury /
deformity of the thoracic cage results in reduced alveolar PO2 (and increased PCO2)
and consequently arterial hypoxaemia.
iii. Diffusion impairment. As previously described, the diffusion of oxygen across from
alveolus to red blood cell is rapid and efficient in healthy lungs. In theory diseases in
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which the alveolar / capillary membrane is thickened, such as in idiopathic
pulmonary fibrosis, result in hypoxia secondary to impaired diffusion. In reality V/Q
mismatch and shunt are likely to make a greater contribution to hypoxia than
diffusion impairment in such diseases.
iv. Shunt. This refers to deoxygenated blood entering the systemic circulation without
passing through ventilated areas of lung. In normal health, a proportion of
deoxygenated bronchial artery and coronary venous blood is shunted directly into
the pulmonary veins and left ventricle respectively. This has a near-negligible effect
on arterial PO2 and is often termed anatomical shunt, or more appropriately, venous
admixture. In diseased lungs in which, for example, there is atelectasis (alveolar
collapse) and consolidation, as occurs in ARDS, shunting is an important
contributor to hypoxaemia.
v. V/Q mismatch. As described previously, a normal lung exhibits areas in which
ventilation and perfusion are not equally matched, and is the main reason arterial
P02 is usually slightly lower than average alveolar P02. Exaggerated V/Q
mismatch is probably the most important contributor to hypoxia in most primary
lung diseases including chronic obstructive pulmonary disease (COPD), diffuse
parenchymal lung disease and ARDS.
1.4.2.2. Anaemic hypoxia.
A healthy individual with normal Hb level of 15 g / 100 ml blood, is potentially able to
carry 20.8 ml oxygen per 100 ml of blood. An anaemic patient with a Hb of 10 g / 100
ml, assuming normal gas exchange, will display a normal arterial PO2, since the affinity
of each Hb molecule to oxygen remains high and gas exchange is unaffected. However
the total oxygen carrying capacity of the blood is reduced by 1/3 to around 13 ml oxygen
per 100 ml blood, potentially leading to tissue hypoxia.
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1.4.2.3. Stagnant or ischaemic hypoxia
This represents a spectrum of pathology from insufficient circulation or perfusion, as may
occur during periods of systemic hypotension, through to complete blood stasis, as occurs
in vascular occlusion. The tissue response to ischaemic hypoxia represents not just the
effects of oxygen deprivation but also the effects of accumulation of waste products.
Blood flow in the centre of a wound is reduced due to thrombosis in the microcirculation.
1.4.2.4. Histotoxic or cytopathic hypoxia
This term refers to impaired cellular utilisation of oxygen such that mitochondrial ATP
generation is reduced despite adequate oxygen supply. This includes exposure to specific
toxins and genetic defects in cellular respiration. Cyanide, sodium azide and rotenone are
potent inhibitors of the mitochondrial electron transport chain and in that respect mimic
severe hypoxia. A number of rare neurological or systemic diseases are caused by
mitochondrial DNA mutations impairing oxidative phosphorylation (reviewed by Johns,
1995). In clinical practice however, it is becoming clear that impaired oxygen utilisation
is not restricted to the models described. In patients with severe sepsis, tissue oxygen
uptake is thought to be impaired. Endotoxin, the lipopolysaccahride (LPS) component of
the outer membrane of Gram-negative organisms, is implicated in the pathogenesis of
sepsis and has been shown to impair oxygen utilisation in vitro (James et al., 1995;
Motterlini et al., 1998). Studies have demonstrated that this impaired utilisation occurs at
the mitochondrial level (Bankey et al., 1994; Zingarelli et al., 1997), though the precise
site of action within the electron transport chain is debated (Fink, 2000).
1.4.3. Methods for measuring cellular and tissue P02
An accurate measurement of oxygen tension at a cellular level is a desirable aim for
experimental studies and in the clinical arena. Direct measures of P02 would seem
desirable, but in the clinical settings, an indirect measure is often more practical.
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1.4.3.1. Polagraphic electrode and optical probes
A commonly used method for directly measuring tissue oxygenation is through
polagraphic electrode and more recently optical probes. Polagraphic probes (e.g. the
Clarke electrode) comprise a platinum electrode and a silver counter / reference electrode
inside a stainless steal sleeve. A gas permeable membrane fits over the sleeve and allows
oxygen to diffuse through it, whereupon it is reduced at the platinum electrode. The
magnitude of the electrical current generated is determined by the rate of diffusion to the
electrode, which is proportional to the partial pressure of oxygen outside the membrane.
Such probes have been used to measure tissue PO2 in clinical and animal studies
(Dewhirst et ah, 2000; Yeh et ah, 1995). Technological advances have resulted in
electrode tips sufficiently small to measure intracellular levels of oxygen (Lau et ah,
1992). The efficacy and reproducibility of one particular system (Eppendorf) has been
demonstrated in a number of studies (reviewed in Dewhirst et ah, 2000). However, there
are concerns that in biological systems, interference from tissue ions may disrupt
miroelectrode measurements.
Fibre optic probes have also recently been developed to measure tissue oxygenation
directly (Collingridge et ah, 1997). A fluorescent or phosphorescent dye (e.g. a
porphyrin) is placed on the tip of a glass fibre which is clad in an oxygen permeable
membrane. The dye is illuminated with blue light from a laser and the lifetime
(quenching) of the resultant fluorescent signal is inversely proportional to the amount of
molecular oxygen in the tissue. As with electrode probes, the membrane may be
susceptible to fouling in the presence of proteins. In addition, neither the polagraphic nor
optic probe methods would be suitable for measuring PO2 in multiple cells or multiple
sites simultaneously.
1.4.3.2 Near infrared spectroscopy (NIRS)
Non-invasive methods, such as NIRS represent a potentially useful method for measuring
tissue oxygenation (Jobsis, 1977). The oxygenation status of haemoglobin, myoglobin
and cytochrome oxidase alters the wavelength and intensity of absorption of near infrared
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light, which may be measured spectrophotometrically. NIRS has been used to assess
hepatic (El-Desoky et al., 2001), cerebral (Hayakawa et ah, 1996; Madsen and Secher,
1999), cardiac (Van Beek et ah, 1996), lung (Okimasa et ah, 2001) and skeletal muscle
(McKinley et ah, 2000) tissue oxygenation. However, absorption signals from ischaemic
tissue is not often homogenous, and the technique does not distinguish oxygenation in
circulating blood from that in tissue.
1.4.3.3. Direct chemical and biological markers of hypoxia
Recently, the phosphorescence quenching principle described for optic probes (1.4.3.1 )
has been adapted to achieve non-invasive measurement of tissue PO2. The quenching in
rat skeletal muscle of a phosphorescent dye injected intravenously was measured by laser
microscope (Shibata et ah, 2001). This technique requires sophisticated hardware. A
number of investigators have reported the use of specific drugs that selectively bind to
hypoxic cells as a means of identifying hypoxic cells in tumours (Evans et al., 2000;
Raleigh et al., 1996) in sepsis models (Hotchkiss et al., 1991) and in lung injury
(Vujaskovic et al., 2001). These drugs are generally 2-nitroimadazole compounds and are
lipophilic and freely diffusible, readily traversing cell membranes (reviewed in Hodgkiss,
1998). The drugs are metabolised (reduction of the nitro-group) in the presence of
oxygen. In hypoxia, bioreduction does not occur and the drug is converted to highly
reactive free radical molecules that bind to proteins and DNA. The drug metabolites may
be detected in tissue sections with anti-nitroimadazole antibodies (Raleigh et al., 1996,
Arteel et al., 1998). Alternatively, if the drug is pre-labelled with an isotope, hypoxic
tissue may be identified by positron emission tomography (PET) and related imaging
modalities.
A limitation of chemical markers of hypoxia is that quantifying tissue oxygenation is
difficult. There is evidence that as oxygen concentration falls from -3-10 %, drug binding
progressively increases to reach a maximum under anoxic conditions (Rasey et al., 1987;
Rasey et al., 1989). However, bioreductive drugs may be more reliable as markers of
presence or absence of hypoxia.
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The 2-nitroimadazole compounds appear to be non-toxic and have been used to study to
tumour hypoxia in patients. However, an attractive proposition may be the detection of a
naturally occurring marker of cellular hypoxia. Hypoxia-inducible factor-la (discussed in
detail in Chapter 1.5.) is a novel basic helix-loop-helix protein, that in vitro cell culture
is thought only to be expressed at PO2 < 5KPa (Huang et al., 1996). In keeping with this
is the finding that in range of normal tissues obtained at biopsy, HIF-la expression was
negligible, compared to significant expression in a variety of tumour biopsy specimens
(Talks et ah, 2000). In contrast however, Stroka et al., 2001 have demonstrated basal
HIF-la expression in brain, kidney, liver, heart and skeletal muscle of mice under
normoxic conditions, with upregulation following hypoxia. Hence, the premise that HIF-
la may only be expressed under hypoxic conditions may not be valid. Indeed, there is a
growing body of evidence that non-hypoxic pathways may induce HIF-la expression
(Hellwig-Burgel et ah, 1999; Feldser et ah, 1999; Haddad and Land, 2001).
1.4.3.4. Markers of oxygen metabolites
Rather than direct measures of molecular oxygen, detection of an oxygen metabolites
such as reactive oxygen species (ROS) have been studied in cell culture systems. A
variety of fluorescent probes are available (Molecular Probes, Eugene, OR) that in the
presence of ROS display a detectable change in fluorescence. Such probes have been
used in studies of hypoxic cells in culture (Vanden Hoek et ah, 1998; Asiedu et ah, 2001).
However, the precise effect of hypoxia on ROS generation is an area of considerable
debate (Chapter 1.5.5), and studies with fluorescent probes demand the use of stringent
controls.
The direct measures of hypoxia dicussed thus far are largely experimental or require
further validation before routine use in clinical practice. In general, measures of tissue
hypoxia in the clinical setting tend be indirect, and these are discussed in the context of
the critically ill patient.
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1.4.4. Hypoxia in the critically ill patient
'Critical illness' in the context of this thesis is a term that encompasses acute medical
conditions, which have in common a requirement for early medical intervention, close
monitoring and carry a significant risk of death. Such patients are optimally managed in
the setting of an intensive care unit (ICU). The spectrum of disease is wide, but sepsis,
trauma, haemorrhage, aspiration injury and pancreatitis are common precipitants for ICU
admission. A characteristic feature of severe disease of this type is the development of
SIRS (Figure 1.1) which may in turn progress to MODS and ARDS.
Systemic and tissue hypoxia is of particular relevance in patients with critical illness. It is
apparent that the spectrum of disease in such patients not only causes hypoxia through a
variety of mechanisms, but also that hypoxia may itself contribute to the progression of
disease and development ofwidespread tissue injury and organ failure.
1.4.4.1 Causes of hypoxia in the critically ill
A number of factors contribute to systemic and tissue hypoxia in critically ill patients. In
patients with major trauma, haemorrhage and hypotension are often self evident, as is
pulmonary shunting in a patient with lobar pneumonia. A significant proportion of
patients develop impaired gas exchange secondary to acute lung injury and ARDS. More
subtle causes of tissue hypoxia are believed to occur at a microvascular level in patients
with SIRS. In such patients, particularly if associated with sepsis, there is evidence of
altered distribution of blood supply between organs (Viires et ah, 1982; Lang et al., 1984;
Fong et al., 1990; Duranteau et ah, 1996), within organs (Carlton et ah, 1976; Ratcliffe et
ah, 1986; Kreimeier et ah, 1990; Drazenovic et ah, 1992), and reduced oxygen uptake
(Bredle et ah, 1989; Simonsen et ah, 1994; Fink, 2000). These factors all contribute to
extreme tissue oxygen deprivation (Uusaro and Russell, 1999; Evans and Smithies,
1999).
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1.4.4.2. Hypoxia as a cause of tissue injury and MODS
Whilst it is generally accepted that the development of MODS is multifactorial (Bone,
1996) there is evidence that tissue hypoxia is itself a significant contributor to the
pathophysiology of organ failure. The profound effects of hypoxia on normal homeostasis
in the in vitro and animal studies make this an attractive proposition. Evidence from
human studies is more circumspect. This reflects the difficulties associated with
measuring tissue oxygenation and correlating this with outcome in a complex disease.
The relatively few prospective studies to date that have attempted to investigate this have
used indirect measures of tissue oxygenation. Accepting the inherent flaws in such
methods, the weight of evidence favours an association between the degree of tissue
hypoxia and development ofMODS.
Oxygen debt is a reasonable measure of tissue hypoxia. However, there have been no
prospective studies that have directly investigated an association between oxygen debt
and MODS. In a small number of studies, interpretation of the available data does allow
this measure to be made. In post-operative patients, those who maintained higher levels
of oxygen delivery (DO2) and oxygen consumption (VO2) and hence lower oxygen debt,
showed a reduction in the progression to multiple organ failure and a 4-5 fold reduction
in mortality (Hayes et al., 1994; Brealey and Singer, 2000). In a study of different
ventilation strategies in ARDS, patients with high oxygen debt had excess mortality and
MODS (Spec-Marn et ah, 1993; Uusaro and Russell, 1999).
Blood lactate is an indirect measure of anaerobic respiration, though factors other than
tissue hypoxia may influence lactate metabolism (James et ah, 1999; Gladden, 2001). In
general however, there is a direct relationship between elevated lactate concentration and
mortality in the critically ill (Broder and Weil, 1964; Vitek and Cowley, 1971; Bakker et
ah, 1991) The relationship between lactate and development of MODS appears to be
strongest in patients with multiple trauma and haemorrhage (Roumen et ah, 1993; Sauaia
et ah, 1994; Moore et ah, 1992; Manikis et ah, 1995).
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It has long been recognised that splanchnic hypoxia may be associated with the
development of organ failure (Rowell et ah, 1968; Price et ah, 1966). Several studies
have identified an association between reduced gastric mucosal pH, a measure of
splanchnic hypoxia, and the development of MODS following trauma (Miller et al.,
1996), sepsis (Marik, 1993) and following major surgery (Doglio et ah, 1991; Mythen
and Webb, 1994).
Hypoxia is clearly detrimental to health. As such, a fundamental therapeutic target in the
critically ill patients is to improve tissue oxygenation, primarily through increased oxygen
supply. Oxygen however is a toxic molecule, and hyperoxia itself an important cause of
tissue injury.
1.4.5. Hyperoxia and disease
Joseph Priestly, the discoverer of the O2 molecule in 1774, not only recognised it as "an
air five or six times as good as common air", but also foresaw its "adverse effects on the
healthy state of the body" (cited in Partington, 1989).
In evolutionary terms, it has been suggested that the diversification of multicellular
organisms has in part been an adaptive response to the progressive rise in atmospheric
oxygen from negligible levels to its current level over millions of years (Knoll, 1996).
Adaptation has harnessed the potential for molecular oxygen to be converted to energy,
whilst developing host defences to protect against toxic oxygen metabolites (Shanklin,
1969; Fridovich, 1978). The rapid acclimatisation of the new-born from an intrauterine
PO2 of 3-4 KPa to one of 20 KPa within the first few postnatal breaths is testament to the
efficiency of these host defences. This ontogenic event represents an innate response to
relative hyperoxia. In human disease, true hyperoxia is invariably a consequence of
therapeutic delivery of oxygen, and as such hyperoxic tissue injury is a phenomenon of
the modern age.
The brain and the neonatal retina are susceptible to hyperoxic injury (Hunter and Mukai,
1992). However, the lung is often exposed to the highest concentrations of oxygen and is
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particularly susceptible to its toxic effects. Much of the damage to cellular DNA, lipids
and proteins is believed to be mediated by reactive oxygen species (ROS), which include
superoxide anion (O2) hydrogen peroxide (H2O2), hydroxyl radical (OH) and
peroxynitrite (ONOO) (Thannickal and Fanburg, 2000; O'Reilly, 2001).
In adult lungs, delivery of 100% oxygen results in characteristic progressive
morphological changes in the lung (Crapo JD, 1986). Within the first 24 hours of
exposure there is little evidence of inflammatory injury. Atelectasis caused by lack of
unabsorbed alveolar nitrogen is evident (Wagner et ah, 1974) but these and any other
functional abnormalities of the lower respiratory tract are transient (Sackner et ah, 1975;
Singer et ah, 1970). Davis et ah, (1983) showed healthy humans exposed to 17 hours of
100% oxygen developed mild but significant lung leak, as measured by protein in BAL
fluid, without inflammatory cell influx. Exposure to these concentrations beyond two to
three days leads to alveolar-capillary wall oedema, neutrophil infiltration, lung protein
leak and hyaline membrane formation; broadly the pathological features of ARDS
(Hasleton, 1981; Sevitt, 1974; Katzenstein, 1976). It is apparent that prolonged exposure
to 100% O2 usually occurs in the context of a ventilated patient with existing
parenchymal lung injury. As such, the toxic effects of oxygen may not be distinguishable
from the underlying disease or from the effects of ventilation (Carvalho et ah, 1998).
However, the association between oxygen delivery and bronchopulmonary dysplasia
(BPD) in non-ventilated neonates supports the notion that 100% oxygen induces lung
injury. At inspiratory concentrations of <50% oxygen toxicity, even after prolonged
exposure, is unlikely to occur (Hayatdavoudi et ah, 1981).
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1.5. THE CELLUAR RESPONSE TO HYPOXIA
Cellular responses to hypoxia appear to be a universal phenomenon; all mammalian cells
and, it is speculated, all bacteria, yeast, invertebrates and vertebrates are able to sense and
respond to hypoxia (Semenza, 1999). The cellular response to hypoxia is determined by:
1) the individual cell phenotype, 2) the degree of oxygen deprivation (anoxia versus
hypoxia) and the period of oxygen deprivation (acute or chronic).
1.5.1. Cell Phenotype and hypoxic response
Whilst all mammalian cells display oxygen-sensing capabilities, some have evolved
specialist oxygen sensing roles. Cells in the carotid body, airway neuroepithelial bodies
and pulmonary arteries mediate homeostatic cardiovascular and pulmonary responses to a
reduction in arterial or alveolar PO2. A reduction in arterial PO2 is sensed by the glomus
type 1 cells of the carotid body. This triggers release of transmitters that determine
afferent nerve discharge, stimulating the brain stem to increase ventilation (McDonald,
1981; Donnelly, 1996). Membrane depolarisation secondary to inhibition in K+ channel
conductance is a charactersitic feature of the hypoxic response in these cells (Lopez-
Barneo et al., 1988). The precise signal transduction pathway from hypoxic sensing to
change in K+ channel activity remains elusive. It has been demonstrated that the sensing
mechanism in these specialist cells may be independent of intracellular events, since even
excised patches of membrane retain an O2 sensing function (reviewed in Haddad and
Jiang, 1997). However there is also evidence that many of the proposed sensing
mechanisms discussed in Chapter 1.5.5 are likely to be applicable to specialist and non-
specialist cells alike.
1.5.2. Anoxia versus hypoxia
Although there is considerable overlap, the cellular response to anoxia differs from its
response to relative hypoxia. Sustained anoxia inevitably leads to cell death; hypoxia,
whilst potentially lethal, may induce a range of adaptive responses (summarised in
Figure 1.5.1).
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Although the nomenclature in the literature is inconsistent, here anoxia refers to a state in
which diffusion of oxygen to the mitochondria falls to below the level required to sustain
oxidative phosphorylation (the critical PO2 or Pcn,) and hypoxia refers to a state in which
oxidative phosphorylation and ATP generation is impaired, though not necessarily
abolished.
1.5.2.1. Bioenergetic response to anoxia
In anoxia, the demand for ATP can be met only through anaerobic glycolysis (the
'Pasteur effect'). This offers limited respite. In most cells, glycolysis can maximally
generate less than 20% of the ATP produced through aerobic mitochondrial
phosphorylation. The stores of fermentable substrate are limited and end-products,
primarily lactic acid, are toxic. As ATP declines therefore, there is failure of the ion-
motive ATPases, followed by membrane depolarisation and uncontrolled influx of Ca2+.
The rise in free cytosolic Ca2+ activates Ca2+- dependent phospholipases and proteases,
hastening further membrane depolarisation and consequently cell swelling and death
through necrosis (Hochachka, 1986). The time of survival is to some extent dependent
upon cell type. Animal studies have revealed that neuroglial cells lose physiological
function within 1 minute, whereas skeletal muscle remains viable for several hours
(Jones, 1996). In vitro, some cell-types are able to adapt to anoxia through 'metabolic
depression'- downregulation of selected ATP-utilising systems, and this may account for
the differing survival times of anoxic tissues. Hepatocytes for example have significant
capacity to arrest non-essential protein synthesis, channelling the energy spared to critical
membrane ion transport activity (Buc-Calderon et al., 1993).
1.5.2.2. Bioenergetic response to hypoxia
In contrast to anoxia, most mammalian cells exhibit a range of adaptive responses to
sustainable levels of hypoxia (Figure 1.5.1). At the mitochondrial level, oxygen supply is
insufficient to maintain maximal ATP generation. There is a change in the reducing
capacity of the electron transport chain, resulting in channelling of some of the energy
reserved to maintain the proton-motive force to the generation of ATP in the
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mitochondrial matrix (Jones, 1996). Studies have revealed that in some cells a degree of
metabolic depression can occur. Cardiac myocytes are able to suppress metabolic rate by
up to 50% without loss of viability (Budinger et al., 1998). This phenomenon does not
imply that hypoxia is without repercussion for cell survival. Not all cells are able to
display such bioenergetic adaptive response, and even in those that do, the dramatic
reduction in ATP will impair ion-motive ATPases. Glycolysis is stimulated at levels
above Pcrit and even small reductions in pH can cause lysosomal rupture and release of
degredative enzymes into the cytoplasm (Ichihara et al., 1991). Uncoupled electron flow
through the mitochondrial chain can result in toxic ROS generation. These mechanisms
may lead to cell death by necrosis, identical to anoxia-induced death but at a slower rate.
Recently however it has become apparent that in addition to necrosis, hypoxia can induce
death through apoptosis.
1.5.3. Hypoxia and apoptosis
Apoptosis, the phenomenon of programmed cell death, is classically characterised by cell
shrinkage, nuclear condensation and pronounced membrane blebbing (Wylie, 1981).
Hypoxia (> 0% O2) has been shown to induce apoptosis in a variety of tumour cell lines,
including HT29 adenocarcinoma cells (Yao et al., 1995), MCF-7 breast cancer cells
(Amellem et al., 1997) and PC-12 cells (Tsujimoto et al., 1997). Similarly, primary
cultures of sympathetic neurons (Rosenbaum et al., 1994) and hepatocytes (Shimizu et
al., 1996) have been shown to undergo apoptosis in hypoxic conditions. However, the
effect of hypoxia on cell survival appears to be more complex than might be surmised
from these data. In thymocytes, rapid induction of hypoxia (0.1% O2) protects against
dexamethasone-induced apoptosis but prolonged exposure to severe hypoxia increased
spontaneous apoptotic cell death (Stefanelli et al., 1995). Recent studies have suggested
the presence of 02-dependent and (^-independent apoptotic pathways in thymocytes
(Torres-Roca et al., 2000).
Myeloid cells, at least in culture, may be particularly tolerant to oxygen deprivation.
Human monocyte-derived macrophages were found not only to be viable for up to 48
hours in a 2% oxygen atmosphere, but also to increase expression of ORP150 (oxygen-
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regulated protein 150 kDa), a novel protein which may convey protection from apoptosis
(Tsukamoto et al., 1996). Extended cell survival has also been described in hypoxic
compared to normoxic neutrophils in vitro (Hannah et al., 1995).
The signalling events that determine cell survival, death through apoptosis or death
through necrosis following oxygen deprivation are elusive. The modulation of
intracellular ROS may be relevant, but pharmacological manipulation of ROS does not
necessarily mimic the effects of hypoxia (Torres-Roca et al., 2000). It has been proposed
that intracellular ATP levels are a determinant of the mode of cell death; if ATP is
depleted then death occurs through necrosis, whereas ATP availability favours apoptosis
































Legend for Figure 1.5.1. The cellular metabolic and adaptive responses to hypoxia
over time. A series of cellular events are initiated within minutes of onset of hypoxia.
These events are designed to both reduce metabolic demand and to initiate adaptive
response required for cell survival. Adapted from Boutilier and St-Pierre, 2000, with the
kind permission of the authors.
1.5.4. Hypoxic gene regulation
It has long been recognised that changes in gene expression are a consistent feature
amongst the adaptive responses to hypoxia,. Our understanding of the mechanisms by
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which this occurs have recently been greatly advanced by studies in the hypoxic
regulation of erythropoeitin and the subsequent discovery of hypoxia inducible factor-1
(HIF-1)
1.5.4.1. Erythropoeitin and the discovery of HIF-1
Erythropoeitin, a glycoprotein hormone required for the proliferation and differentiation
of erythroid cells (reviewed in Jelkmann, 1992), is produced in peritubular interstitial
renal and specialised hepatic cells. The finding that EPO gene transcription also occurred
in Hep3B and HepG2 human hepatoma cell lines (Goldberg et al., 1987) allowed
investigators to study its transcriptional regulation. A region in the 3'-flanking region of
the gene which appeared essential for hypoxic induction of EPO synthesis (Beck et al.,
1991; Pugh et al., 1991; Semenza et al., 1991) was identified. This 50-nucleotide (nt)
sequence, designated a hypoxia responsive element (HRE), was found to bind to a protein
(HIF-1) from nuclear extracts from hypoxic, but not normoxic Hep3B cells (Semenza and
Wang, 1992).
The hypoxic inducibilty of HIF-1 is found to be generalised, occurring in all cell types
tested (Wang and Semenza, 1993). Consistent with this was the finding that transient
transfection of the 50-nt element, coupled to a gene other than EPO (e.g. alpha-globin),
resulted in hypoxic inducibility of the coupled gene in a wide variety of cell lines
(Maxwell et al., 1993). These data strongly supported the hypothesis that much of the
machinery for hypoxia sensing and signal transduction is shared between different cell
types.
1.5.4.2. HIF-1 protein characterisation
Biochemical purification and DNA affinity chromatography has revealed that HIF-1 was
a heterodimer consisting ofHIF-la (120 kDa, 826 amino acids) and HIF-1 p (91/94 kDa,
774/789 amino acids) subunits. Both subunits contact DNA in the major groove at a site
containing the core sequence 5'-BRCGTGSK-3', where B is C or G or T, S is C or G, K
is G or T and R is A or G (Wang and Semenza, 1995). Subsequent protein microsequence
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analysis and cDNA cloning has revealed that both proteins contain a basic helix-loop
helix (bHLH) motif which is common to many transcription factors. This domain
mediates protein dimerisation through juxtapostion of basic amino acids from each
monomer subunit to form a functional DNA-binding domain. HIF-1 belongs to a subset
of bHLH proteins that require a second domain for efficient dimerisation. This domain is
termed the PAS domain [an acronym derived from Period (PER), aryl hydrocarbon
receptor nuclear transporter (ARNT), and single-minded (SIM)] and, as with the bHLH
domain is sited at the amino (N) terminal halfofboth HIF-la and HIF-1 p.
Analysis of HIF-1 p revealed this protein to be identical to ARNT, a ligand-activated
transcription factor involved in cellular responses to xenobiotic agents (reviewed in
Hankinson, 1995). HEF-la, in contrast, was identified as a novel bHLH-PAS protein.
Cloning experiments have greatly expanded the number of recognised bHLH-PAS
proteins and recently a protein which shows 48% sequence homology to HIF-la has been
identified by several groups independently and reported as endothelial PAS protein-1
(EPAS-1) (Tian et ah, 1997), HIF-like factor (HLF) (Ema et al., 1997), member of PAS
superfamily 2 (MOP2) (Hogenesch et ah, 1997) and HIF-related factor (HRF) (Flamme
et ah, 1997). EPAS-1, like HIF-la, is hypoxia-inducible and can dimerise with HIF-ip
and bind to similar DNA elements. Its role in gene transcription has not been as well
studied as that for HEF-la.
1.5.4.3. Regulation of HIF-1 a protein
ARNT protein is constitutively present in both cell cytoplasm and nuclei under normoxic
conditions. Hypoxia induces a moderate rise in nuclear P-subunit levels. By contrast HIF-
la protein is virtually absent in normoxic cells, but can be detected in nuclei within
minutes of hypoxic induction, reaching peak levels after 4-8 hours of continuous hypoxia
and thereafter gradually falling (Wang et ah, 1995A). The activity of HIF-1 is thought
therefore to be governed principally by the a-subunit. Under hypoxic conditions (PO2 < 5
KPa), HIF-la protein levels are detectable through enhanced protein stability (Huang et
ah, 1996; Salceda and Caro, 1997; Pugh et ah, 1997). Upon re-exposure to normoxia,
HEF-a protein rapidly decays with a half-life of <5 min. By employing a panel of peptide
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aldehydes that specifically inhibit the lysosomal proteases, calpains and the proteosome
pathways, it has been shown that HIF-la degradation occurs specifically via the
ubiquitin-proteosome pathway (Huang et al., 1998). The target for the ubiquitination
process is a regulatory element in the C-terminal region of HIF-1 termed the oxygen
dependent domain (ODD). Only complete deletion of the ODD results in a stable HIF-
la expression. Partial deletions yield varying degrees of instability (Huang et al., 1998).
Until recently, it was not known how the ODD interacted with the ubiquitin-proteosome
pathway. Maxwell et al., 1999 however showed that in renal carcinoma cell lines, the von
Hippel-Lindau protein (pVHL) physically interacted with HIF-1 a. This interaction
occurs when hypoxia activates a prolyl hydroxylase enzyme which results in
hydroxylation of a specific proline residue within the ODD (Ivan et al., 2001; Jaakkola et
al., 2001). The bound pVHL is thought to mediate covalent attachment of multiple
ubiquitin molecules to the protein complex and subsequent degradation by the 26S
proteosome (Tanimoto et al., 2000).
In addition to direct protein interactions, phosphorylation appears to play a role in HIF-
la activation (Salceda et al., 1997a). The p42/p44 mitogen-activated protein kinases
(MAPKs) (Richard et al., 1999) and the ERK MAPKs (Minet et al., 2000) have been
shown to phosphorylate HIF-la. This phosphorylation occurs primarily on serine
residues, though phosphorylation has not been shown to be either sufficient or necessary
for HIF-la stabilisation (Sutter et al., 2000).
1,5.5. Mechanisms for hypoxic sensing
The nature of the oxygen sensor in multicellular organisms is still unknown. The studies
of EPO regulation have fuelled the quest for a 'universal oxygen sensor'. Since the
bioenergetic response to hypoxia is common to virtually all mammalian cells, a
'metabolic' sensor such as ATP depletion or acidosis might seem attractive. However
since many of the adaptive responses in Figure 1.5.1 occur at PO2 levels well in excess of
the Pcrit, this is unlikely to be the case. At least 3 models for oxygen sensing have been
proposed.
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1.5.5.1. A haem-protein model for oxygen sensing
One postulated mechanism is ligand/receptor model, whereby oxygen binds to a specific
receptor inducing downstream signalling. Given the peculiar properties of oxygen
however, there are relatively few molecules to which it may bind. Oxygen is known to
bind to and react with haem proteins and indeed in the bacterium Rhizobium meliloti, the
oxygen sensor is an integral membrane haem-containing kinase (FixL) whose activity is
modulated by 02-binding (Gilles-Gonzales et al., 1991). Haem proteins have thus been
suggested as candidate 02-sensors in mammalian cells such that in hypoxic conditions the
sensor switches from an'oxy' to a 'deoxy'-haemoprotein state (Goldberg et ah, 1988).
The strongest evidence for this comes from studies in which carbon monoxide (CO) has
been shown to disrupt the hypoxic signalling pathway (reviewed in Zhu and Bunn ,
1999). CO displays avid binding affinity to ferrous haem groups in proteins such as
haemoglobin, myoglobin and particular cytochromes. This binding appears to be
remarkably specific to haem proteins. The finding that CO suppresses the expression of
several hypoxia-mediated genes including EPO (Goldberg et ah, 1988) and the
expression of HIF-1 (Liu et ah, 1998, Huang et ah, 1999) is circumstantial evidence that
the sensor is a haem protein. In addition, it is well established that certain transition
metals including Co2+, Ni2+ and Mn2+ can 'mimic' hypoxia, inducing expression of
hypoxia-inducible genes via activation of HIF-1 (reviewed in Bunn and Poyton, 1996). If
the oxygen sensor is a haem protein, then it is proposed that cobalt, nickel and manganese
atoms, which do not bind oxygen, may substitute for the iron atom in the haem moiety
and lock it in the 'deoxy' conformation.
There are however several lines of evidence that are not easily accommodated by this
relatively simple model of direct oxygen sensing. Similarly to transition metals, the iron
chelator desferrioxamine (DFO) 'mimics' hypoxia in a non-additive manner, suggesting a
common pathway (Wang and Semenza, 1993A). Haem iron is however non-chelatable.
Oxygen has been shown to directly interact with iron-sulphur clusters (Iwai et al., 1998),
and there are examples of non-haem ferroprotein sensors in which labile iron atoms are
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susceptible to chelation (Spiro and Guest, 1990). The initial report that HIF-1 contained
non-haem iron would have clearly implicated this protein as a direct oxygen sensor
(Srinivas et ah, 1998); the authors however were unable to reproduce the data (Salceda
and Caro, 1999). Nonetheless PAS domains are utilised in oxygen-sensing in certain
prokaryotic organisms (reviewed by Taylor and Zhulin, 1999) which implies that HIF-1
activity may indeed be directly influenced by molecular oxygen concentration.
1.5.5.2. Cellular reduction-oxidation (redox) models for oxygen sensing.
Rather than direct oxygen sensing, an alternative model is the sensing of a metabolite of
oxygen. In this model changes in oxygen concentration result in a shift in the redox state
of the cell. Within this model there are two distinct mechanisms postulated.
The first proposes that the sensor may be a flavo-haem protein which functions as an
NAD(P)H oxidase, chemically reducing oxygen to superoxide anion (O2") which in turn
is converted to hydrogen peroxide (H2O2) by superoxide dismutase (SOD). Thus as
oxygen concentration falls, so too does the production of O2" and H2O2, providing a redox
signal for hypoxia. Fandrey et al. (1994) showed that in Hep3B cells, catalase increased
expression and H2O2 reduced expression of EPO, suggesting a central regulatory role for
reactive oxygen species (ROS) in oxygen sensing. A similar integral relationship between
ROS and NF-kB activation has been proposed (reviewed by Li and Karin, 1999). Indeed
as with NF-kB, HIF-1 a contains a conserved redox-sensitive cysteine residue (Ema et al.,
1999). The effect of DFO in this model may be reconciled by its effect on chelating free
iron which catalyses the generation of ROS from H2O2 via the Fenton reaction. Hence
DFO would reduce ROS generation and mimic hypoxia. Against this model is the
knowledge that many antioxidants fail to mimic the effects of hypoxia on gene expression
(Wenger, 2000), and indeed several antioxidants inhibit HEF-1 and hypoxic signalling
(Haddad and Land, 2000; Chandel et al., 1997).
In the NAD(P)H model of sensing, a membrane bound NAD(P)H oxidase generates ROS
in direct proportion to environmental oxygen. Hence, hypoxia would result in a net
reduction in ROS generation. There is now a substantial body of evidence that this model
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may be most relevant in Type 1 carotid body cells and pulmonary neuroepithelial bodies,
sites of oxygen sensing in mammals (Gonzalez et al., 1994, Youngson et al., 1993). In the
former, studies employing direct spectral analysis provided evidence that the oxygen
sensor is a cytochrome Mike NAD(P)H oxidase (Acker, 1994) and patch clamp
experiments localised it to the plasma membrane (Ganfornina and Lopez-Barneo, 1991)
Diphenylene iodinium (DPI), an inhibitor of NAD(P)H oxidases (and other
flavoproteins), stimulates depolarisation of carotid (Cross et al., 1990) and neuroepithelial
(Youngson et al., 1993; Fu et al., 2000) bodies, as predicted by this model.
The role of an NAD(P)H oxidase as a universal oxygen sensor however is disputed.
Patients with genetic subtypes of chronic granulomatous disease (CGD), who have absent
or abnormal NAD(P)H subunits, exhibit normal oxygen sensing. Moreover elegant
studies in knock-out mice and specific NAD(P)H subunit-deficient cell lines have
demonstrated normal oxygen sensing (Wenger et al., 1996, Archer et al., 1999). In
hypoxic hepatoma cell lines, DPI inhibits HIF-1 and downstream genes when the
opposite effect would have been predicted by this model (Gleadle et al., 1995).
The alternative model of oxygen sensing via changes in redox state implicates the
mitochondrial electron transport chain (ETC) complex IV (cytochrome c and cytochrome
oxidase complex, also referred to as cyt aa3) in a pivotal role. The mitochondrion is the
primary site for oxygen metabolism and hence a role in oxygen sensing might seem
logical. Under hypoxic conditions, the fmax of cyt aa3 decreases and the km increases
(Chandel et al., 1996), hence the reduction of oxygen to H2O is inhibited. This 'blockade'
of the ETC results in release of electrons upstream at complex III (b-Cj complex). These
electrons generate increased O2" via univalent transfer to oxygen. In hepatocytes and
cardiac myocytes, graded decreases in PO2 from 4.5 to 1 KPa resulted in a progressive
increase in ROS as measured by fluorescent probe. This effect was mimicked by cobalt
and correlated with HIF-1 induction and EPO gene expression (Chandel et al., 1998). In
p° cells, which lack mitochondrial DNA and ETC activity, hypoxia fails to induce ROS
production or the expression of HIF-1 and downstream genes (Chandel and Schumacker,
1999). This model of sensing conflicts directly with that described above in which a
cytochrome Mike oxidase generates decreased levels of ROS during hypoxia.
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Indeed recent studies also report normal HIF-la expression in a range ofmutant p° cells
(Vaux et al., 2001; Srinivas et al., 2001). The conflict over the role of the mitochondrial
chain in hypoxic sensing remains unresolved.
1.5.5.3. A nitric oxide (NO) model for oxygen sensing
Finally, in a novel approach utilising model organisms to explore the hypoxic sensing
mechanism, Wingrove and O'Farrell (1999) have demonstrated that in Drosophila
melanoganster, both acute and chronic hypoxic responses are impaired in flies in which
the nitric oxide (NO) metabolism is disrupted either genetically or pharmacologically. For
example flies exposed to the nitric oxide synthase (NOS) inhibitor L-NAME have
impaired hypoxia-induced cell cycle arrest, but the hypoxic effect can be induced by
exogenous expression ofNOS.
The evidence for a direct role for NO in hypoxic sensing in mammals is largely
circumstantial: the nitric oxide synthase gene is itself HIF-1 regulated (Melillo et al.,
1995); NO inhibits HIF-1 induction (Sogawa et al., 1998, Huang et ah, 1999) and
prevents hypoxic upregulation of relevant genes (Ohigashi et ah, 1993, Liu et ah, 1998);
NO has been shown to inhibit the activity of the mitochondrial ETC complex IV
(Clementi et ah, 1999); lastly NO has been shown to be produced endogenously at low
levels by mitochondria (Giulivi, 1998), raising the notion that NO:oxygen ratio at
mitochondrial level is a critical parameter in oxygen sensing. Only recently has there
been data to support a direct coupling between oxygen sensing and NO signalling (Eu et
al., 2000)
It is possible that rather than a single universal oxygen sensor, the response to hypoxia
may depend upon the orchestrated response of several 'sensing mechanisms'. It is also
apparent that the balance of sensing mechanisms may vary between cell phenotypes, for



















Legend for Figure 1.5.2. Redox models for oxygen sensing.
a. The oxygen sensor is a membrane-bound NAD(p)H oxidase that generates ROS in
direct proportion to environmental oxygen. Thus, hypoxia results in reduced ROS and
signalling.
B. The oxygen sensor resides within the mitochondrial electron transport chain,
specifically within complex IV. Hypoxia inhibits the activity of cytochrome oxidase,
blockading normal electron transport and generating increased ROS.
1.5.6. HIF-1 mediated gene expression
Following the identification of the HRE in the EPO gene, it became apparent that several
other genes contain within their promoter or enhancer regions potential binding sites for
HIF-1. Hypoxia regulated genes, in which a functional HIF-1 binding site has been
definitively identified, or in which hypoxic induction can be mimicked by transition
metals or DFO (thus implicating HIF-1 in transcriptional regulation), are summarised in
Table 1.5.6. The majority of these studies have been in non-human cell lines, and it is
apparent that hypoxic regulation of genes varies between cell lines (Gleadle and Ratcliffe,
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1998; Lewis et al., 1999; Faller et al., 1999). The core sequence 5'-RCGTG-3', common
to all the genes which have been shown to bind HIF-1, may be present in either the sense
or antisense strand. However, for efficient hypoxic regulation, additional flanking regions
around the HIF-1 binding site are necessary. For example the EPO, VEGF and ALDA
genes all contain a site 5'-CACAG-3' close to the HIF-1 site which, if disrupted, prevents
hypoxic upregulation. Hence it is likely that a functional HRE consists of at least a pair of
contiguous transcription factor binding sites, at least one of which binds to HIF-1
(Semenza et al., 1996).
In the EPO gene the HRE is sited in an enhancer region 3' of the poly-A site. For most
other genes studied the HRE is sited 5' of the transcription initiation site. The distance
from this site however may be short, as in the endothelin-1 gene (-118 nt upstream) or
relatively long, as in the transferrin gene (-3.5Kb upstream). Once bound to its concensus
site, HIF-1 is able to recruit essential transcriptional coactivators such as the histone
acetyltransferases CBP/p300 (Arany et al., 1996; Kallio et al., 1998; Ebert and Bunn,
1998) and transcription intermediary factor 2 (TIF2) and steroid receptor coactivator-1
(SRC-1) (Carrero et al., 2000).
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Table 1.5.6.
Process Gene Product References
Erythropoiesis Erythropoietin (EPO) Firth et al., 1994, Wang and Semenza,
1993
Glycolysis Aldolase A (ALDA) Firth et al., 1994; Semenza et al., 1994;
Ebert et al., 1995; Firth et al., 1995;
Semenza et al., 1996; Iyer et al., 1998
Enolase 1 (ENOl)
Lactate dehydrogenase A (LDHA)
Phosphofructokinase L (PFKL)




Iyer et al., 1998; Graven et al., 1999
Glucose transporters Glucose Transporter (GLUT) 1,2*,3 Ebert et al., 1995; Iyer et al., 1998
a1B-adrenergic receptor Eckhart et al., 1997
Adrenomedullin Nguyen and Claycomb, 1999
Energy metabolism Adenylate kinase 3 O'Rourke et al., 1996;
Wood et al., 1998
Growth factors Vascular endothelial growth factor (VEGF) Goldberg and Schneider, 1994; Gleadle et
al., 1995; Liu et al., 1995; Levy et al.,
1995; Forsythe et al., 1996
Flt-1 (VEGF receptor-1) Gerber et al., 1997
Platelet derived growth factor (PDGF) A
and B
Kourembanas et al., 1990; Gleadle et al.,
1995
Placental growth factor (PLGF)* Gleadle et al., 1995;
Khaliq et al., 1999
TGF-P3 Caniggia et al., 2000
Vasomotor
regulation
Inducible nitric oxide synthase (iNOS) Melillo et al., 1995; Melillo et al., 1997;
Palmer et al., 1998
Constitutive nitric oxide synthase (cNOS)* Phelan and Faller 1996
Endothelin-P Bodi eta!., 1995; Hu et al., 1998
Haemoxygenase-1 (HO-1) Hernandez-Eyssen et al., 1996; Lee et al.,
1997
Iron metabolism Transferrin^ Rolfs et al., 1997




P35srj (CBP/p300 antagonist) Bhattacharya et al., 1999
Cell cycle
regulation
p21 Carmeliet et al., 1998
Others Caeruloplasmin Mukhopadhyay et al., 2000
Insulin-like growth factor (IGF) binding
protein -1
Tazuke et al., 1998; Feldseret al., 1999
Peroxisome Proliferator-activated receptor
a (PPAR)*
Narravula and Colgan, 2001
Legend for Table 1.5.6. Genes regulated by hypoxia in which HIF-1 has been
implicated
* These genes are downregulated by hypoxia. A critical role for HIF-1 regulation in cNOS, GLUT-2 and
PLGF downregulation is not established. PPAR is the only gene shown to be downregulated by a HIF-1
dependent mechanism
+ One or more of the HIF-1 binding sitesare present on the antisense strand
Additional notes:
VEGF - mRNA transcription and stability is increased under hypoxic conditions
Flt-1 - may be regulated by HIF-2 rather than HIF-1.
HO - HIF-1 essential for regulation in rat vascular smooth muscle cells but not in CHO cells. AP-1 and
other transcription factors are also relevant in hypoxic regulation of HO
Given the novel properties of HIF-1 and its clear involvement in the regulation ofmany
genes critical to cell survival, HEF-1 has been termed a master regulator of hypoxic
responses (Semenza et al., 1999). However, recent evidence suggests that HEF-la
expression is not exclusively hypoxia-dependent. As with many other transcription
factors, HEF-1 a expression may also be induced by inflammatory mediators and growth
factors (Haddad and Land, 2001; Richard et al., 2000; Zelzer et al., 1998). Conversely,
there is growing evidence that transcription factors such as AP-1 and NF-kB, most
commonly associated with cell survival and inflammatory gene expression, may be
oxygen-regulated. The role of hypoxia in the regulation of AP-1, NF-kB and other
transcription factors is discussed in Chapter 5.3.
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1.6. HYPOTHESES AND AIMS OF THESIS
ARDS represents the severe end of a spectrum of lung injury that evolves over a period of
hours or days in a subgroup of at-risk. In clinical studies of trauma patients in the very
early at-risk period of ARDS, soon after the initiating insult, we have observed raised
levels of intrapulmonary interleukin-8 (IL-8), but not other inflammatory cytokines, are
associated with subsequent progression to ARDS (n=56, P<0.001). The high IL-8 levels
were detected within a few hours (range 0.75 - 4 hr) of the trauma incident.
Immunohistochemical analysis implicated the alveolar macrophage as a potent source of
intrapulmonary IL-8. The mechanisms by which IL-8 may be rapidly generated in this
clinical setting are unknown.
Our clinical observations suggest that events occurring in the immediate aftermath of a
trauma incident contribute to the generation of IL-8 in macrophages. I hypothesised that
clinically relevant physiological events may include:
1) A neuro-endocrine 'stress' response to major trauma. This would result in the rapid
intrapulmonary and systemic release of clinically relevant stress mediators including
catecholamines and neuropeptides that may stimulate the macrophage to generate IL-
8.
2) Acute tissue hypoxia and hyperoxia. By the time of sampling, the trauma victims
were likely to have undergone a period of sustained tissue hypoxia secondary to head-
injury, atelectasis and lung contusion and subsequent resuscitation with delivery of
high flow oxygen. I hypothesised that hypoxia / hyperoxia would act as a direct
multiple-stimuli or 'hits' to generate IL-8 in macrophages.
To test these hypotheses perform the following studies:
1) I aimed to study the potential for a range of 'stress' mediators to stimulate IL-8
generation in human monocyte-derived macrophages. I aimed to develop a
reproducible in vitro model for altering macrophage oxygenation to study the effects
of acute hypoxia and hyperoxia on IL-8 generation.
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I aimed to develop a novel animal model of direct and indirect acute lung injury in
which to specifically test the effect of acute hypoxia / hyperoxia on intrapulmonary
IL-8 generation.
I aimed to study the transcriptional regulation of the IL-8 gene in response to acute






The reagents used in these studies were purchased from the following sources:
Gibco Life Technologies (Paisley, Scotland, UK)
Iscove's Dulbecco's modified medium, without supplements, with L-glutamine
(Iscove's MDM). Iscove's Dulbecco's modified Eagles medium, without
supplements (Iscove's DMEM). Culture supplements penicillin (10000 IU/ml) /
streptomycin (10 mg/ml), L-glutamine (200 mM), non-essential amino acids (lOOx),
geneticin (G418 sulphate, 50 mg/ml), fetal calf serum. TRIzol® reagent.
Acrylamide/bis (30% w/v). SDS (Ultrapure, 10%). Subcloning efficiency DH5a™
competent cells.
R&D Systems Europe Ltd (Oxon, UK)
Monoclonal (capture) mouse anti-human IL-8 (500 pg), TNF-a (500 pg) and IL-ip
(500 pg) antibodies, dissolved in PBS and stored at -20°C. Biotinylated (detection)
anti-human IL-8 (50 pg/ml), TNF-a (50 pg/ml) and IL-ip (50 pg/ml) antibodies,
dissolved in PBS and stored at -20°C. Recombinant human TNF-a (10 pg) and IL-
ip (5 pg) protein, reconstituted in PBS and stored at -70°C .
Promega (Southampton, UK)
RT-PCR reagents: AMV reverse transcriptase (5-10 U/pl), oligo-(dT) primer (0.5
pg/pl), rRNasin (40 U/pl), MgCl (25 mM), dNTPs (10 mM), T/7 DNA polymerase (5
U/pl). Restriction enymes: Pst 1, BatnH 1, Xba 1, EcoR 1 with buffers. EMSA
reagents: T4 polynucleotide kinase with lOx buffer, NF-kB consensus
oligonucleotides. Transfection reagents: Tfx™-10 reagent, pSV-P-Galctosidase
control vector, pCAT®-Control vector. Acryl-a-Mix® 6 polyacryamide gel solution.
pGEM®-T vector.
Amersham Pharmacia Biotech (Bucks., UK)
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Radio-labelling reagents: ReadyToGo™ DNA labelling beads (-dCTP), [a- P]-
dCTP, [y-32p]-dATP, [a-32p] UTP. Percoll (100%).
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Boehringer Mannheim (E.Sussex, UK)
CAT and P-GAL ELISA systems. Complete™ protease inhibitor cocktail.
Other sources
Diff-Quick stain (Oberkochen, Germany). Streptavidin-peroxidase conjugate for use
in ELISAs was from Dako (Cambs., UK). BCA protein assay kit for measurement of
total protein was from Pierce (Rockford, IL, USA). Specific oligonucleotide
sequences were purchased from MWG Biotech (UK) Ltd. DNA plasmid maxiprep
(Quantum™) kit was purchased from BioRad Labs (Herts., UK). Nonidet P40 was
purchased from BDH (Poole, UK). Monoclonal antibodies to p50, p65, c-Jun and c-
Fos for use in EMSAs were purchased from Santa Cruz Biotech (CA., USA). Rabbit
serum was obtained from SAPU (Lanarks., UK). RiboQuant® multi-probe RNase
protection assay system (Pharmingen, San Diego, CA) was purchased through
Becton Dickinson Ltd (Oxford, UK). Nylon membrane (Genescreen Plus) for
transfer of RNA was obtained from Du Pont NEN (Brussels, Belguim). Rabbit
capture and detection antibodies, and recombinant-rabbit 1L-8 protein were a kind
gift from Dr Caroline Hebert, Genentech Inc., CA., USA. HIF-1 expressing and non-
expressing CHO-K1 cells were a kind gift from Prof Peter Ratcliffe, Oxford, UK.
For the animal model of lung injury, Hypnorm® was obtained from Janssen-Cilag
Ltd., High Wycombe, UK, midazolam (Hypnovel®) from Roche Products Ltd.,
Welwyn Garden City, UK and Pavulon® from Organon Labs. Ltd., Cambridge
All other reagents were purchased from Sigma Chemical Company (Poole,
Dorset, UK).
The source of equipment used is cited within the text of the Methods (Chapter
2.2)
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2.2. METHODS USED IN IN VITRO STUDIES
2.2.1 Cell Culture
2.2.1.1 Purification of human peripheral blood mononuclear cells
Human peripheral blood mononuclear cells (PBMC) were purified according to the
method of Haslett et al., (1985) with slight modification. Freshly drawn venous blood
was collected into 50 ml polypropylene tubes primed with anticoagulant (4 ml 3.8%
sodium citrate / 36 ml blood). Tubes were centrifuged (300g, 20 min) and the plasma
carefully aspirated and used to prepare autologous serum by adding CaCb (final
concentration 20 pM) to plasma in a glass tube and incubating at 37°C for 1 hr. To
the residual volume containing cell pellet, 5 ml of 6% dextran (MW 500,000, 37°C)
and ~ 20 ml 0.9% saline (37°C) was added to a final volume of 50 ml. Tubes were
mixed by gentle inversion and allowed to stand for 30 min resulting in red cells
sedimentation. The leukocyte-rich upper layer was carefully aspirated and
centrifuged (300g, 5 min), leaving a white-cell pellet. Isotonic Percoll was prepared
by adding 1 part 10X PBS (-) to 9 parts neat Percoll. This isotonic solution was then
diluted with PBS (-) to 81%, 70% and 55% solutions. The 70% solution (3 ml) was
gently layered onto 3 ml of 80% solution in a 15 ml polypropylene tube. The white
cell pellet was resuspended in 55% Percoll, gently layered onto the 70% solution,
and the tubes centrifuged (700g, 20 min). PBMC were aspirated from the 55% / 70%
Percoll interface and were washed twice in PBS (-) before counting by
haemocytometer. Neutrophils sedimented at the 70% / 81% interface and red cells
pelleted to the bottom of the tube.
The phenotype of the harvested cells was checked by flow cytometry with
appropriate gating. Neutrophil contamination of PBMC was routinely <1%.
Depending upon donor variability, monocytes constituted between 15 and 30% of the
PBMC population.
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2.2.1.2. Monocyte selection and culture to macrophages
PBMC were suspended in serum-free Iscove's modified Dulbecco's medium (MDM)
supplemented with 50 U/ml penicillin and 50 mg/ml streptomycin at 4 x 106/ ml and
3 ml aliquots added to each well of 6-well plates. The plates were incubated at 37°C /
1 hr during which monocytes selectively adhered to the plastic. Non-adherent
lymphocytes were then removed by washing with warm medium. Adherent
monocytes were then overlayed with medium containing 10% autologous serum. For
maturation to macrophages, cells were incubated for 5-7 days (37°C in humidified,
5% CO2 atmosphere). The medium was replenished on day 3.
2.2.1.3. THP-1 cell culture
THP-1 human monocyte cells (a kind gift from Dr Simon Hart, University of
Edinburgh) were maintained in suspension in Iscove's MDM containing 10% heat-
inactivated FCS and supplemented with 50 U/ml penicillin and 50 mg/ml
streptomycin. In experiments, 2 ml aliquots of cell suspension at a density of 1 X 106
cell perml were plated per well of a 6-well plate.
2.2.1.4. Rabbit alveolar macrophage cell culture
Bronchoalveolar lavage (BAL) of rabbit lungs is described in Chapter 2.3.5. BAL
fluid was centrifuged (400g, 6 min, 4°C) and the cell pellet washed once withcold
PBS(-). In some cases a hypotonic red-cell lysis procedure was performed as follows;
the cell pellet was suspended in sterile water (19 ml, 4°C) for exactly 20 seconds.
Sterile 3.6% saline (6 ml, 4°C) was then rapidly added and mixed by inversion
followed by centrifugation (6 min, 4°C). The phenotype of the lavaged cells was
assessed by pelleting ~0.15xl06 cells onto glass slides (Cytospin 2, Shandon
Scientific, Cheshire, UK) and staining with Diff-Quick (these should be in the
reagents section), a modified Wright-Giemsa stain. BAL fluid from normal rabbit
lungs contained >98% alveolar macrophages (Figure 2.2.1.4). The cells were finally
suspended at 0.5xl06 cells/ml in Iscove's MDM supplemented with 50 U/ml
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penicillin, 50 mg/ml streptomycin and 10% heat-inactivated FCS and 2 ml aliquots
(lxl06 cells) dispensed into 6-well plates. Alveolar macrophages were left in culture
(37°C, 5% CO2) for 48 hours to allow adherence to plastic prior to experimental
manipulation.
2.2.1.5. C4.5 and Kal3 CHO cell culture
C4.5 and Kal3 cells were a kind gift from Morwenna Wood (Oxford). These cells
are derived from CHO K1 cells as described by Wood et al., (1998). Cells were
cultured in Dulbecco's modified Eagles medium (DMEM) supplemented with 10%
heat -inactivated foetal calf serum (FCS), L-glutamine (2 mM), penicillin (50 U/ml),
streptomycin (50 mg/ml), non-essential amino acids (lx) and geneticin (G418, 500
pg/ml). Cells were grown in 162 cm2 sterile flasks and serially passaged when 95-
100% confluent.
2.2.1.6. Normoxic cell culture
In all experiments, 'normoxic' cell culture refers to culture in a standard humidified
incubator at 37°C, 5% CO2, 21% O2.
2.2.1.7. Hypoxic cell culture
Two different incubators were available for hypoxic culture. The NAPCO hypoxic
incubator (37°C, 0.1% O2, 5% C02)(Precision Scientific Ltd., UK) was a standard
Alveolar macrophages comprise > 98
% ofBAL cells. Cytospin stained with
Diff-Quick (a modified Wright-
Giemsa stain)
Figure 2.2.1.4. Cells recovered from
bronchoalveolar lavage of healthy
rabbit lungs.
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incubator in which the hypoxic environment was achieved through constant flushing
with N2. The MK3 anaerobic unit (37°C, 80% N2 / 10% H2 / 10% C02) (Don
Whitley Scientific Ltd. UK) was a sealed chamber constantly flushed with gas
mixture. This latter incubator maintains a near-anaerobic atmosphere (<25 ppm
oxygen) through the reduction of oxygen by hydrogen in the presence of a palladium
catalyst. A sealed interface allowed cultured cells to be accessed directly in the MK3
unit, without exposure to the environment. In contrast, transferring or manipulating
cells in the NAPCO incubator could only be achieved by opening the chamber door
and thus allowing air to enter the incubator. Brief periods of reoxygenation were
therefore likely to occur in this system. Both incubators were used in preliminary
experiments to asses the effect of hypoxic incubation on oxygen content and pH of
culture medium (Chapter 3). However, unless otherwise stated, all data presented in
this thesis pertaining to hypoxic incubation was derived from experiments using the
MK3 anaerobic unit.
2.2.1.8. Hyperoxic cell culture
Hyperoxic incubation was achieved using portable air-tight 2 litre chambers which
were flushed with 90% 02 / 10% C02 at a rate of 4 L/min for 2 min and then sealed
manually. The chambers were humidified by placing saturated paper towels in the
chamber base. The sealed units were then placed in a 37°C incubator.
2.2.2. Measuring dissolved oxygen in medium
An OXEL-1 probe, which is based upon the electrode described by Clark and IS02
meter (World Precision Instruments, Inc. Florida, USA) was used to measure
dissolved oxygen. Briefly, the OXEL-probe houses a platinum electrode and a silver
counter / reference electrode inside a stainless steal sleeve. A gas permeable
membrane fits over the sleeve and allows oxygen to diffuse through it, whereupon it
is reduced at the platinum electrode. The magnitude of the electrical current
generated is determined by the rate of diffusion to the electrode, which is
proportional to the partial pressure of oxygen outside the membrane. Liquids, ions
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and particulate matter are unable to pass through the membrane. The probe tip is 2
mm in diameter, and as such was not suitable for measuring PO2 in the immediate
peri-cellular vicinity. Instead, the tip was positioned ~5 mm above the cell surface.
The oxygen probe was calibrated by placing the tip in PBS at 37°C and bubbling
either N2 (0% oxygen) or room air (20.4% oxygen) at a rate of 2 L/min for up to 30
min to achieve equilibration. Measurement of PO2 in samples was made by placing
the 2-mm probe-tip 5 mm above the bottom of the plate.
In some instances, the results obtained with the OXEL-1 probe were compared to
those derived using an automated gas analyser (model ABL-330, Radiometer,
Copenhagen). This analyser simultaneously measured the partial pressure of O2 and
CO2 and the pH in 250pl aliquot of sample fluid. The oxygen-sensing component of
the automated analyser, as with the OXEL-1 probe, is based upon the Clark
electrode.
2.2.3. Measurement of Lactate Dehydrogenase (LDH)
LDH assay, together with Trypan-blue exclusion, was used to measure cell viability.
For each sample 2ml of Phosphate Buffer (PB), 0.1 mol/1., at pH 7.5 was placed in a
5ml Falcon tube and kept on crushed ice. The technique is based upon an assay
originally described by Wrobleski and Landue (1955, LDH activity in blood PSEBM
90 210-213).
NADH (preweighed and damp protected, Sigma) was gently taken up in PB to a final
concentration of 0.4 mg/ml; then 200 pi added to each Falcon tube. Samples of
medium were centrifuged at 10,000 g for 3 min. A 700 pi aliquot was added to the
Falcon and mixed well by inversion. Samples of cell lysates were obtained by
scraping cells into 700 pi PBS containing 0.1% Nonidet-P and keeping the sample on
ice for 30 min. The mixture was centrifuged at 10,000g for 3 min and the supernatant
added to the Falcon.
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The contents of the Falcon were transferred into a 3 ml cuvette and allowed to stand
at room temperature for 20 minutes. The cuvette was then installed in the holder (at
37°C) of a Philips PU8 700 spectrophotometer and allowed 3 minutes to warm up
before 100 pi of sodium pyruvate (22.7 mmol/1 in PB) was added directly to the
cuvette and mixed with a plastic paddle. The spectrophotometer was programmed to
measure the rate of change of absorbance for light at 340 nm, determined and
averaged over 3 minutes, sampling every 30 seconds. A standard curve was
established using human erythrocyte LDFI (Sigma), in the range 0.025 units to 0.5
units.
LDH assays were performed on fresh samples, or samples stored for a maximum of
24 hours at 4°C.
2.2.4 Enzyme-linked immunosorbent assay for human IL-8, TNF-a and IL-ip
Monoclonal and biotinylated anti-human IL-8, TNF-a and IL-1 (3 antibodies were
obtained from R&D Systems and the assays performed as per the manufacturer's
protocol. Flat-bottomed 96-well microtitre plates were coated with 100 pi per well of
monoclonal antibody (4 pg/ml for IL-8, TNF-a and IL-ip) in PBS (pH 7.4)
overnight at room temperature. Wells were washed three times with wash buffer
(0.05% Tween 20 in PBS) and 200 pi of 1% BSA in PBS added per well to block
non-specific binding sites. Plates were incubated for 1 hour with blocking solution
and wells subsequently washed three times. Samples were diluted if required in
diluent buffer; 0.1% BSA, 0.05% Tween 20 in Tris buffered saline (20 mM Trizma
base, 150 mM NaCl, pH 7.3). Samples aliquots (100 pi) added to wells in triplicate.
Recombinant human (rh) TNF-a and IL-ip, obtained from R&D, were used to make
up ten standard 1 in 2 serial dilutions starting at 10 ng/ml for TNF-a and 1 ng/ml for
IL-ip. In the case of IL-8, rhIL-8 was obtained from NIBSC and serial dilutions
started at 20 ng/ml. Standards were measured in duplicate. Control (blank) wells
consisted of diluent buffer only. Plates were incubated at RT for 2 hours without
shaking. After further washing, 100 pi per well of secondary biotinylated antibody
(20 ng/ml for IL-8, 200 ng/ml for TNF-a and 100 ng/ml for IL-ip) was added and
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the plates incubated for 2 hours. Plates were washed and incubated for 20 min with
streptavidin-peroxidase conjugate (Dako, Denmark) diluted 1 in 20,000. After
washing, substrate solution consisting of TMB 100 pg/ml, 4.5 mM H2O2 in 0.1 M
sodium acetate-citrate pH 4.9 was added and the plates incubated in darkness to the
desired extinction. The reaction was stopped with 50 pi of 0.5 M H2S04. Plates were
read at 450 nm (Dynatech MR5000).
2.2.5. Northern blotting
2.2.5.1. Preparation of diethyl pyrocarbonate (DEPC) water and RNase free
equipment
DEPC water was prepared by adding 50 pi of diethyl pyrocarbonate in 500 pi
ethanol to 500 ml MilliQ water and warming to 37°C with gentle stirring overnight
in a fume hood. The water was then autoclaved (15 mins /121 °C / 200 KPa).
Pipette-tips and glass-ware were rendered RNase-ffee by autoclaving. Non-
autoclavable items were treated with 3% H2O2 overnight, or RNaseZAP™. Solutions
were constituted in DEPC-treated water.
2.2.5.2. Extracting RNA from cultured cells
RNA from cultured cells was extracted using Trizol™, as per the manufacturers
protocol. This method is a based on the phenol / chloroform extraction technique
described by Chomczynski and Sacchi, 1987. Adherent cells were lysed directly in 6-
well plates by addition of 800 pi of Trizol™ reagent per well for 5 min at RT. The
lysate was transferred to 1 ml tubes and 200 pi chloroform added and vortexed. The
mixture was incubated at RT for 3 min then centrifuged at 12,000g for 15 min at
4°C. The resulting upper RNA-containing aqueous phase was gently aspirated,
without disturbing the interphase (DNA and lipid-soluble proteins) or lower organic
phase (protein).
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The RNA was precipitated from the aqueous phase by addition of an equal volume of
isopropanol and incubation for 10 min at RT (or overnight at -20°C) followed by
centrifugation at 12,000g for 10 min at 4°C. The resulting RNA pellet was washed in
75% ethanol, centrifuge at 7500g for 5' at 4°C and allowed to air dry. RNA was
dissolved in DEPC water and stored at -70°C. The quantity of RNA was measured
by spectrophotometry (Pharmacia Biotech, Ultraspec 2000). RNA purity was
determined by measuring A26o/280 (typically 1.6-1.8 using this method) and by
resolving 1 pg of RNA in a non-denaturing 1.5% agarose gel and observing resolved
1 Is and 18s bands.
2.2.5.3. Constructing a human IL-8 cDNA probe for northern blotting
A human IL-8 cDNA probe had previously been cloned into a pBS+ vector
(Bluescribe, Stratagene, CA) by Dr Mark Lawson, Rayne Laboratory, University of
Edinburgh. Briefly, total RNA from human peripheral blood monocytes stimulated
with LPS was extracted and RT-PCR performed using the primers -ATT TCT GCA
GCT CTG TGT GA- (downstream, sense) and -TGT GGA TCC TGG CTA GCA
GA- (upstream, antisense). These primers contained internal restriction sites for Pst-1
and Bam HI respectively (in bold), and spanned the 4 exons and three introns of the
IL-8 gene (Schmid and Weissmann, 1987).
A 747 bp product was cloned into a pBS+ plamid vector (Bluescribe, Stratagene, La
Jolla, CA) precut with Pstl and BamHl. The successful clone, JB-1, was
transformed in bacteria, cultured in LB medium and pure plasmid DNA derived
using the Promega DNA Maxiprep™. JB-1 plasmid (2 pg) was incubated with 40U
BamHl, 40U of Pst-1 in lx BamHl buffer for 37°C for 2 hours. The DNA was then
run on an agarose gel (Figure 2.2.5.3), The 747 bp IL-8 cDNA band was cut from




Legend for Figure 2.2.5.3 IL-8 cDNA
probe (747 bp) cut from JB-1 plasmid.
Plasmid was cut as described in text, to
yield a 747 bp human IL-8 cDNA product
for use in northern blotting. (U=uncut
plasmid, C= cut plasmid)
2.2.5.4. Resolving RNA samples in formaldehyde gel
RNA samples (15 pg in < 15 pi) were prepared by adding 15 pi of RNA loading
buffer with ethidium bromide, heat-denaturing the sample/buffer mixture at 65°C for
15 min and immediately plunging in ice. Samples were loaded onto a 1.2% 2x
MOPS / formaldehyde-agarose gel (40 mM 3-morpholinopropanesulphonic acid,
pH7.0, 10 mM sodium acetate, 1 mM EDTA, 2 M formaldehyde) and
electrophoresed at 100V for 2 hours in lx MOPS. The gel was then viewed under
UV light to assess consistency in RNA loading between samples.
2.2.5.5. Capillary transfer ofRNA to membrane
Following electrophoresis, the formaldehyde gel was immersed in 0.05 M NaOH for
10 min with gentle agitation. The gel was than gently washed twice in DEPC water
for 10 min and finally in 2x SSC for 20 min. This process aided cleavage of larger
(>800 bp) species of RNA and removed formaldehyde from the gel. The nylon
membrane (Du Pont NEN Genescreen Plus) was prepared by soaking in DEPC water
for 10 min followed by immersion in 2x SSC for at least 20 min. The blotting
apparatus was constructed as per Figure2.2.5.5. Following overnight transfer, the
membrane was placed in 2x SSC, enclosed in Saran-Wrap™ and wet cross-linked











Figure 2.2.5.5. Apparatus for northern blotting
2.2.5.6. Radio-labelling cDNA probe
The cDNA probe was labelled using 'Ready-to-go' DNA labelling beads (Pharmacia
Biotech) as per the manufacturers protocol. Twenty nanograms of DNA denatured by
heating to 98°C for 5 min then plunged into ice. The linearised DNA was then added
to reconstituted labelling beads and incubate at 37°C for 30 min to 1 hr with 5 pi [a-
32P]dCTP (3000Ci/mmol).
2.2.5.7. Membrane hybridisation
The cross-linked membrane was pre-hybridised for 2 hr at 65°C in 20 ml lx Chuch
and Gilbert buffer [0.5 M NaHP04, 7% SDS and 1 mM EDTA (pH 7.2)]. Fresh
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buffer containing [a- P]dCTP-labelled cDNA probe was then added and
hybridisation continued for 18 hours at 65°C. The membranes were washed three
times in O.lx SSC, 0.1% SDS, once at 65°C and twice at room temperature.
Membranes were exposed to Biomax MR film (Kodak) with intensifying screens at -
70°C. Membranes were subsequently stripped with boiling 0.1% SDS and re-probed
with a housekeeping 18s cDNA probe.
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2.2.6. Multi-probe RNase Protection Assay (RPA)
The detection of multiple mRNA species expression in total RNA was achieved
using multiple RNA riboprobe templates and the RiboQuant assay system
(Pharmingen, San Diego, USA). The assay was performed as per the manufacturers
protocol.
2.2.6.1. Multi-probe synthesis
All reagents were bought to room temperature unless otherwise stated. The following
reagents were co-incubated at 37°C for 1 hour: 1 pi RNasin, 1 pi GACU
oligonucleotide pool, 2 pi DTT, 4 pi 5X transcription buffer, 1 pi RPA template set,
10 pi [a- 32P]UTP and 1 pi T7 bacteriophage RNA polymerase. This reaction
generates highly specific radiolabelled antisense RNA in large quantity from specific
cDNA templates. The reaction was terminated by adding 2 pi ofDNase, and the mix
incubated for a further 30 min at 37°C. Protein was removed from the reaction mix
using phenol/chloroform: 26 pi 20 mM EDTA, 25 pi Tris-saturated phenol, 25 pi
chloroform:isoamyl alcohol (50:1) and 2 pi yeast tRNA was added to the tube,
vortexed into an emulsion and centifuged at 12,000g for 5 min at RT. The upper,
riboprobe-containing, aqueous phase was removed and the lower phase discarded. A
further 50 pi chloroform:isoamyl alcohol (50:1) was added to the riboprobes, the
mixture vortexed and centrifuged at 12,000g for 2 min at RT. The upper phase was
removed and unincorporated radiolabel removed by precipitation in 250 pi ice-cold
100% ethanol in the presence of 50 pi 4 M ammonium acetate, the sample
centrifuged at 12,000g for 15 min at 4°C. The waste supernatant was removed, 100
pi ice-cold 90% ethanol added to the pellet and the tube spun at 12,000g for 5 min at
4°C. After removal of the supernatant, the pellet was air-dried for 10 min and
dissolved in 50,pi hybridisation buffer. The labelling efficiency was determined by
measuring the cpm/pl in a 1 pi sample in a scintillation counter. An acceptable lower
limit was ~ 3 X 10"5 Cherenkov counts/pl.
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2.2.6.2. Hybridisation of riboprobes with RNA and RNase treatment.
The purified riboprobes were allowed to hybridise in excess with sample total RNA
(2 jig per reaction) to generate probe annealed to homologous sequences in the
sample RNA. Hybridisation was performed at 56°C overnight. Remaining non-
hybridised single stranded RNA was digested with an RNase specific for single-
stranded species (RNase A in RNase A buffer, 45 min at 37°C). The double-stranded
RNA / RNA hybrids were recovered by ethanol precipitation as above. Prior to
loading onto the gel, 5 pi of IX loading buffer was added to each sample and the
mixture heated to 90°C for 3 min and immediately plunged into ice.
2.2.6.3.Gel resolution of protected species
The RNA / RNA hybrids were resolved on a denaturing polyacrylamide gel. Glass
plates were cleaned with 70% ethanol and the short plate siliconized. The denaturing
gel-mix was made up as follows to a final concentration of 5% acrylamide:
• 8.85 ml 40% acrylamide
• 9.31 ml of 2% bis acrylamide
• 7.45 ml of 10X TBE
• 35.82 g ofUrea
• Made up to 74.5 ml with distilled water
Immediately prior to pouring, 450 pi of ammonium sulphate (10%) and 60 pi of
TEMED was added to the gel-mix. Following polymerisation, the gel was placed in a
vertical electrophoresis apparatus (Biorad-Quentum) and prerun at 40 watts constant
power for 45 min in 0.5X TBE running buffer. The desired gel temperature was
~50°C. The samples were loaded onto the gel, as was a dilution of the template probe
set (~ 1000 cpm / lane) in loading buffer which would serve as ladder. The gel was
run at 50 watts constant power until the leading edge of the bromophenol blue
reached 30 cm. After adsorbing onto to Whatman paper and covering in Saran wrap,
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the gel was dried under vacuum for 1 hour at 80°C. Dried gels were exposed to X-
ray film and densitometry performed.
2.2.7. Electromobility shift assay
Total nuclear proteins were extracted from cells using a method modified from that
previously described (Andrews et al, 1991). Macrophages were kept on ice and
scraped into cold buffer containing 10 mM HEPES - KOH pH 7.8, 2 mM MgCb , 1
mM dithiothreitol, 0.1 mM EDTA protease inhibitor cocktail (Complete™ ,
Boehringer Mannheim). The cells were allowed to swell on ice for 15 min then lysed
by adding 0.4% Nonidet P40 and centrifuged (12,000 g for 1 min at 4°C). The
supernatant was carefully removed and the pellet resuspended in 50 pi of cold buffer
containing 50 mM HEPES - KOH pH 7.8, 50 mM KC1, 300 mM NaCl, 1 mM
dithiothreitol, 10% glycerol, 0.1 mM EDTA and protease inhibitor cocktail.
Following 20 min incubation at 4°C with gentle agitation and centrifugation (12,000
g for 1 min at 4°C) the supernatant was carefully removed and protein content
assayed by BCA protein assay (Pierce, Rockford, IL). The binding reaction was
performed at RT as follows: 4 pg aliquots of protein were incubated for 5 min in
binding buffer containing 5 mM Tris, 0.5mM EDTA, 8% glycerol, 1 mM MgCl2, 50
mM NaCl, 0.5 mM DTT and 1.2 pg of polydl-dC and then a further 15 min with an
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appropriate [y- P]-labelled oligonucleotide. In the case of supershift assays nuclear
extracts were first co-incubated at 4°C with rabbit anti-human polyclonal IgG
antibodies to p50 and p65 (Santa Cruz) for 4 hours or with antibodies to c-jun and c-
fos (Santa Cruz) for 20 hours in binding buffer minus DTT. These were subsequently
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incubated at RT with appropriate [y- P]-labelled oligonucleotide in the presence of
0.5 mM DTT. The reaction mixtures were separated on a 6% polyacrylamide gel at
180 V at room temperature in 0.5% TBE buffer. After drying, gels were exposed to




















AP-1 consensus 5'- CGCTTGATGAGTCAGCCGGAA- 3'
NF-kB consensus 5'- AGTTGAGGGGACTTTCCCAGGC-3'
Table 2.2.7 Oligonucleotide probes used in EMSA studies
2.2.8. Extraction of total cellular protein
Total cellular protein was extracted from cells using the Trizol™ reagent, as used for
RNA extraction. This method offered the advantage of simultaneously obtaining total
cellular protein and RNA from a single sample of cells. The procedure is as
described for RNA extraction (2.2.5.2). Following chloroform phase separation of
the RNA, 0.3 ml 100% ethanol was added per 1 ml ofTrizol initially used was added
to the DNA- and protein-containing phases. Samples were stored for 2-3 min at RT
and the DNA precipitated by centrifuge at 2000g (5000 rpm) for 5' at 4°C. Protein in
the supernatant was precipitated in isopropanol (10 min incubation at RT followed
by centrifugation 12,000g/10 min/4°C. The protein pellet was washed 3-times in 0.3
M guanidine hydrochloride in 95% ethanol, with a final wash in 100% ethanol. After
air-drying, the pellet was dissolved in 1% SDS.
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2.2.9. Measurement of protein concentration
Cellular protein extracts were quantified using a BCA protein assay (Pierce, IL,
USA). This assay is based on the ability of protein in the test samples to cause a
reduction of Cu2+ to Cu+ and bicinichoninic acid (BCA) to chelate Cu+ forming a
purple compound which may be measured spectrophotometrically at 526 nm.
Samples were diluted up to 1 in 10 in dH20 and lOpl incubated with 200 pi of test
reagent for 30 min at 37°C. Plates were analysed by automated plate reader
(MR5000, Dynatech, UK). Samples were assayed protein concentration measured
with reference to standard curves derived from BSA standards.
2.2.10.Western blotting for HIF-la
This method was provided by Dr M. Wiesener (Wellcome Trust Centre for Human
Genetics, Oxford, UK), who also kindly performed preliminary blotting experiments.
Total protein extracts (80 pg) were resolved in an SDS/10% polyacrylamide gel and
transferred to Immobolin P (Millipore, Bedford, MA) overnight in 10 mM Tris, 100
mM glycine, 10% methanol and 0.05% SDS. Membranes were blocked with PBS
containing 5% fat-free dried milk and 0.1% Tween 20. Immunoblotting for HIF-la
was with MoAb 28B (4 pg/ml)(Wiesener et al., 1999). Detection was with HRP-
conjugated goat anti-mouse Igs and enhanced chemiluminescence (SuperSignal
Ultra; Pierce, Rockford IL). After analysis, membranes were stained with Ponceau S
to verify equal protein loading and transfer.
2.2.11. Immunofluorescent staining for E-selectin and CD2
This was performed on C4.5 cells, the phenotype ofwhich is described in Chapter 6.
Cells cultured in 6-well plates were washed twice with cold PBS (-) and 1 ml PBS (-)
/ EDTA 0.002 M / BSA 0.1% added to each well. The plates were incubated on ice
for 30 min. Cells were aspirated, transferred to a 1 ml Eppendorf tube and
centrifuged at 10,000 g for 5 min at 4°C. The cell pellet was resuspended in flow
80
buffer (0.1% BSA / 0.1% sodium azide) at a concentration of 1X106 / ml. Aliquots of
100,000 cells were added to flat-bottomed 96-well plates that were subsequently
centrifuged at 200 g for 2 min. The supernatant was removed by flipping the plates,
and cells incubated with monoclonal antibodies (50 pi) to human E-selectin (1 in
100), human CD2 (neat) and appropriate controls (anti-human CD5 (SAPU) and
anti-mouse MOPC) for 30 min on ice. Washing was repeated twice with flow buffer
as above, and the secondary antibody, goat anti-mouse Ig (F(ab')2 (1 in 40 in flow
buffer) (DAKO). Following a further 30 min incubation on ice and two washes, 200
pi flow buffer was added to each well and the resuspended cells analysed by FACS.
2.2.12. Transfection experiments with the human CAT-linked IL-8 promoter
The human IL-8 wild type promoter (280 bp), cloned into the pCAT basic vector,
was obtained (a kind gift from Prof. R Strieter, CA). The pCAT basic vector map,




Figure 2.2.13. Maps for CAT-linked
vectors. The IL-8 wild-type promoter
was cloned into pCAT Basic vector
(A). The pSV-p-Gal (B) and pCAT
Control (C) vectors were used as
controls in transfection studies
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2.2.12.1. Transformation of the IL-8 CAT-linked promoter in bacteria
A 50 pi aliquot of DH5a (E.Coli) competent cells was thawed on ice and 10 pg of
vector DNA added and gently mixed by pipetting. The cells were incubated on ice
for 30 min followed by heat-shock for 20 sec at 40°C. Nine hundred and fifty pi of
room temperature S.O.C. medium was added and the tube shaken at 225 rpm for 1 hr
at 37°C for expression. The tube was then gently vortexed and 100 pi of neat or 1 in
10 dilution (in S.O.C.) of reaction was spread onto LB plates with 100 pg/ml
ampicillin. The plates were incubated overnight at 37°C. Five colonies were picked
by gentle scraping with a sterile pipette-tip and were used to inoculate 10 ml of LB
broth containing 100 pg/ml ampicillin. These cultures were incubated overnight with
vigorous shaking at 37°C. Growth from these cultures was screened for the IL-8 gene
(clone of interest) by using small-scale plasmid DNA preparations (minipreps)
followed by restriction enzyme digestion.
2.2.12.2. Screening transformants for the IL-8 promoter
The Wizard™ minipreps DNA purification system (Promega) was used as per the
manufacture's protocol. A 2 ml aliquot of culture medium was centrifuged at
12,000g and the cell pellet resuspended in cell resuspension solution (Tris-HCl 50
mM, pH 7.5; EDTA 10 mM; RNase A 100 pg/ml) and transferred to a fresh 2 ml
tube. 200 pi of cell lysis solution (NaOH 0.2 M, SDS 1%) was added and mixed by
inversion, resulting in a clear solution. Two hundred pi of neutalisation solution
(potassium acetate 1.32 M) was next added and the tube again inverted several times
to allow mixing. Following spinning at 12000g for 5 min the clear supernatant as
decanted to a new tube. One ml of purification resin (well mixed) was added to the
supernatant and mixed by inversion. This solution was then transferred into 3 ml
syringe onto which a minicolumn has been attached and gently pushed through the
column with the plunger. The syringe was the detached and filled with 2 ml column
wash (NaCl 200 mM, Tris-HCl 20 mM, EDTA 5 mM all diluted 1:1.4 with 95%
ethanol) which was then gently pushed through the minicolumn. The minicolumn
was then inserted into a 1.5 ml tube and spun at 12,000g for 2 min. The DNA was
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then eluted by transferring the column to a fresh tube, adding 50 jul of warm (70°C)
TE buffer and allowing to stand for 1 min before spinning at 12,000g for 20 sec. The
concentration of DNA eluted was measured by UV spectrophotometric measurement
of the O.D. at 260 nm.
Purified plasmid DNA was digested with Pst 1 and Xba 1 restriction enzymes in the
following reaction mixture:
DNA 0.12 p/pl 20 pi
Autoclaved MiliQ water 21.6 pi
Buffer D(1Ox) 4 pi
BSA(10mg/ml) 0.4 pi
Digestion was performed for 1 hr at 37°C. Twenty pi of digestion mix was run on a
1.2 % agarose gel in lx TAE buffer. A successful digestion of a plasmid containing
the IL-8 promoter would be expected to yield a 280 bp product based on the known
restriction sites. Figure 2.2.13.2 demonstrates this in 2 successful clones. One
successful clone was subsequently used in a large-scale culture and DNA preparation
(method similar to that described for mini-preps above) to yield sufficient quantities










Legend for Figure 2.2.13.2 IL-8 promoter cut from
transformed plasmid.
A 280 bp product, representing the IL-8 wild-type
promoter was cut from 2 successfully transformed pCAT
basic plasmids
2.2.12.3 Protocol for liposome-mediated cell transfection.
This protocol is adapted from that described in the 'Transfection Guide' published by
Promega (Promega, Southampton, UK) and was applied to transfection experiments
in CHO-K1, the CHO-K1 HIF-1 expressing (C4.5) and non-expressing (Kal3)
variants, and human monocyte derived macrophages.
Tfx™-10 reagent (3.1 mg) was allowed to equilibrate to room temperature and
dissolved in 400 pi of nuclease-free water (1 mM final concentration of the cationic
lipid component). The sample was vigorously vortexed and then placed in a water
bath at 65°C for 1 min. The reagent was then stored at -20°C until use (stable for up
to 8 weeks). Transfections were performed in 6 well plates when cells were 70-80%
confluent. Seeding CHO-K1 or C4.5 cells at 2xl05 cells per well and Kal3 cells at
3xl05 cells per well in 3 ml medium supplemented with 10% FCS resulted in 70-80%
confluency over 2-3 days. Human monocyte derived macrophages were cultured as
described in 2.2.1.1, The transfection parameters used were 2.5 pg total DNA per
well with a Tfx:DNA ratio of 2:1 in 1 ml of serum-free (SF) medium (studies
described in Chapter 6 showed this to be the optimum ratio for transfection
efficiency in CHO cells. The constituents of a transfection mixture for 1 well were:
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1 mlSF medium (to final volume)
The DNA was first added to warm SF medium and vortexed. The Tfx™-10 reagent
was then added, the mixture vortexed, and incubated for 15 min. Supematants from
cultured cells were carefully removed and 1 ml of transfection mixture (vortexed) per
well overlain. Transfection was performed 37°C for 1 hr, following which 1 ml pre-
warmed medium supplemented with 20% FCS was added to each well. The cells
were treated with normoxia, hypoxia, CoCl (100 pM), DFO (100 pm) or PMA (100
nM) for 18 hr.
2,2.12.4, Cell lysis and ELISA for CAT and P-Gal protein
Cell lysis and ELISA's were performed using the appropriate kits (Boehringer
Mannheim) as per the manufacturers protocol. Briefly, the supernatant from the
treated cells was removed and the cells washed with cold PBS. One ml of lysis buffer
was added to each well and the plates incubated at RT for 30 min. The lysis buffer
(containing all cytoplasmic and nucleoplasmic proteins) was then gently aspirated
and centrifuged at 12,000g for 15 min at 4°C to remove cell debris. Samples were
aliquoted and stored at -70°C until analysis.
Total protein was measured using the BCA protein assay (Pierce, IL, USA). The
CAT and p-Gal ELISA's are based on the sandwich ELISA principle. Samples
(undiluted for CAT, diluted 1 in 10 for P-Gal estimation) or standards were added to
wells pre-coated with anti-CAT or anti-P-Gal antibody. Following incubation for 1
hr at 37°C, the wells were washed and a digoxigenin-labelled antibody to CAT or P*
Gal added. After further incubation for 1 hr and washing, the peroxidase substrate,
Abts® was added and absorbance measured at 405 nm on a plate reader. A
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calibration curve was plotted from the standards and sample values calculated by
extrapolation from the linear portion of this curve.
2.3. METHODS USED FOR IN VIVO MODEL OF ACUTE LUNG INJURY
2.3.1 Animal sedation, anaesthetic and intravascular monitoring
Female New Zealand rabbits weighing 2.8 - 3.5 kg (Charles River Ltd. Margate,
Kent) were sedated with intramuscular fentanyl citrate and fluanisone (Hypnorm®
0.3 ml/kg bolus followed by 0.3 ml/kg/h) then anaesthetised with intravenous (i.v.)
midazolam (Hypnovel® @ 2 mg/ml, 0.75 ml/kg) via marginal ear vein. The animals
were placed in the prone position and temperature regulated by rectal thermistor and
a heating blanket beneath the animal. A 22-gauge intravenous cannula was secured
in both marginal ear veins for fluid and drug administration. A tracheotomy was
performed and a purpose-made endotracheal tube inserted and secured. A size 3F
cannula, primed with saline/10 U./ml. heparin, was inserted and tied into the right
femoral artery then attached to a heart rate and blood pressure monitor (Model VT-
15, Weco,UK).
A multiprobe sensor (Paratrend 7, Diametrics Ltd., High Wycombe, UK) was
inserted via an introducer into the left femoral artery and advanced toward the iliac
artery. This provided a continuous digital and graphical readout of arterial PC02,
P02, pH and temperature. Prior to ventilation, the animals were paralysed with i.v.
pancuronium bromide (Pavulon®, 0.45 mg/kg bolus then 0.3 mg/kg/h, Organon
Labs. Ltd., Cambridge). Saline was infused subcutaneously at 2.5 ml/hr throughout
the experiment. The animals were ventilated with a pressure-controlled respirator
(Model RSP1002, Kent Scientific Corp.), the initial settings being 30 bpm, 12.5 cm.
H20 for max. inspiratory pressure and zero end-expiratory pressure. The ventilator
inlet was connected to a 15 litre gas reservoir initially supplied with room air and
animals allowed to equilibrate with this system for 30 min prior to instillation of
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acid. Fifteen minutes prior to acid-instillation, the animals were injected with 4 ml of
Evans blue-labelled albumin (0.25% Evans blue, 4% BSA) intravenously.
2.3.2. Localised bronchoscopic instillation of hydrochloric acid
HC1 pH 1.5 (-0.05 M) was prepared by adding HC1 to V3 normal saline as previously
described (Folkesson et al., 1995). A customised T-piece, which permitted the animal
to be ventilated whilst being bronchoscoped, was interconnected between the
endotracheal tube and the ventilator. The tip of a neonatal bronchoscope (Olympus
BF type 3C10) was wedged under direct vision into the left lower lobe of the animal.
A pre-measured length of nylon tubing (0.94 mm o.d., Portex Ltd., Hythe, Kent) was
threaded down the instrument port of the bronchoscope until its tip could be viewed
emerging distally from the bronchoscope, HC1 (1.0 ml/kg) was then slowly injected
(over 2 minutes) through the nylon tube into the lobe, followed by a bolus of air to
ensure complete delivery of the acid. The nylon tubing and the bronchoscope were
withdrawn and the direct connection of the ventilator to the animal restored.
2.3.4. Ventilation strategy and induction of hypoxia, reoxygenation and
hyperoxia
All animals were ventilated for 4 hours following acid instillation. The 'normoxic'
animals received air and minor adjustments to ventilation parameters were made in
order to maintain an arterial PO2 of 11 KPa (acceptable range range 9.5 - 12 KPa),
PCO2 of 4.3 KPa (acceptable range 3.8 - 5.0 KPa) and a pH of 7.5 (acceptable range
7.38 - 7.6). This was achieved with a respiratory rate of 38 bpm (range 33-44) and a
peak inspiratory pressure of 13 cm H20 (acceptable range 11 - 16). In the hypoxic /
hyperoxic group, animals received a gas mixture of 83% N / 17% O2 for 2 hours to
induce hypoxia (PO2 of 5 KPa, acceptable range 4.0-5.5 KPa) followed by 100% O2
for 2 hours to induce hyperoxia (PO2 60 KPa, acceptable range 52 - 70 KPa). Minor
adjustments were made to the ventilation parameters in order to maintain normal
PCO2 and pH. In the hypoxic / controlled reoxygenation group, animals received a
gas mixture of 83% N / 17% O2 for 2 hours to induce hypoxia as above, followed by
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a gas mixture of 70% N2 / 30% O2 for 2 hours to achieve controlled reoxygenation
(PO2 15 KPa, acceptable range 13-17 KPa). All animals received a 3-second 'sigh'
(peak inspiratory pressure increased to 22 cm H20) every 30 min during ventilation
to prevent atelectasis. The overall protocol for the animal studies is shown in Figure
2.3.4 A. A representative print-out obtained from continuous monitoring of PO2,




Ventilation for up to 4 hours.
















instilled into left lower
lobe (direct lung injury).
Right lower lobe acts as
site for potential indirect
lung injury
2 or 4 hours.
Bronchoscopic lavage. Animal
sacrificed and lung tissue
obtained from both directly-injured
left lower lobe and indirectly-
injured right lower lobe. Final
plasma sample for Evans blue
measurement
Figure 2.3.4.B Legend for figure 2.3.4.A and B.
The left lower lobe in
anaesthetised, ventilated rabbits
was instilled with HCI. Arterial
oxygenation in the ventilated
animal was manipulated by
altering FiC>2 only. The Paratrend
sensor allows continuous
monitoring of arterial pH, PCO2
and PO2. Animals could be
ventilated for up to 2 hours under
hypoxic or hyperoxic conditions
without significantly influencing
PCO2 or pH. The trace shown is
from an animal ventilated under
hypoxic / hyperoxic conditions
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2.3.5. Bronchoalveolar lavage (BAL) and lung excision.
Both the left lower lobe (acid instilled) and right lower lobe (no acid) were lavaged
bronchoscopically in animals. The bronchoscope was advanced through the T-piece
and endotracheal tube and its tip steered then wedged into the appropriate lobe. Ten
ml of sterile saline (4°C) was injected via the appropriate channel into the lobe and
allowed to stand for 2 minutes. Lavage fluid was gently aspirated back through the
bronchoscope and a further 5 ml of saline was similarly instilled and lavaged. The
total volume of lavage fluid recovered using this technique was 11.5 ml (range 10.5 -
12.2 ml). BAL fluid was centrfiuged at 1500 rpm (600 g) for 5 min at 4°C to recover
cells. Total cell counts were performed with a haemocytometer. Samples of cells
were pelleted onto glass slides with a Cytospin 2 (Shandon Scientific, Cheshire, UK)
and stained with Diff-Quick (Oberckochen, Germany), a modified Wright-Giemsa
stain. Differential counts were made by counting 500 cells under oil immersion (x
100). The BAL supernatant was recentrifuged at 1000 g for 10 min at 4°C to remove
cellular debris and used to determine protein leak and IL-8 level as described below.
Immediately following lavage the animal was euthanased with sodium
pentabarbitone (Sagatal, 200 mg/ml, Rhone Merieux Ltd., Harlow, Essex) and both
lungs excised and placed on ice. Pieces of both left and right lower lobes were snap
frozen in liquid nitrogen until use.
2.3.6. Lung tissue homogenisation for protein and RNA
Lung homogenisation was performed using a Polytron® homogeniser (Kinematica,
Switzerland). For tissue to be used in protein assay and IL-8 ELISA, lung pieces
(~300 mg) were homogenised from frozen at 20,000 rpm for 30 seconds in a buffer
containing PBS, protease inhibitor cocktail (Complete™ Boehringer Mannheim) and
0.05 % Nonidet P40. The sample was the spun at 1000 g for 10 min at 4°C and the
supernatant assayed for total protein content and IL-8 concentration by Pierce assay
and ELISA respectively. For RNA extraction, lung tissue (~150 mg) was
homogenised from frozen in 3 ml TRIzol® reagent at 20,000 rpm for 45 seconds.
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The sample was then spun at 500 g for 5 min at 4° C to remove debris. The
supernatant was then processed as per the manufacturers' protocol, based on the
method of Chomczynski and Sacchi, (1987). Total RNA was dissolved in DEPC-
treated water and stored at -70° C until use.
2.3.7. Measurement of lung protein leak
Leakage of Evans blue-labelled albumin in the bronchoalveolar lavage fluid was
used to determine lung protein leak, a modification of a previously described method
(Patterson et ah, 1992). An aliquot of BAL fluid was taken and the optical density at
620 nM measured by spectrophotometry ( P8700, Philips). This result was converted
into a measure of albumin content using a pre-determined standard curve and
compared with that obtained from blood plasma (obtained at the time of lavage). The
degree of lung leak is expressed as 'plasma equivalents', that is the amount ofplasma
that would have been required to pass into the alveolar space to account for the
presence of Evans blue-labelled albumin in lavage fluid. This method has been
found to be as sensitive as using 125I-labelled albumin leak (Patterson et al., 1992),
and has been used as a measure of lung protein leak in several animal studies (Mason
and Efffos, 1983; Rogers et al., 1989).
2.3.8. Rabbit IL-8 ELISA
Rabbit IL-8 ELISA was performed on BAL fluid and lung tissue homogenate using
reagents kindly supplied by Dr Caroline Hebert (Genentech Inc., CA) and using
minor modifications of a previously described method (Folkesson et al., 1995).
Microtitre plates (96-well; Costar, Cambridge, MA) were coated overnight at RT
with a mouse anti-human IL-8 monoclonal antibody (ARIL8.2; final concentration 2
pg/ml, diluted in 0.5% BSA / 0.05% Tween 20 / PBS). Wells were washed 3 times
with was buffer (0.05% Tween 20 in PBS) and non-specific binding sites blocked for
1 hour with 200 pi of 1% BSA in PBS. Rabbit recombinant IL-8 (rIL-8) and samples
(BAL fluid or lung homogenate, both without dilution) were added to the wells and
incubated at RT for 2 hrs. After washing, the secondary antibody (biotinylated
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8C1.1.6; 1 in 3500 in 0.5% BSA / 0.05% Tween 20 / PBS) was added and following
a further 2 hr incubation and subsequent wash, horseradish peroxidase - conjugated
streptavidin (1:20,000) was added for 30 min. Substrate solution consisting of
tetramethyl benzidine 100 pg/ml, 4.5 mM H2O in 0.1 M sodium acetate-citrate pH
4.9 was added and the plates incubated in darkness at room temperature for 30 min.
The reaction was stopped with 50 pi of 0.5 M H2SO4.
Plates were read at 450 nm in an plate reader (Dynatech MR5000). Sample values
were determined using a software package (Assayzap) from a standard curve. The
linear range was -320-7500 pg/ml, and the lower limit of detection 60 pg/ml. Despite
measuring rabbit samples undiluted, IL-8 levels tended to fall below the linear range.
However, the sensitivity of the assay was sufficient to allow reproducible
measurements. For lung homogenate samples, IL-8 results were corrected for total
protein, measured by BCA protein assay and expressed in pg/ml/mg total protein. As
BAL volumes were consistent with minimal variability (median 11.5, range 10.5 -
12.2 ml), no correction was applied and the results expressed in pg/ml.
2.3.9, Semi-quantitative rabbit IL-8 RT-PCR
IL-8 mRNA levels in lung tissue were determined by semi-quantitative RT-PCR
from total RNA derived from lung homogenates as described. First strand cDNA was
synthesised from 1 pg total RNA in a reaction mix containing 0.5 pg Oligo-dT
primer, 1 mM dNTPs, 16U RNasin, 20U AMV-RT and 10 mM MgCl. The reaction
mix was incubated for 45 min at 48°C. Rabbit IL-8 primers, designed from the
GenBank succession sequence number M57439 (Yoshimura et al., 1991) were; 5'-
ATG AAC TCC AAG CTG GCT-3' (sense) and 5'-TTA TGA CTC TTG CTG
CTC AGC-3' (antisense). These primers reside respectively in exon 2 and exon 4 of
the rabbit IL-8 gene, and hence span 2 introns. The predicted and observed product
size for rabbit IL-8 using these primers was 308 bp.
PCR conditions were: 94°C for 1 min (denaturation), 55°C for 1 min (annealing) and
72°C for 1 min (extension) followed by a final 5 min extension at 72°C. The human
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P-actin gene was employed as a housekeeping product. The primers used were: 5'-
CCA CCA ACT GGG ACG ACA TG-3' (sense) and 5'- GTC TCA AAC ATG
ATC TGG GTC ATC-3' (antisense). The PCR conditions for P-actin were: 94°C
for 1 min (denaturation), 60°C for 1 min (annealing) and 72°C for 1 min (extension)
followed by a final 5 min extension at 72°C. The predicted product size, based on
human studies, was 180 bp.
A series of experiments were performed to validate and refine the rabbit IL-8 and p-
actin RT-PCR (Figure 2.3.9A). These included an experiment to define the linear
phase for PCR product versus cycle number (Figure 2.3.9B), and based on these
results, 26 cycles were used in subsequent RT-PCR experiments.
Figure 2.3.9A
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Legend for Figure 2.3.9A. Validation of Rabbit IL-8 RT-PCR
A series of control experiments were performed to validate the rabbit RT-PCR. Total
RNA from rabbit alveolar macrophages stimulated for 4 hours with LPS (500 ng/ml)
was used in RT-PCR reactions, using reagents described in text. Lanes 1 and 2 show
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Legendfor Figure 2.3.9A continued
a 308 bp and 180 bp IL-8 and P-actin PCR product respectively. In Lane 3, both IL-8
and P-actin primers were used in the same reaction ('multiplex-PCR'). Although the
bands are distinguishable, the intensity of both is reduced. Lanes 4 and 5 represent
IL-8 and P-actin primers respectively in the absence of RNA. The visible LMW
bands represent primer pairs. Although IL-8 and P-actin primers were designed to
span at least one intron, additional controls were performed to ensure the PCR
products did not represent amplified genomic rabbit DNA. In Lanes 6 and 7, the IL-8
RT-PCR reaction was 'spiked' with 2 ng and 20 ng of genomic rabbit DNA
respectively. The observed 308 bp IL-8 product was not affected. In Lanes 8 and 9,
100 ng of genomic rabbit DNA was amplified with IL-8 and P-actin primers in the
absence of RNA or RT-AMV. A smear is seen, demonstrating that neither IL-8 nor
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Legend for Figure 2.3.9.B Cycle number versus product for rabbit IL-8 and P-actin
RT-PCR. Rabbit alveolar macrophages were stimulated with LPS 500 ng/ml.
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Legendfor Figure 2.3.9B continued
Total RNA was extracted and RT-PCR performed using primers and conditions
described in text. Product increases exponentially with increasing cycle number for
both IL-8 and p-actin. 26 cycles falls within the linear portion for both PCR
products, and this cycle number was used for measuring rabbit IL-8 mRNA
expression by RT-PCR in subsequent experiments. The PCR gels (top) and
densitometry (lower) from n=l experiment are shown.
2.4. STATISTICAL ANALYSIS
For in vitro experiments, results are reported as pooled data from n separate
experiments performed in triplicate unless otherwise stated, where n=T refers to an
individual donor, in which each treatment condition is replicated 3 times. The gel
images shown are representative of n>3 experiments. For in vivo experiments, results
are reported as pooled data from n separate experiments, where n=l refers to an
individual animal. Data is presented as mean ± SEM unless otherwise stated.




IN VITRO STUDIES OF ACUTE HYPOXIA, HYPEROXIA AND STRESS
MEDIATORS ON IL-8 GENERATION IN MACROPHAGES
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3.1. INTRODUCTION
It is a well-recognised phenomenon that only a subgroup of patients with major
predisposing insults, such as multiple trauma, sepsis, aspiration or pancreatitis, develop
the catastrophic inflammatory response characteristic of acute respiratory distress
syndrome (ARDS) (Fowler et ah, 1983). Our group has previously demonstrated that
raised intrapulmonary IL-8 levels are associated with progression to ARDS (Donnelly et
al., 1993; Hirani et ah, 2001). In patients with major trauma, these raised levels of IL-8
were detectable in bronchoalveolar lavage (BAL) fluid within a few hours of the
initiating event (median 95 minutes, range 30-240 min), well before clinical evidence of
ARDS. Immunohistochemical analysis has implicated the alveolar macrophage as a
potent source of IL-8. The mechanisms by which intrapulmonary IL-8 may be
upregulated in this context are unknown.
The immediate aftermath of a major trauma event is characterised by a constellation of
rapid and often profound physiological and metabolic events. Hypotension, hypoxaemia,
tissue hypoxia and acidosis are frequently exhibited. Activation of the hypothalamic-
pituitary-adrenal (HPA) axis and the sympathetic nervous system generates both systemic
and localised release of catecholamines (Elenkov et al., 2000) and neuro-endocrine
mediators. Circulating and tissue levels of archetypal early proinflammatory cytokines
such as IL-1, IL-6 and TNF-a may be raised and generate a 'cytokine cascade'.
Endotoxin has been implicated as a potential 'hit' post- trauma, with the suggestion that
commensal bacteria are able to translocate from compromised gut into the circulation
during a period of hypovolaemic shock (Baker et al., 1988; Rush et al., 1988).
Furthermore, the resuscitation phase following trauma introduces additional potential hits
in the form of reperfusion, reoxygenation, hyperoxia, and ventilation-induced barotrauma
(Saadia, 1996; Rocker, 1997; Czermak et al., 1999; Dos Santos and Slutsky, 2000).
In the context of a vastly complex stress response, I have focused on a selection of
potential inflammatory stimuli to which the lung may be exposed following major
trauma: 1) hypoxia, a consequence of several factors including hypoventilation,
atelectasis, and contusion. Our clinical study had revealed a relationship between
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impaired gas exchange, as manifest by reduced PaC>2 / Fi02, and raised IL-8 (r = -0.56,
PO.OOl, n=42) (Hirani et al., 2001); 2) hyperoxia, which is relevant in the immediate
resuscitation phase of trauma, during which high flow oxygen is delivered to the
ventilated lung; 3) the stress mediators adrenalin, substance P and MIF, and the
archetypal proinflammatory mediators endotoxin, TNF-a and IL-ip.
The aim of this study was to determine the in vitro effects of these potential stimuli in
human monocyte-derived macrophages. Based on our clinical observations, particular
emphasis was placed on the acute in vitro effects of hypoxia and hyperoxia.
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3.2. RESULTS
3.2.1. Rate of equilibration of medium without cells with environmental oxygen
under hypoxic or hyperoxic conditions.
One of the key aims of this study was to determine the effects of acute hypoxia and
hyperoxia on cultured cells. It was therefore important to determine the time required for
culture medium to equilibrate with changes in environmental oxygen. In initial studies
medium with 2% serum, without cells, was aliquoted into 35 mm (6-well) plates, 2.5 ml
per well, and incubated in a normoxic incubator (PO2 21%, PCO2 5%), the NAPCO
incubator (PO2 0.1%, PCO2 5%), the MK3 anaerobic unit (PCO2 10%, H2 10%, N2 80%)
or a hyperoxic chamber (PO2 95%, PCO2 5%). The plate lids were left on during the
incubations. The partial pressure of dissolved oxygen was measured at intervals with an
OXEL-1 oxygen probe, the tip placed -5 mm above the base of the plate. For
incubations performed in the MK3 anaerobic unit, these measurements were made
without removing the plates from the chamber. This technique was not feasible for
incubations performed in the normoxic, NAPCO hypoxic or hyperoxic conditions. In
these cases, the plates were removed from the incubator and the PO2 in the medium
immediately measured. The results are shown in Figure 3.2.1
3.2.2. Effect of cultured macrophages on PO2 of medium in hypoxic conditions and
following reoxygenation
The studies of oxygen equilibration under hypoxic and hyperoxic conditions were
performed in medium with 2% serum without cells. Under severely hypoxic conditions
(0% and 0.1% oxygen), the equilibrated PO2 in solution was -3.8 KPa, as measured by
OXEL-1 probe. However, it is likely that the presence of actively metabolising cells
would influence medium oxygenation. To explore this further, mature human monocyte-
derived macrophages cultured in 6-well plates were transferred from a normoxic
incubator to the MK3 anaerobic chamber. The overlying culture medium was removed
and replaced with 2.5 ml of medium with 2% serum, which had been pre-incubated in the
anaerobic unit for 16 hours. The PO2 of the medium was measured at intervals, -5 mm
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Figure 3.2.1









Legend for Figure 3.2.1. Partial pressure of oxygen in medium without cells
incubated in normoxic, hypoxic or hyperoxic conditions over time.
The PO2 in medium was measured by OXEL-1 probe placed 5mm above the bottom of 6-
well plate containing 2.5 ml of medium with 2% serum. Under these conditions,
equilibration with a 0% and 0.1% atmosphere was achieved by approximately 5 hours
(-3.8 KPa). Equilibration in the hyperoxic chambers approached equilibration by 2 hours
(~ 70 KPa). The data shown is from n=l experiment. The experiment was repeated once,
with very similar results (data not shown).
above the cells with the OXEL-1 probe. In addition, because of the possibility protein
may foul the OXEL-1 probe tip in the presence of cells, PO2 was also measured by
automated gas analyser (model ABL-330, Radiometer Copenhagen, see Chapter 2). After
4 hours, the plates were removed from the anaerobic chamber, returned to the normoxic
incubator and the PO2 ofmedium again measured at intervals. The results are presented in
Figure. 3.2.2. The P02in hypoxia-equilibrated medium fell slightly within 15 min of
transfer onto macrophages, and reached an apparent equilibrium by 30 min at PO2 ~ 3.5
KPa. Re-exposure to a normoxic environment resulted in a slow reoxygenation of the
medium, such that the PO2 value was - 6 KPa by 1 hour and -12 KPa by 4 hours, as
measured by OXEL-1 probe. Measurement of PO2 by automated gas analysis yielded
similar results, except at 4 hours post-reoxygenation, a time-point at which PO2 measured
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Legend for Figure 3.2.2. Partial pressure of oxygen in medium in the presence of
macrophages under hypoxic conditions, and following re-exposure to normoxia.
Monocyte-derived macrophages were transferred from a normoxic incubator to the MK3
anaerobic chamber, and the overlying medium replaced with medium with 2% serum pre-
incubated in the anaerobic chamber (Time 0). At 4 hours, the culture plates were
transferred back to a normoxic incubator. Automated gas analyser or OXEL-1 probe was
used to measure PO2 in medium at intervals. The data-points represent the mean from
n=2 separate experiments.
3.2.3. The effect of varying oxygenation on pH of medium
Since the partial pressure of CO2 also varied between the normoxic, NAPCO, MK3 and
hyperoxic incubations, the pH of the medium in the presence of cells was also measured
after 4 hours incubation. An automated gas analyser was used, which in addition to pH,
also measured dissolved oxygen and carbon dioxide (Table 3.2.3). Sterile PBS and H2O
were also incubated in the MK3 anaerobic chamber. Although PCO2 levels were higher in
medium cultured in the anaerobic unit, pH was not greatly affected, presumably reflecting
the buffering capacity of medium. The effects of severe acute hypoxia and hyperoxia on
glucose concentration in medium was also assessed (Randox glucose assay, kindly
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performed by Clinical Biochemistry, Edinburgh Royal Infirmary). Glucose levels were
not significantly different between treatments.
Table 3.2.3 OXEL-1 Automated Gas Analyser Glucose
probe (mM)
P02 po2 PC02 PH
Normoxic Medium / 2% 19.8 22.1 4.5 7.36 24.2
incubator serum 19.4 19.8 4.3 7.32 23.5
21% 02 / 5%
C02
MK3 anaerobic Medium / 2% 3.8 4.4 6.5 7.30 23.5
unit serum 3.9 4.1 6.4 7.31 24.6
80% N2/ 10% pbs 3.5 4.0 6.1 7.33 0
H2/ 3.7 4.3 6.9 7.37 0
10% co2
Sterile water 3.8 4.0 6.1 7.0 0
(no cells) 3.7 3.8 6.9 6.8 0
NAPCO hypoxic Medium / 2% 3.9 4.4 5.3 7.32 24.2
incubator serum 3.5 4.7 4.9 7.3 23.6
95% N2/ 5% C02
/ 0.1%O2
Hyperoxic sealed Medium / 2% 73 80 6.1 7.42 22.7
chambers serum 78 84 5.9 7.44 23.4
95% 02 / 5% C02
Legend for Table 3.2.3 The effects of varying gas exposures on medium Dissolved
oxygen in solution in the presence of cells (except sterile water, which was without cells)
was measured by OXEL-1 probe and by automated analyser. The latter also measured
CO2 and pH. All measurements were made after 4 hours incubation at 37°C. Experiments
were performed twice, and both values are shown.
The studies of medium glucose levels suggest only that the effects of hypoxia and
hyperoxia described later were not a result of glucose deprivation. The precise effects on
cellular metabolism are not determined by this method.
The presented studies of oxygen equilibration have shown that equilibration of oxygen
content in medium with environmental oxygen takes place over a period of hours. In
order to expose cells to rapid changes in oxygenation, the medium therefore requires pre¬
incubation in the relevant environment. In all subsequent experiments, medium was
aspirated from cells and replaced with pre-incubated medium to achieve rapid hypoxia,
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reoxygenation or hyperoxia (Figure 3.2.3.1). All hypoxic experiments were performed in
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Legend for Figure 3.2.3.1 Experimental protocol used to achieve rapid changes in
oxygenation in cell culture. The studies of rate of equilibration of culture medium in
varying oxygen environments suggest that rapid changes in oxygenation may only be
achieved by pre-incubation of medium in the required environment. This protocol was
employed for subsequent hypoxia, reoxygenation and hyperoxia experiments
3.2.4. Viability ofmacrophages following hypoxia, reoxygenation and hyperoxia.
Cell viability was assessed by Trypan blue exclusion and LDH assay in cell supematants.
Under all conditions, > 95% of cells excluded Trypan blue at the end of the experimental
treatment. Levels of LDH were assayed in n=3 experiments. Monocyte-derived
macrophages were cultured in 2% serum for 6 hours in normoxia, hypoxia or hyperoxia,
or 3 hours hypoxia / 3 hours hyperoxia. LDH activity was measured by comparison with
a standard curve obtained with human erythrocyte LDH solution containing 2% human
serum. An LDH value of < 0.03 U was consistently obtained in cell supematants under all
conditions, compared to 23±4 U in positive controls (macrophages lysed with 0.1%
Nonidet-P40).
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3.2.5. IL-8 secretion from hypoxic macrophages over 4 hours
Hypoxia increased secreted IL-8 by 2 hours incubation (0.94 ± 0.18 v 0.54 ±0.1 IU/ml,
n=9, P<0.02)(Figure 3.2.5). At 1 hour there was a trend to increased IL-8











Legend for Figure 3.2.5. Interleukin-8 secretion from hypoxic and LPS treated
macrophages over time. Hypoxia significantly increased IL-8 secretion at 2 hours but
not at other time-points. LPS significantly increased IL-8 secretion compared to normoxia
and hypoxia at all time points. Data presented as mean ± S.E.M. n=9 separate donor
experiments for 2 hours. n>8 separate donor experiments for other time-points. *P<0.02
compared to normoxic control
3.2.6. Inter- and intra-donor variability in IL-8 secretion in response to 2 hours
hypoxia
The individual response to 2 hours hypoxia from macrophages derived from n=9 healthy
donors is shown in Figure 3.2.6A. Whilst hypoxia increased IL-8 secretion from all
donors, there was considerable variability in the response, from a 10 % increase (donor E)
to a 120 % increase (donor C). Experiments with macrophages from donor D (80 %
increase) and donor E (10 % increase) were repeated on 3 separate occasions (Figure
103
3.2.6B) Donor E demonstrated a consistent lack of effect with 2 hours hypoxia. Donor D
demonstrated an increase in IL-8 release on each occasion and the magnitude of the
response was similar on each occasion (80 %, 90 % and 118 % increase in experiments










Legend for figure 3.2.6. Individual variation in IL-8 secretion from donor
macrophages in response to 2 hours hypoxia. There was variation in hypoxia-induced
IL-8 secretion between donors (A-I)(3.2.6A). Experiments with donor D (a high IL-8
responder) and donor E (a low IL-8 responder) were repeated on 3 separate occasions
(1,2 and 3)(3.2.6B) with similar hypoxic responses each time.
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3.2.7. IL-8 secretion from macrophages treated with IL-ip, TNF-a, Substance P,
adrenalin or MIF
It was apparent that the 2 hour IL-8 response to hypoxia, whilst statistically significant,
was small (1.7-fold increase), particularly in comparison to that seen with LPS (Figure
3.2.5). Since this early time-point may be relevant with regard to the at-risk period of
ARDS, the effect of other potentially clinically relevant mediators on macrophage IL-8
secretion were also studied. Monocyte-derived macrophages from healthy volunteers
were treated with IL-ip, TNF -a, LPS, Substance P, adrenalin or MIF, and the IL-8
secretion into the cell supernatants after 2 and 8 hours was measured. Compared to
controls, IL-ip , TNF -a, LPS and Substance P at 10~6 and 10~7 M significantly increased
IL-8 secretion by 8 hours. Adrenalin 1CT6 10"7 M significantly inhibited basal IL-8
secretion compared to controls at this time-point (Figure 3.2.7A). By 2 hours, IL-ip,
TNF-a and LPS significantly increased IL-8 secretion compared to normoxia. Substance
P, adrenalin and MIF had no effect on IL-8 secretion at this early time-point (Figure
3.2.7B), Hence, at the early time-point, only the archetypal proinflammatory mediators
significantly increased IL-8 secretion. Furthermore, the magnitude of the IL-8 response to
IL-ip and TNF-a at the two hour time-point (1.6-fold increase and 2.1-fold increase
respectively) were similar to that observed with hypoxia.
3.2.8. Hypoxic monocyte-derived macrophages do not store intracellular IL-8
To establish if hypoxia increased intracellular stores of IL-8, levels were measured in
cultured macrophages lysed in PBS / 0.1% Nonidet P40 following careful washing in
complete medium. Lysate levels of IL-8 in normoxic and hypoxic macrophages were
below the level of detection (<0.004 IU/ml) at all time points up to and including 4 hours.
Macrophages at To (i.e. cells that had been cultured to maturity in 10% serum over 5 days
and then lysed immediately prior to normoxic / hypoxic culture in 2% serum) were also
found to have undetectable intracellular IL-8. Hence IL-8 release from hypoxic











































Legend for Figure 3.2.7. IL-8 secretion from human monocyte derived macrophages
treated with stress mediators and classical proinflammatory mediators. Macrophages
were cultured for 8 hrs (3.2.7A) or 2 hrs (3.2.7B) with IL-lp (10 ng/ml), TNF-a (10
ng/ml), LPS (1 pg/ml), Substance P (SP, 10"1U to 10"3 M ), adrenalin (Ad, 10"10 to 10"° M )
or macrophage inhibitory factor (MIF, 0.1-20 ng/ml). At 8 hours, IL-1 p, TNF-a, LPS and
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Legendfor Figure 3.2.7 continued
the higher doses of SP significantly increased IL-8 secretion, and Ad 10"6 and 10"7
significantly inhibited IL-8 secretion compared to normoxic controls (C). At 2 hours, IL-
ip, TNF-a and LPS significantly increased IL-8 secretion compared to controls. Data
presented as mean ± S.E.M. n = 5 separate donor experiments for each condition.
*P<0.05 compared to controls.
3.2.8. Acute hypoxia does not stimulate macrophage TNF-a or IL-lp secretion.
Secreted levels of both TNF-a and IL-ip were below the level of detection (<15.6 pg/ml
and < 3.9 pg/ml respectively) in hypoxic macrophages at all time points (Figure 3.2.8).
LPS significantly increased secretion of both cytokines by 1 hour and 2 hours
respectively. This suggests that the increase in IL-8 secretion by 2 hours hypoxia was
phenomenon secondary to increased macrophage TNF-a or IL-ip release.
Figure 3.2.8.
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Legend for Figure 3.2.8, Interleukin-ip and TNF-a secretion from hypoxic and LPS
treated macrophages. Secreted levels of IL-ip and TNF-a were below the level of
detectability from normoxic or hypoxic macrophages. LPS treatment significantly
increased secretion of both cytokines compared to normoxic controls. TNF-a secretion
following LPS was significantly greater than that of IL-ip at all time points. Data
presented as mean ± S.E.M. n=4 separate experiments for each time-point. *P<0.01
compared to normoxic control
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3.2.9. The effect of acute reoxygenation and hyperoxia on IL-8 expression in
macrophages
The finding that hypoxia increased IL-8 protein secretion by 2 hours was consistent with
the premise that acute hypoxia may represent an inflammatory stimulus or 'hit'.
However, reoxygenation and hyperoxia potentially represent clinically relevant secondary
stimuli or hits. The effects of acute reoxygenation and hyperoxia on macrophage IL-8
generation were therefore studied.
Rapid changes in macrophage oxygenation were achieved by carefully removing hypoxic
medium after 2 hours culture, transferring the plates to normoxic (5% CO2 / 95% air) or
hyperoxic (5% CO2 / 95% O2) conditions, overlaying cells with fresh medium pre-
incubated in the desired atmosphere and culturing for a further 2 hours (as per Figure
3.2.3.1). Total IL-8 secreted over the 4 hour experiment was measured by ELISA in
pooled supernatants.
Of the conditions tested, hypoxia / hyperoxia was the most potent stimulus for IL-8
generation, resulting in significantly greater protein secretion than hyperoxia / hyperoxia
or hypoxia / reoxygenation. Hypoxia / hypoxia did not significantly increase IL-8 protein
expression compared to normoxic controls. Steady-state IL-8 mRNA expression
paralleled protein expression except for hypoxia / hypoxia, which resulted in a significant
increase in mRNA expression without corresponding increase in secreted protein
3.2.10. The effect of acute reoxygenation and hyperoxia on IL-lp and TNF-a
expression in macrophages
In contrast to the effects on IL-8 secretion, hyperoxia alone was the most potent stimulus
for TNF-a or IL-ip secretion (Figure 3.2.10). Reoxygenation to normoxia following
hypoxia does not induce detectable levels of either cytokine. In addition, the levels
expressed following hyperoxia were <150 pg/ml, approximately ten-fold less than
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Legend for Figure 3.2.9. The effect of hypoxia, reoxygenation and hyperoxia on IL-8
protein and mRNA expression in macrophages
3.2.9A. Hyperoxia resulted in significantly greater IL-8 protein secretion than normoxia
or hypoxia. The multiple-hit of hypoxia / hyperoxia was the most potent stimulus for IL-8
protein secretion. Hypoxia / normoxia however resulted in IL-8 levels similar to
normoxic controls.
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Legendfor Figure 3.2.9. continued.
3.2.9B. IL-8 mRNA densitometry expressed relative to normoxic control, corrected for
18s (housekeeping gene) expression. As with protein expression, hypoxia / hyperoxia was
a more potent stimulus than hyperoxia alone. Hypoxia alone increases IL-8 mRNA
expression without corresponding increase in protein secretion. The data for IL-8 protein
expression represents mean ± SEM of n=4 separate experiments. IL-8 mRNA expression
data represents mean ± SEM from n=3 separate experiments. The northern blot shown
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Legend for Figure 3.2.10. The effect of hypoxia, reoxygenation and hyperoxia on IL-
ip and TNF-a protein secretion . Hyperoxia significantly increased secretion ofboth
cytokines in monocyte-derived macrophages, and was a more potent stimulus than
hypoxia / hyperoxia. The data represents mean ± SEM of n=4 separate experiments.
*P<0.05 compared to all other conditions.
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3.3. DISCUSSION
In this chapter, the effects of acute hypoxia, reoxygenation and hyperoxia were studied in
human monocyte-derived macrophages. The rate of equilibration of culture medium with
varying environmental oxygen was shown to occur over several hours, suggesting the
need to pre-incubate medium to achieve rapid changes in oxygenation. Acute hypoxia
was shown to increase IL-8 protein secretion at 2 hours. The increase at this time-point
was comparable to that seen with TNF-a and IL-1(3, whilst a selection of stress mediators
were shown not to induce IL-8 secretion at this early time-point. Finally, hypoxia /
hyperoxia, was found to be a potent stimulus for IL-8 generation. The potential relevance
of these findings to raised intrapulmonary IL-8 in trauma patients at-risk of ARDS are
discussed.
The inherent limitations of in vitro studies in which oxygenation is manipulated have
been recognised for many years (Chapman et al., 1970). In order to fully interpret the
apparent effects of hypoxia or hyperoxia on cell function, direct measurement of PO2 in
culture medium, ideally in the peri-cellular environment is desirable and perhaps even
essential (Ebbesen et al., 2000). In the studies herein, medium (without cells) transferred
into hypoxic (0% or 0.1% O2) or hyperoxic conditions, required up to 5 hours to achieve
oxygen equilibration (3.9 KPa and -70 KPa for hypoxic and hyperoxic environments
respectively).
Several factors are likely to influence the rate of equilibration of medium in vitro. These
include the surface area to volume ratio of the medium, the nature of the plate lid (vented
or intact) and convection forces (associated with flushing for example) generated in the
incubator. Allen et al., (2001) have demonstrated that in 100-mm plates, lid perforations
allowed cell-free medium to equilibrate with a 100% N atmosphere by 2 hours, compared
to over 3 hours with intact lids. Equilibration of medium in T-75 flasks with perforated
lids, (high surface area : volume) was significantly faster than in 100-mm plates, but still
required over 1 hour to achieve. These data support the presented observation that
equilibration is not a rapid phenomenon in vitro, and justify the use of pre-incubation to
achieve rapid changes in oxygenation.
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It has been reported that actively metabolising cells significantly affect oxygen
equilibrium in hypoxic conditions (Wolff et al., 1993; Metzen et al., 1995; Allen et al.,
2001). When medium pre-incubated in anoxic conditions was added to cultured
macrophages and maintained in an anoxic environment, the PO2 fell from -3.8 KPa to
-3.2 KPa after 4 hours, as measured by OXEL-1 probe. Measurement by automated gas
analyser consistently showed a slightly lower value of -2.8 KPa. It is however unlikely
that either method accurately reflected peri-cellular PO2 in these circumstances. The
OXEL-1 probe, which has a tip diameter of 2 mm, was positioned 5 mm above the cell
monolayer. The gas-permeable membrane of the OXEL-1 is reportedly affected by
protein coating in the presence of cell culture, which may significantly hamper oxygen
measurement (Technical Assistance, World Precision Instruments Inc. USA, personal
communication). Similarly, the automated gas analyser measures PO2 in a sample of
medium aspirated from the cultured cells, and is not a direct measure of peri-cellular
oxygenation. Both methods are therefore likely to have underestimated the degree of
hypoxia experienced by cells in this environment. In the presence of constant oxygen
utilisation in an anoxic environment, it is likely that the peri-cellular PO2 would be lower.
Using a fibre-optic oxygen probe (which is not affected by protein fouling), positioned
1.5 mm above confluent A549 cells, Allen et al., (2001) showed that the peri-cellular PO2
fell from -20 KPa to 0 KPa by 90 min of transfer to an anoxic environment. Previous
studies in which PO2 in cell cultures has been directly measured or estimated have also
suggested very low oxygen tensions in the peri-cellular region (McLimans et al., 1968;
Stevens, 1965). Indeed, it has been shown that even in normoxic conditions (21 %
oxygen), the measured peri-cellular PO2 of hepatoma (HepG2 and Hep3B) cells is zero,
compared to -10 KPa in a bovine endothelial cell-line and 15 KPa in renal epithelial cells
(Metzen et al., 1995). These data expose a potentially critical aspect of oxygenation
studies; the standard classification employed in studies of hypoxia, normoxia and
hyperoxia do not reflect physiological cellular oxygenation in vivo, and neither do they
necessarily reflect cellular oxygenation in vitro culture. Hence, 'normoxia' in in vitro
studies is generally accepted as equivalent to ambient air, though this is only likely to be
biologically relevant to the lining cells of the upper respiratory tract (Figure 1.4.1).
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Exposing hepatoma cells to severe hypoxia in vitro would seem a reasonable model for
studying the pathology of hepatic ischaemic injury, but the observation that the peri¬
cellular PO2 of 'normoxic' hepatoma cells approaches zero needs consideration when
interpreting the results. In the light of these observations, it has recently been proposed
that studies of oxygenation in vitro should attempt to directly measure peri-cellular
oxygenation and to define normoxia, hypoxia and hyperoxia based upon current
knowledge of physiologically relevant PO2 for individual cell-types cell in health and in
disease states (Ebbesen et al., 2000).
Interleukin-8 protein secretion from macrophages under hypoxic conditions was
significantly higher than normoxic controls by 2 hours, but not at earlier time-points. By
4 hours, protein secretion from hypoxic cells was similar to controls. It is apparent that
even under 'basal' normoxic controls, macrophages continue to secrete IL-8. It is possible
that the switch from 10% serum in which the macrophages were derived, to 2% serum for
experiments, acted as a 'serum-withdrawl' stimulus. It is also possible that the 2 hour
effect is a response to a progressively falling pericellular PO2 as equilibrated hypoxic
medium is added to actively metabolising cells. An inter-donor variation in the 2 hour
hypoxic response was observed which may reflect an underlying genetic polymorphism,
several of which have recently been described for the IL-8 gene (Hull et al., 2001;
Renzoni et al., 2000; Emi et al., 1999). However, it should be emphasised that as all the
experiments were performed in the presence of autologous serum, the hypoxic IL-8
response may reflect the presence of an unidentified serum factor or factors.
The magnitude of the IL-8 response by 2 hours hypoxia was comparatively smaller than
that observed with LPS, it was similar to that seen with TNF-a and IL-ip stimulation.
This comparison is valid since endotoxin, TNF-a and IL-lp are well-characterised
inflammatory mediators with established roles in the pathogenesis of the inflammatory
response (Morrisson and Ryan, 1987; Tracey et al., 1986; Tracey and Cerami, 1994;
Dinarello, 1992). Elevated levels of both cytokines are found in the alveolar airspaces of
patients both at-risk of, and with, established ARDS (Chapter 1.1). The clinical
relevance of endotoxin in trauma patients, in whom there is no obvious cause for
endotoxaemia, is unresolved. The translocation of endotoxin from bowel under conditions
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of hypo-perfusion and hypotension has been demonstrated in animal models and patients
in an intensive care setting (Moore et ah, 1991; Rouman et ah, 1993C; Rush et al., 1988).
However, the association between gut translocation and the development of MODS or
ARDS remains contentious (Hoch et ah, 1993; Ayala et ah, 1990; Donnelley et ah,
1994A; Saadia and Lipman, 1995; Hassoun et ah, 2001). In our own study of trauma
patients, we found no association between initial endotoxin levels in BAL fluid or blood
and progression to ARDS (Hirani et ah, 2001).
In contrast to the much-studied roles of endotoxin, TNF-a and IL-ip in trauma and the
inflammatory response, there is comparatively little in vitro or in vivo data regarding
stress mediators in this setting. Substance P (SP), adrenalin and MEF may however be
relevant to the acute systemic inflammatory process, and in particular to the at-risk period
of ARDS. In human studies, raised plasma SP levels have been reported following soft-
tissue injury and burns when compared to healthy controls (Onuoha and Alpar, 1999;
Onuoha and Alpar, 2001). The plasma concentration of SP in injured patients, measured
within 24 hours of injury, was in the picomolar range. Within the lung, SP secreting
fibres are present at all levels of the airways, as part of the non-adrenergic, non-
cholinergic (NANC) neural network (Fox et ah, 1980; Barnes, 1986). In a study of seven
patients with established ARDS, BAL levels of SP were in the 10~10 range and 3-4 fold
higher than in controls with congestive heart failure (Espiritu et ah, 1992). The potential
importance of SP in acute lung injury has been demonstrated in studies of genetically
engineered mice deficient in the SP receptor NK-1R. In wild-type mice, intravenous
delivery of chicken egg albumin and intra-tracheal rabbit antibody to chicken egg
albumin resulted in an acute neutrophil influx and alveolar protein leak. Lung injury was
significantly attenuated in NK-1R knockout mice (Bozic et ah, 1996). A similar
observation was made in a pancreatitis-induced model of ALI (Bhatia et ah, 1998 in
PNASU). Finally, a specific NK-1R antagonist has been shown to attenuate immune
complex mediated lung injury in mice (Kaltreider et ah, 1997).
In the presented study, SP was found to have no effect on human macrophage IL-8
release by 2 hours. However at doses of 10~7 to 10~5 M, SP significantly increased IL-8
secretion by at 8 hours. In previous studies, human monocytes have been shown to
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secrete IL-1, TNF-a and IL-6 in response to SP by 6 hours, at an optimal dose of 10" M
(Lotz et al, 1988). SP at doses in the nanomolar range increases TNF-a secretion from
human cord blood monocyte-derived macrophages (Ho et al., 1996), and IL-8 secretion
from human astrocytoma cells (Lieb et al., 1997) over 24 hrs. Hence, SP represents a pro¬
inflammatory mediator, which may be relevant in the pathogenesis of acute lung injury
and ARDS. However, it was found not to be a rapid inducer of IL-8 generation from
macrophages in vitro.
Following a major insult, the stress-induced 'fight or fight' reaction is principally
mediated through enhanced production of catecholamines. Reported maximum plasma
adrenalin levels in unstressed, supine, normotensive control human subjects are 100-150
pg/ml (Cryer, 1980; Rosano et al., 1991). Immediately following trauma for example,
levels increase 10 to 100-fold, with a near linear relationship between severity of injury
and plasma adrenalin (Little et al., 1985). Adrenoceptors have been identified on
pulmonary endothelial, epithelial, smooth muscle and macrophage cells (Barnes, 1984).
Adrenergic innervation in the human lung is however comparatively sparse (Barnes,
1986) and this suggests that the majority of intrapulmonary effects are mediated by
circulating catecholamines. In the presence of lung leak, a feature of acute lung injury,
alveolar cells will be exposed to plasma adrenalin. In patients with established ARDS,
circulating adrenalin levels measured at a single time-point have been reported to range
from 0 to 75,000 pg/ml (Ware and Matthay, 2001).
In monocyte-derived macrophages, adrenalin inhibited basal IL-8 secretion by 8 hours,
but had no effect at 2 hours. In general, adrenalin is considered to promote anti¬
inflammatory responses (Uusaro and Russell 2000), including inhibiting TNF-a
production (Liao et al., 1995; Monastra and Secchi, 1993; van der Poll et al., 1996). In
LPS-stimulated THP-1 cells, (a human macrophage cell line) and human whole blood,
adrenalin significantly inhibited TNF-a production over 7 hours (Severn et al., 1992).
However, in contrast to the inhibitory effects on TNF-a, there is evidence that
catecholamines may enhance IL-8 production. Adrenalin (10"7 to 10~5 M) increased IL-8
production in whole blood co-treated with LPS over 16 hours (van der Poll and Lowry,
1997). Similarly, isoprenalin (10"7), a potent p2-receptor agonist was found to increase
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basal IL-8 secretion from a bronchial epithelial cell line over 18 hours (Linden, 1996). It
is likely therefore that the cytokine response to adrenalin is cell-specific.
Macrophage migration inhibitory factor (MIF) has been identified as a potentially
important proinflammatory stress mediator (Bucala, 1996; Donnelly et al., 2000). Median
circulating levels ofMIF in multiple-trauma patients are reportedly ~ 20 ng/ml, fourteen-
fold higher than controls (Joshi et al., 2000). Within the lung, raised MIF levels in the
nanogram range in patients with established ARDS (Donnelly et al., 1996) and asthma
(Rossi et al., 1998) have been reported. Whilst some intrapulmonary MIF is likely
derived from plasma in patients with lung leak, the alveolar macrophage is also identified
as a source of IL-8 (Donnelly et al., 1996). At doses of 0.1 - 20 ng/ml, MIF did not
stimulate IL-8 generation from macrophages at 2 or 8 hours. In contrast, Donnelly et al.,
(1996) have previously shown that MIF 10 ng/ml increased IL-8 generation fromalveolar
cells lavaged from patients with ARDS.
There are clearly a number of important differences between cells from ARDS lavage
samples and monocyte-derived macrophages, which could account for the different IL-8
responses seen with MIF. Firstly, alveolar macrophages typically represent only 30-60 %
of lavage cells from ARDS lungs, the remainder being neutrophils (Holter et al., 1986;
Steinberg et al., 1994; McGuire et al., 1982). The relative contribution to MIF generation
from these two cell populations is not known. Secondly, the monocyte-derived
macrophage, relative to the alveolar macrophage, may be MIF insensitive. Lastly, cells
derived from patients with ARDS may represent an 'activated' phenotype, in contrast to
the comparatively 'quiescent' monocyte-derived macrophages studied in the current
experiments.
Having established that 2 hours of hypoxia upregulated IL-8 protein secretion, the effects
rapid reoxygenation and hyperoxia were studied. Acute hyperoxia following acute
hypoxia was found to be a greater stimulus for IL-8 generation than hypoxia, hyperoxia
or hypoxia / normoxia. Cell viability, as measured by trypan blue exclusion and LDH
release, was found to be unaffected by hypoxia, reoxygenation or hyperoxia over the
time-periods studied. In general, it appears that macrophages are reasonably tolerant of
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oxygen-deprivation (Lewis et al., 1999). Human monocyte-derived macrophages were
found not only to be viable for up to 48 hours in a 2% oxygen atmosphere, but also to
increase expression of ORP150 (oxygen-regulated protein 150 kDa), a novel protein
which may convey protection from apoptosis (Tsukamoto et al., 1996). Guinea pig
alveolar macrophages retain high viability even after 24 hours in an anoxic environment
(Cazin et al., 1990). In Kupffer cells, reoxygenation following a period of hypoxia
appears to inflict greater injury than hypoxia alone, though significant necrosis only
occurs after several hours of experimental exposure (Rymsa et al., 1990; Rymsa et al.,
1991). Alveolar macrophages remain viable for at least 24 hours in hyperoxic (85 - 95%
O2) culture (Deaton PR et al., 1994; Desmarquest et al., 1998; Pepperl et al., 2001).
Several studies have reported the effects of prolonged hypoxia and or hyperoxia on
cytokine generation in macrophages in vitro (O'Brien-Ladner et al., 1995; Deaton et al.,
1994; VanOtteren et al., 1995). In human monocytes, anoxia / hyperoxia over a 24 hour
period was found to be a potent stimulus for IL-8 generation (Metinko et al., 1992).
Alveolar macrophages from patients with interstitial lung disease, secreted increased IL-8
protein in response to 24-48 hours hyperoxia whilst inhibiting TNF-a, IL-ip and IL-6
release (Desmarquest et al., 1998).
In contrast to these studies of prolonged exposure, there have been relatively few studies
exploring the acute effects of hypoxia and reoxygenation in macrophages in vitro. Koga
et al., (1992) demonstrated that 3 hours hypoxia (<4 KPa as measured in atmosphere,
without pre-incubation of medium) followed by 3 hours normoxia was insufficient to
generate IL-1 from human monocyte-derived macrophages, but that after 6 hours
reoxygenation, increased levels of IL-1 were detected in supernatants. Even prolonged
exposures however failed to induce detectable TNF-a secretion. Interpretation of the
effects of acute exposure to changes in oxygenation is dependent upon the precise
methodology. In studies in which medium or peri-cellular PO2 is not directly measured,
the effects or lack of effects may reflect time taken for the medium to equilibrate.
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Finally, it is appropriate to consider if the levels of hypoxia and hyperoxia in the in vitro
studies are clinically relevant in the airspaces of trauma patients at-risk of ARDS. In
health, the mean alveolar PO2 is -14 KPa, and this is therefore likely to represent the
average level of oxygenation to which the alveolar macrophage would be exposed.
Following major trauma, hypoventilation, atelectasis, pulmonary contusion and aspiration
are all likely to contribute to regional alveolar hypoxia (Julien et al., 1987; Silverston,
1989; Vlessis and Trunkey, 1997; Mizushima et ah, 2000; Miller et ah, 2001). Direct
measurement of alveolar PO2 in this acute setting is not feasible. Parameters such as Pa02
/ Fi02, afford a measure of overall gas exchange but do not reflect alveolar PO2. The
observation that virtually all our studied trauma victims exhibited impaired gas exchange
(Pa02 / FiC>2 median 42 KPa, range 27 - 61) in the absence of radiographic evidence of
ARDS, suggests the presence of shunting, presumably through atelectatic and contused
lungs (Hirani et ah, 2001). However, the correlation between reduced PaC^/ FiC>2 and IL-
8 was only moderately strong (r= - 0.56). Miller et ah, (2001) have shown a strong
association between the extent of contusion injury and the development of ARDS. In
spite of these supporting data, it remains that there is no direct evidence to show that the
alveolar macrophage is subject to severe hypoxia in the trauma setting.
In contrast to hypoxia, the concept that alveolar macrophages are exposed to hyperoxia is
entirely plausible in trauma patients during resuscitation. The delivery of high flow
oxygen (60-100%) is considered mandatory in severely injured patients (Trunkey, 1991;
American College of Surgeons Committee on Trauma, 1997). In a ventilated patient,
alveolar PO2 levels of 60-90 KPa would be expected under these circumstances.
Furthermore, if the patient is intubated and receives positive-pressure ventilation, as in
our reported study, then previously atelectatic (and presumed hypoxic) regions of the
lung will be recruited and exposed to hyperoxia. This forms the basis of acute hypoxia /
hyperoxia as potential multiple hits patients at-risk of ARDS, and is further explored in
an in vivo model of lung injury.
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CHAPTER 4
HYPOXIA / HYPEROXIA IN AN IN VIVO MODEL OF ACUTE LUNG INJURY
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4.1 INTRODUCTION
The multiple-hit hypothesis has been previously advocated as a model to account for the
evolution of the multiple-organ dysfunction syndrome (MODS) following a major insult
such as trauma or sepsis (Moore and Moore, 1995; Bone, 1996; Saadia and Lipman,
1996). It may however be equally applicable to the development of ARDS. In this model,
it is postulated that the initial systemic inflammatory response is appropriate to the
primary clinical event or hit and is aimed at maintaining or upregulating the host immune
system and initiating wound healing. However a second hit (or hits) generates an
exaggerated or overwhelming inflammatory response, beyond the requirement for
maintaining host defence and precipitating tissue injury (Figure 4.1.1), This model of
evolving inflammation seems intuitively attractive, in part since it accommodates the
chronological progression of events in patients who progress to MODS and ARDS.
For the purpose of this study, it was postulated that multiple-hits, occurring sequentially
and / or simultaneously, may be responsible for rapid IL-8 generation in the lungs of
patients that progress to ARDS. The precise nature of these hits is speculative. In Chapter
3, acute hypoxia and hyperoxia were proposed as clinically relevant potential hits, and
were found to upregulate IL-8 synthesis in human monocyte-derived macrophages.
However, in the clinical practice, hypoxia and hyperoxia do not generally occur in
isolation, but rather in the context of a systemic inflammatory response initiated by a
significant insult. The potential role of oxygenation in this complex setting may be better
studied in an in vivo model
Several animal models of acute lung injury have been described and have greatly
advanced our understanding of the pathogenesis of ARDS (Vedder et al., 1988; Sekido et
al., 1993; Folkesson et al., 1995; Czermak et al., 1999; Frevert et ah, 2000; Nagase et ah,
2000). Since our recent clinical data reported raised intrapulmonary IL-8 levels
specifically in trauma patients (Hirani et ah, 2001), it would seem appropriate to
complement these studies with a trauma model in which to test the multi-hit hypothesis.
A number of such models have been described (Armstead et ah, 1997; Rawlins et ah,
1999; Rubinstein et ah, 1998; Bless et ah, 1999), but these may be subject to both
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logistical and ethical constraints. Furthermore, our observations suggest that the
relationship between raised alveolar IL-8 and progression to ARDS is not peculiar to
trauma patients, but is valid in a variety of conditions associated with ARDS (Donnelly et
al„ 1993).
A novel animal model of localised acid instillation in an anaesthetised, ventilated rabbit
was developed. The methodology is described in Chapter 2. The principle aim was to
generate a reproducible model of acute lung injury, in which to test the specific















Legend for Figure 4.1.1. A multi-hit model for the pathogenesis of ARDS.
The precise nature of the hits remains speculative. Acute hypoxia and hyperoxia may
however represent clinically relevant multiple hits, which through increasing




4.2.1. and 4.2.2 Acute hypoxia increases IL-8 mRNA but not IL-8 protein
expression in rabbit alveolar macrophages
In chapter 3, two hours hypoxia was found to be a stimulus for IL-8 protein generation in
human monocyte-derived macrophages. To establish if rabbit alveolar macrophages
responded similarly to hypoxia, cells lavaged ex-vivo from healthy rabbits were exposed
to hypoxia for up to 2 hours. IL-8 protein secretion from hypoxic alveolar macrophages
was not significantly different to that from normoxic cells (Figure 4.2.1). Steady-state
IL-8 mRNA expression, as measured by RT-PCR, was however significantly higher in
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Legend for Figure 4.2.1. The effect of acute hypoxia on rabbit alveolar macrophage
IL-8 protein secretion.
Alveolar macrophages cultured in 10% FCS were incubated in hypoxic conditions for up
to 2 hours. IL-8 protein secretion was not significantly different to normoxic controls.
LPS (1 ng /ml) significantly increased IL-8 release by 1 hour. The data is presented as
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Legend for Figure 4.2.2. Effect of acute hypoxia on rabbit alveolar macrophage IL-8
mRNA expression.
Alveolar macrophages cultured in 10% FCS were exposed to acute hypoxia for up to 2
hours. In contrast to IL-8 protein secretion, IL-8 mRNA expression was significantly
higher than normoxic controls. LPS (1 ng/ml) significantly increased IL-8 m RNA
expression by 1 hour. Each value in 4.2.2A represents mean ± SEM of n=3 separate
experiments. *P<0.05 compared to normoxic controls. A representative RT-PCR gel is
shown in 4.2.2B.
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4.2.3 Localised acid instillation induces direct lung injury in the instilled lobe but no
injury in the contralateral lung, in normoxic ventilated rabbits
In anaesthetised, ventilated rabbits, HC1 was carefully instilled into the left lower lobe of
lung under direct vision, via a bronchoscope. Control animals were instilled with an equal
volume of air. The animals were then ventilated under normoxic conditions (Fi02 -20%,
arterial PO2 -10.5 KPa) for up to 4 hours. Ventilation strategy was identical in control
and acid-instilled animals, and there was no significant difference in arterial PO2, PCO2
and pH, heart-rate and blood pressure between control and acid-instilled animals (Table
4.2.1), Both right and left lower lobes were then lavaged. The degree of lung injury was
assessed by the neutrophil count and alveolar-capillary (lung) protein leak as measured by
detection of Evans Blue / BSA in BAL fluid. In some animals, BAL was not performed to
allow histological assessment of lung injury to be made without lavage artefact.
The lung injury data for directly-instilled lungs and contralateral lungs at 2 and 4 hours
post instillation in animals ventilated under normoxic conditions is summarised in Table
4.2.2. By 2 hours, compared to saline-instilled controls, acid-instillation induced lung
injury, as quantified by a 14-fold increase in lung leak and significantly raised BAL
neutrophils in the directly injured lobe. The degree of lung injury as measured by these
parameters was not significantly different by 4 hours. In contrast, localised acid
instillation did not cause significant lung injury in the contralateral lung by 4 hours.
Representative BAL cytospins from control and acid injured lungs at 2 and 4 hours are
shown in Figure 4.2.3.1 Histology of acid-injured lung at 2 and 4 hours post-instillation
revealed neutrophil influx into the lung interstitium and airspaces. There was evidence of
proteinaceous leak with fibrinoid deposition in the alveoli. The majority of the acute
inflammatory infiltrate was located centrally in the lung. Histology of the contralateral
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64±6 60.515.3 6814.9 62.315.7 63.516.2 6813.7 62.516
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Table 4.2.1. Ventilatory and physiological parameters in experimental animals
The required variation in arterial PO2 in experimental groups was achieved through
altering FiCL only. Localised instillation of acid into the left lower lobe did not have any
significant effect on heart rate, mean arterial pressure, pH, PO2 or PCO2 compared to
control animals over 2 or 4 hours. Hypoxic ventilation with a FiC>2 of 17% achieved a
target arterial PO2 of ~5 KPa. However, significant hypotension and acidosis occurred
after approximately 3 hours of hypoxic ventilation (data not shown). Hence, hypoxia
experiments were performed for up to 2 hours only with equivalent normoxic controls.
Ventilatory parameters were not significantly different between experimental groups.
Other than a significant increase in heart rate in the hypoxic / hyperoxic group, there was
no significant difference in physiological parameters between groups. Data presented as
mean ± SEM, except heart rate (median ± SD). *P=0.04
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leak (ml) 0.028±0.01 0.02±0.01 0.39±0.1* 0.033L0.02 0.038±0.01 0.4410.08**
BAL
neutrophils 0.810.5 1.010.4 34114* 1.110.5 1.210.8 35110**
BAL
neutrophils
cells x 105 /10
ml BAL fluid
0.1210.07 0.1810.06 23.218* 0.1410.12 0.1810.4 22.514**
Table 4.2.2. Localised acid instillation on measures of lung injury at 2 and 4 hours in
animals ventilated under normoxic conditions.
Data are presented as means! SEM, except BAL neutrophils, which are represented by
median ± SD. *P < 0.01 compared to 2 hour control animals and 2 hour contralateral
lung. **P < 0.01 compared to 4 hour control animals and 4 hour contralateral lung.
4.2.4. Localised acid instillation increases IL-8 protein expression in the directly
injured but not the contralateral lung
Compared to controls (no acid), acid-injured lungs expressed significantly greater IL-8
protein in BAL fluid (162±19 v 90±12 pg/ml, P<0.02) (Figure 4.2.4.1) and lung
homogenate (635±68 v 312±85 pg/ml/mg P<0.02) (Figure 4.2.4.2) by 2 hours. In the
contralateral lung, compared to control animals, neither BAL IL-8 levels nor lung
homogenate IL-8 levels were significantly different. The values at 4 hours were similar,
with significantly raised IL-8 in the acid-injured lungs and levels similar to control
animals in the contralateral lung.
Serum levels of IL-8 were not detectable at any time point during experiments in acid-
instilled or control animals.
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Figure 4.2.3.1
A. 2 hour contralateral B. 2 hour acid-instilled
Legend for Figure 4.2.3.1. Bronchoalveolar lavage cytospins from acid-injured and
contralateral lungs.
Rabbits were ventilated for 2 hours and 4 hours under normoxic conditions following
localised acid instillation into the left lower lobe. Both directly-injured and contralateral
lungs were lavaged. The cytospins show presence of neutrophils (arrowed) in the




A. 4 hour contralateral lung (x 40) B. 4 hour acid-instilled lung (x 40)
C. 2 hour contralateral lung (x200) D. 2 hour acid-instilled lung (x 200)
Legend for Figure 4.2.3.2. Histology of acid-injured and contralateral lungs.
Rabbits were ventilated for 2 hours and 4 hours under normoxic conditions following
localised acid instillation into the left lower lobe. Tissue sections were taken from non-
lavaged lungs. Acid-instillation resulted in neutrophil infiltration into the lung
interstitium and airspaces (solid arrows). Presence of fibrin (broken arrow) in the alveolar
space indicates proteinaceous fluid leak.
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Having established a reproducible model of direct and potentially indirect lung injury, the
effects of acute hypoxia and hyperoxia on intrapulmonary IL-8 generation were studied.
As described in Chapter 2.2, changes in arterial oxygenation were affected through
reducing or increasing FiC>2 only, without altering ventilatory parameters. Table 4.2.1
summarises the levels of oxygenation achieved, and shows that the ventilation strategy
between experimental groups was similar. However, prolonged hypoxia beyond 3 hours
resulted in significant reduction in arterial pH (data not shown), hence hypoxia
experiments were limited to 2 hours. Varying oxygenation had no significant effect on
physiological parameters other than heart-rate, which was significantly higher in the
hypoxia / hyperoxia group.
4.2.4. Acute hypoxia has no effect on acute lung injury
Following acid instillation, animals were ventilated under hypoxic (FiC>2 17%, arterial
PO2 ~5 KPa) or normoxic conditions.
Hypoxia for 2 hours had no significant effect on, protein leak or BAL neutrophils in











leak (ml) 0.02 ±0.01 0.032 ± 0.02 0.39 ±0.1 0.32 ±0.06
BAL PMN (%) 1.0 ±0.4 1.3 ±0.4 34 ± 14 30 ±8
BAL PMN
(cells xlO5 / 10
ml BAL fluid)
0.18 ±0.06 0.22 ± 0.06 23.2 ± 8 21.6 ± 9
Legend for Table 4.2.3. Effect of 2 hours hypoxia on lung injury in acid-induced
lung injury
Results are presented as mean ± SEM, except BAL PMN (%) which are represented by
median ± SD. There is no significant difference in measures of lung injury between
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Legend for Figures 4.2.4.1 and 4.2.4.2. Direct and indirect effect of localised acid
instillation on intrapulmonary IL-8 generation.
Localised instillation of acid followed by ventilation under normoxic conditions
significantly increased BAL IL-8 (Figure 4.2.4.1) and lung homogenate IL-8 (Figure
4.2.4.1) in the directly injured lung at 2 hours (n=4), and 4 hours (n=6) compared to
control ventilated animals (n=3) without acid instillation. There was no significant effect
on intrapulmonary IL-8 in the contralateral lungs of acid-instilled animals *P<0.02.
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4.2.5. The effect of acute hypoxia on IL-8 protein generation in the acid-induced
lung injury model
Hypoxia had no significant effect on IL-8 protein expression in directly injured or
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Legend for Figure 4.2.5. IL-8 protein in BAL and lung homogenate in normoxic and
hypoxic animals. There was no significant (ns) difference in IL-8 protein expression
between hypoxia and normoxic (N) animals in BAL (A) or lung homogenate (B). Results
are expressed as mean ± SEM. n=4 normoxic and n=3 hypoxic animals.
4.2.6. The effect of acute hypoxia on IL-8 mRNA expression in the acid-induced lung
injury model
Interleukin-8 mRNA expression in lung homogenate was determined by RT-PCR. In the
acid-injured lungs, IL-8 mRNA expression was 2.1 fold greater in hypoxic compared to
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Figure 4.2.6. IL-8 mRNA expression in acid-instilled and contralateral lungs in
normoxic and hypoxic animals. Acid-instillation significantly increased IL-8 mRNA
expression in lung homogenate from directly-injured but not contralateral lungs. Hypoxia
further upregulated IL-8 mRNA expression in the directly-injured lungs. IL-8
densitometry (A) was corrected for P-actin expression from the PCR gel shown (B).
Results are expressed as mean ± SEM. *P<0.05
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4.2.7. The effect hypoxia / hyperoxia and hypoxia / controlled reoxygenation on
acute lung injury and IL-8 generation
Having found that hypoxia significantly increased intrapulmonary IL-8 mRNA
expression but not protein expression or measures of lung injury, a further potential 'hit'
was introduced with reoxygenation to hyperoxic levels (FiC>2 100 %, arterial PO2 ~ 55
KPa mmHg), or to relatively normoxic levels (controlled reoxygenation (CR),
FiC>2 -40%, arterial PO2 -15 KPa). Following acid-instillation, animals were ventilated
for 4 hours under normoxic or 2 hr hypoxic / 2 hr hyperoxic, or 2 hours hypoxia / 2 hours
CR conditions (Figure 4.2.7)
Lung protein leak and BAL neutrophil data is summarised in Table 4.2.7. In the directly
injured lung, compared to normoxia, hypoxia / hyperoxia resulted in a 2-fold increase in
lung protein leak. There was also a trend for greater number of BAL neutrophils though
this did not reach statistical significance (P=0.07).
In the contra-lateral lung, hypoxia / hyperoxia resulted 4.8-fold increase in lung protein
leak compared to normoxic controls. BAL levels of neutrophils were not significantly
different to controls. Hypoxia / CR significantly attenuated lung protein leak in both
directly-injured and contralateral lungs and reduced BAL neutrophils in the directly-
injured lung (P=0.06)
In the directly injured lung, hypoxia / hyperoxia resulted in significantly increased IL-8
protein in BAL fluid and lung homogenate compared to normoxia. In the contralateral
lung, IL-8 levels were not significantly higher than controls in BAL fluid or lung
homogenate. As with lung leak, controlled reoxygenation significantly attenuated IL-8
generation (Figure 4.2.7)
Serum IL-8 levels were undetectable at all time points.
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0.038 ±0.01 0.184 ±0.09* 0.07 ± 0.03 0.44 ± 0.8 0.82 ± 0.15t 0.46 ±0.11
BAL PMN
(%)





0.18 ±0.4 0.29 ±0.16 0.36 ±0.3 22.5 ±4 31 ±5* 20.2 ± 3
Table 4.2.7. Effect of hypoxia / hyperoxia and hypoxia / CR (controlled
reoxygenation) on lung injury
Data are presented as means ± SEM, except BAL PMN (%) which is represented by
median ± SD. N=6 normoxia, n=6 hypoxia / hyperoxia, n=4 hypoxia / CR
*P<0.05 compared to contralateral lung in 4 hour normoxic and hypoxic/ CR groups.
'P<0.05 compared to directly-injured lung in 4 hour normoxic and hypoxic / CR group
*P=0.07 compared to directly injured lung in 4 hour normoxic group and P=0.06
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Figure 4.2.7. The effect of hypoxia / hyperoxia and hypoxia / controlled
reoxygenation on IL-8 generation in directly injured and contralateral lungs. In the
directly injured lung, hypoxia / hyperoxia (H/H) significantly increased IL-8 levels in
both BAL fluid (A) and lung homogenate (B), compared to normoxia (N). Hypoxia /
controlled reoxygenation (H/CR) significantly attenuated this effect. Varying
oxygenation had no effect on IL-8 generation in the contralateral lung. Results are
expressed as mean ± SEM. n=6 normoxia, n=6 H/H, n=4 H/CR. *P<0.02
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4.3. DISCUSSION
In these studies, a novel model of acute lung injury was developed in which to study the
effects of acute hypoxia and hyperoxia on intrapulmonary IL-8 generation. Localised acid
instillation induced acute lung injury with raised IL-8, lung protein leak and neutrophil
influx in the directly injured lobe, but no injury in the contralateral lung. Acute
hypoxaemia, achieved by reducing Fi02, was associated with increased IL-8 mRNA but
not protein expression in the acid-injured lung. Acute hyperoxia following hypoxia
generated raised intrapulmonary IL-8 protein expression and exacerbated lung leak, and
both were attenuated if hyperoxia was substituted with controlled reoxygenation. In the
contralateral lung, a model of potential indirect lung injury, changes in oxygenation did
not induce IL-8 upregulation, but hypoxia / hyperoxia resulted in significant lung leak.
Direct instillation of acid into the left lower lobe induced acute lung injury as
characterised by increased neutrophils in airspaces and alveolar-capillary protein leak
(lung leak). Localised lung injury was apparent by 2 hours following acid instillation and
was associated with raised intrapulmonary and BAL IL-8. As with ARDS, the neutrophil
is thought to play a significant role in acid-induced lung injury (Folkesson et al., 1995;
Goldman et al., 1992; Knight et al., 1992). Our studies were limited to the early phase
post-injury. Hence, they do not serve to investigate the role of increased intrapulmonary
IL-8 generation on the progression of acute lung injury to ARDS. However, there is
evidence that IL-8 plays a central role in the pathogenesis of acute lung injury in rabbits.
Targeting IL-8 with an anti-IL-8 antibody has been shown to attenuate rabbit lung injury
secondary to acid-aspiration (Folkesson et al., 1995; Modelska et al., 1999), ischaemia /
reperfusion (Sekido et al., 1993) and pulmonary re-expansion (Nakamura et al., 2000).
Based on these studies, it is likely that raised intrapulmonary IL-8 in our multiple-hit
model of lung injury would have a prominent role in progression of lung injury.
It is accepted that reducing Fi02 is not a relevant mechanism for causing hypoxia in
clinical situations associated with acute lung injury, except perhaps in the lung injury
associated with high altitude (high altitude pulmonary oedema, HAPE). The closest
clinical analogy to the model presented in this study is aspiration of gastric contents, an
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event usually associated with impaired consciousness (Adnet and Baud, 1996; Marik,
2001). Hypoventilation would be a more clinically relevant cause of alveolar hypoxia in
this context. However, it is also known that ventilation strategies may influence lung
injury. Ventilation-associated stretch or barotrauma is known to influence intrapulmonary
cytokine generation (Tremblay et al., 1997) and induce lung injury (Kolobow et al., 1987;
Tsuno et al., 1991; Dos Santos and Slutsky, 2000). Since the principle hypothesis being
tested in the presented studies concerned the influence of oxygenation on intrapulmonary
IL-8 generation, it was thought important to minimise the effects of these variables in the
model. Hence, care was taken to manipulate oxygenation only, whilst maintaining
baseline ventilatory and physiological parameters.
Through reducing FiC>2 to 17%, a stable arterial PO2 of 5 KPa was achieved for 2 hours
without altering ventilation parameters and whilst maintaining normal arterial pH and
PCO2. In healthy lungs, this strategy would result in a mean alveolar PO2 of ~10 KPa
(Chapter 1.4). Thus, it might reasonably be argued that alveolar cells were not rendered
significantly hypoxic in this model. In the non-injured right lung, this may be one
explanation for the lack of effect of 'hypoxia' on intrapulmonary IL-8 generation.
However, in the acid-injured left lower lobe, in which there was interstitial oedema and
airspace flooding, a significant degree of alveolar hypoxia may have been achieved. In
the absence of a cellular marker for hypoxia, this is not proven. The finding that IL-8
mRNA expression in acid-injured lung was significantly higher in hypoxic compared to
normoxic animals, ventilated under identical conditions with only FiC>2 varied, suggests a
role for hypoxia in intrapulmonary IL-8 generation.
In the context of a multi-hit model of inflammation, one interpretation of this data is that
hypoxia, through generation of increased IL-8 mRNA, acts as a proinflammatory hit in
vivo. A further hit, namely hyperoxia, was required to significantly increased IL-8 protein
expression in the acid-injured lung, in which there was also a trend (P=0.07) towards
increased BAL neutrophil count. In the contralateral lung, hypoxia / hyperoxia did not
influence IL-8 expression. Since our experiments did not include a '4 hour hyperoxia'
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group, it cannot be determined if hypoxia / hyperoxia is a more potent stimulus for IL-8
generation than hyperoxia alone, as was demonstrated in-vitro. However, our primary aim
was to mimic a typical clinical scenario in which acute hypoxia is followed by acute
hyperoxia, and to determine if this stimulus is sufficient to raise intrapulmonary IL-8
levels. The data suggests that in our model, hypoxia / hyperoxia is able to rapidly
upregulate intrapulmonary IL-8 in the setting of direct lung injury.
Many studies have demonstrated that hyperoxia induces lung leak, but only following
prolonged (>24 hours) exposure (Shasby et al., 1982; Crapo 1986; Adawi A et ah, 1998;
Come et ah, 2000). Such studies have been performed in non-ventilated animals and in
the absence of co-existing localised or distant injury. In contrast, our data shows that
compared to normoxic controls, acute hypoxia / hyperoxia in ventilated animals with
localised acute lung injury significantly increased lung leak in both the acid-injured and
contralateral lung. Thus, acute hyperoxia may be injurious, but only as part of one or
more inflammatory 'hits' (Smith et ah, 1990). In a rat model, the combination of 90% O2
and intravenous bleomycin induced acute lung injury by 4 hours, though neither agent
was injurious in isolation at this time point (Hay et ah, 1987)
Our finding of increased lung leak in the contralateral lung is of interest. The absence of
associated raised IL-8 or BAL neutrophils suggests lung leak occurred via a mechanism
that may be neutrophil-independent. It has been suggested that increased reactive oxygen
species (ROS) direct injure alveolar epithelial cells and play a role in hyperoxia-induced
lung injury (Crapo, 1986; Folz et al., 1999. Nader-Djalal et al., 1998) The lung leak as
measured in our model represents passage of albumin into the alveolar airspace. This
provides a potential mechanism for exacerbating lung injury, since circulating
inflammatory mediators, such as cytokines and endotoxin, may also pass into the alveolar
space and further activate inflammatory cells including the alveolar macrophage. It is
acknowledged however that a degree of albumin leak may have been induced by the BAL
procedure itself, as has been described in human studies (Ward et al., 1992; Baughman
RP, 1997). Hence the absolute degree of albumin leak into the alveolar airspaces must be
interpreted with some caution.
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Our finding that increased IL-8 and lung leak was attenuated to baseline levels if acute
hypoxia was followed by controlled (Fi02 -40%) rather than hyperoxic (Fi02 100%)
reoxygenation may be of clinical relevance. In the acute resuscitation scenario, the
delivery of 80-100% oxygen to hypoxic critically-ill patients is standard practice. Our
animal data supports the hypothesis that acute hyperoxia in this setting may exacerbate
sub-clinical acute lung injury and induce intra-pulmonary IL-8 generation. Resuscitating
hypoxic patients with controlled oxygen to physiological levels may attenuate the
intrapulmonary inflammatory response in the early at-risk period of ARDS. However,
this strategy would need to be countered with the potentially lethal consequences of acute
severe tissue hypoxia.
With regard to our clinical observations in at-risk patients, it is acknowledged that these
animal studies do not fully explain our finding of early raised intrapulmonary IL-8
generation in those that progress to ARDS. The controlled strategy for inducing hypoxia
and hyperoxia only through varying FiC>2 served to exclude factors such as atelectasis
and barotrauma. Both phenomena are however likely to be relevant in the acute clinical
setting and may contribute to intrapulmonary inflammation.
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CHAPTER 5




In the previous chapters, it has been shown that 2 hours hypoxia significantly increased
IL-8 protein secretion from monocyte-derived macrophages. By 4 hours, IL-8 secretion
was no different to normoxic controls, but steady-state IL-8 mRNA expression was
increased. In rabbit alveolar macrophages, and in rabbit acid-injured lungs, acute hypoxia
was associated with increased IL-8 mRNA expression, but not increased protein.
The 5'-flanking DNA of the IL-8 gene contains potential binding sites for a number of
transcription factors (Figure 5.1). However, based upon DNAse footprinting and
transcriptional fusion studies, the 130 bp sequence immediately upstream of the TATA
box has been shown to be sufficient for maximal transcriptional responses to most pro¬
inflammatory mediators (Mukaida et al., 1994; Yasumoto et ah, 1992; Nakamura et ah,
1991). Within this region, lie functional binding sites for activator protein-1, (AP-1),
CCAAT/Enhancer binding protein-P (C/EBP-P, also termed nuclear factor-IL-6, NF-IL-
6) and NF-kB. A putative HIF-1 binding site located 3' of the TATA box and
immediately upstream of the transcription initiation site is discussed in Chapter 6.
In this chapter, I aimed to further determine the molecular mechanisms involved in acute
hypoxia - induced IL-8 mRNA expression in monocyte-derived macrophages. In
particular, the regulation of transcription factors AP-1, C/EBP-P and NF-kB by hypoxia




















Figure 5.1. The IL-8 gene promoter region with transcription factor binding sites.
Several transcription factor binding sites have been identified within 1.5 Kb 5' region of the IL-8 gene.
However, the 130 bp region upstream of the TATA box is sufficient to induce maximal gene transcription
for most stimuli. This region contains the binding sites for AP-1, C/EBP-p and NF-kB.
Additional sites of likely functional significance are:
i) An Oct-1 element that overlaps with the C/EBP-p site and has been shown to repress IL-8 transcription
(Wu et al., 1997)
ii) An AP-2 element (GAGTGGCC site located -868 to -876, consensus GCCNNNGGC or GSSWGSC)
which is required for the IL-8 response to the Pseudomonas autoinducer N-3-oxododecanoyl homoserine
lactone (Smith et al., 2001)
iii) An interferon stimulated response element (IRSE) - (consensus GAAASYGAAASY or
GAAAASYGAAAASY). A number of GAAA sites are harboured upstream, including one within the
RSVRE
iv) A respiratory syncytial virus-induced element (RSVRE) located -132 to -162
(ACTCCGTATTTGATAAGGAACAAATAGGAAG) (Casola et al., 2001). This sequence contains an
IRSE and a putative HNF-3 (=IRS, insulin response sequence).
There are several putative binding sites, the functional significance of which is unknown. These include
ones for hepatic nuclear factor-1 (HNF-1 consensus GGTTAATNATTAAC with ATTAAC identified -376
to -381), glucocorticoid response element (GRE consensus GGTACANNNTGTTCT, with TGTTCT
identified -330 to -325), heat shock element (HSE consensus generally NGAAN often as multiple copies as
seen in the 5' IL-8 promoter) and early growth factor-1 (Egr-1 consensus sequence GCG(G/T)GGCG, with
CCGTAAGGGGAGG located on the antisense strand at -1350 to 1361). Finally, a putative HIF-1 binding




5.2.1 Hypoxia increases IL-8 mRNA in macrophages.
Macrophage IL-8 mRNA expression was measured by northern blotting. Hypoxia
significantly increased steady-state IL-8 mRNA levels by 30 min, 1 hour, 2 hours and 4
hours (90±25, 104±19, 157+19 and 318±91 respectively, expressed as percentage
increase over normoxic controls. P<0.01) (Figure. 5.2.1). An increase in mRNA
transcription and / or mRNA stability may account for the raised steady-state expression
of IL-8 under hypoxic conditions. However, the finding that within 30 min of hypoxic
exposure, IL-8 mRNA levels were 88±19 % higher than at To (macrophages cultured over
5 days and RNA extracted), suggests increased gene transcription at least plays a part in
raising IL-8 mRNA expression.
Three transcription factors, NF-kB, AP-1 and C/EBP-P have been implicated in IL-8
regulation by a range of stimuli and in a variety of cell lines (Roebuck, 1999). Using
EMSA, nuclear levels of these proteins were determined following acute hypoxic
exposure. For comparison, macrophages were also stimulated with LPS, an archetypal
proinflammatory stimulus shown in Chapter 3 to be a potent inducer of IL-8 protein
expression from macrophages.
5.2.2. Hypoxia does not increase nuclear NF-kB levels
Hypoxia for up to 30 min did not increase nuclear NF-kB above normoxic levels. LPS by
contrast increased NF-kB levels by 322+34% by 30 min (Figure 5.2.2). The specificity
of the observed band was confirmed by non-radiolabelled (cold) NF-kB competition
protein binding. A supershift assay with LPS-treated macrophages revealed two
supershifted bands with a p50 antibody and one with a p65 antibody, suggesting the
























Legend for Figure. 5.2.1. Effect of hypoxia on Macrophage IL-8 mRNA expression.
Steady-state mRNA expression was measured by northern blotting. Hypoxia significantly
increased steady-state IL-8 mRNA levels by 30 min, 1 hour, 2 hours and 4 hours (90±25,
104±19, 157±19 and 318±91 respectively, expressed as percentage increase over
normoxic controls. (P<0.01). Each value in 5.2.1A represents mean ± SEM of >3
experiments on n=4 donors. The northern blots shown are from macrophages derived
from one donor on two separate occasions. After probing for IL-8 (5.2.IB), blots were
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Legend for Figure 5.2.2. Hypoxia does not increase nuclear NF-kB levels.
Macrophages were incubated under normoxic (N) or hypoxic (H) conditions for up to
30min and nuclear levels of NF-kB determined by EMSA. Hypoxia did not increase
nuclear NF-kB abundance above basal levels. LPS (1 pg/ml for 30 min) strongly induced
nuclear NF-kB activation. Each value in 5.2.2A represents mean ± SEM from n=4
separate experiments (*P<0.01).
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Legendfor Figure 5.2.2. continued
5.2.2 B. A representative EMSA is shown including a competition assay. Lane 3
contains 4 pg of protein from LPS-stimulated macrophages. Lane 2 as 3 with the addition
of 100 X excess cold non-competitor (oligonucleotide with mutated NF-kB binding site).
Lane 1. 100 X excess cold NF-kB competitor.
5.2.2 C. A supershift assay further defines this LPS-induced band. Lane 4 contains
nuclear extracts from LPS-stimulated macrophages (as Lane 1). Subsequent lanes with
addition of 2 pi control rabbit serum (Lane 5). p50 antibody (Lane 6 , revealing two
distinct supershifted bands [broken arrow]) or p65 antibody (Lane 7, revealing one
supershifted band [solid arrow]). This implies that the presence both p50 and p65
subunits within the NF-kB complex, but the precise dimerisation characteristics are not
identifiable from this study. The supershift is representative of n=2 studies.
5.2.3. Hypoxia increases nuclear AP-1 levels
Hypoxia increased nuclear AP-1 levels by 67±11% and 130±34% at 15 and 30 min
respectively as measured by densitometry (P < 0.02, n=4) (Figure 5.2.3). LPS (1 pg/ml)
did not significantly affect AP-1 levels by 30 min of exposure. Phorbol myristate acetate
(PMA) (100 nM) was used as an alternative positive control, and was found to increase
AP-1 levels by 610±95 % by 30 min compared to normoxia. The specificity of the AP-1
band was confirmed by competition assay. Co-incubation with c-Jun, but not c-Fos
antibody, demonstrated a supershifted band.
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Figure 5.2.3
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Legend for Figure 5.2.3 Hypoxia increases nuclear AP-1 levels
Macrophages were incubated under normoxic (N) or hypoxic (H) conditions for up to 30
min and nuclear levels ofAP-1 determined by EMSA.
Compared to normoxic controls, hypoxia significantly increased AP-1 levels by 15 and
30 min as measured by densitometry. Each value in 5.2.3A represents mean ± SEM of
n=4 separate experiments. (*P=0.02). LPS (1 pg/ml) for 30 min does not induce AP-1
activation. PMA (100 nM), a known upregulator ofAP-1 was used as a positive control.
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Legendfor Figure 5.2.3 continued.
A representative EMSA is shown (5.2.3B). The specificity and nature of the observed
AP-1 band is addressed by competition and supershift assay. Lane 1 contains 4 pg
nuclear protein from hypoxic macrophages incubated with end-labelled AP-1
oligonucleotide probe only. Subsequent lanes are as Lane 1 with the addition of 100 X
excess cold AP-1 competitor (Lane 2), 100 X excess cold non-competitor
(oligonucleotide with mutated AP-1 binding site (Lane 3). 2 pi rabbit serum (Lane 4 with
non-specific band), c-Fos antibody (Lane 5) or c-Jun antibody (Lane 6 with supershifted
band).
5.2.4. Hypoxia increases nuclear C/EBP-P levels
Hypoxia increased nuclear C/EBP-p levels by 79±9% and 82±18% at 15 and 30 min
respectively as measured by densitometry (Figure 5.2.4). By comparison, LPS induced a
160±26 % increase in levels by 30 min compared to normoxic controls (P < 0.02, n=4).
The specificity of the band-shift observed was confirmed by competition assay, which
showed no affect with excess cold non-competitor and abolishment with excess cold
competitor.
5.2.5. N-acetylcysteine inhibits IL-8 mRNA expression in association with reduced
nuclear AP-1, but not basal NF-kB, activation.
The finding that hypoxia increased nuclear AP-1 and C/EBP-P, but not NF-kB, nuclear
expression was unexpected. Most, though not all, inducers of IL-8 gene transcription are
associated with NF-kB activation (Roebuck et al., 1999). It is apparent however that the
macrophages in the present studies expressed basal levels of NF-kB under normoxic
conditions without stimulation (Figures 5.2.2 and 5.2.5). N-acetylcysteine (NAC), a
thiol anti-oxidant, has been shown to inhibit inflammatory gene transcription (Pahan et
ah, 1998; Sprong et ah, 1998) and may have differential effects on AP-1 and NF-kB
activation (Schreck et ah, 1991). Macrophages were co-incubated under hypoxic
conditions with NAC. Hypoxia-induced IL-8 mRNA expression at 30 min was attenuated
by NAC 0.5 mM and 5 mM. Basal nuclear NF-kB expression was unchanged, but nuclear
AP-1 abundance was reduced at these doses (Figure 5.2.5), The pH of the medium
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Legend for Figure 5.2.4. Hypoxia increases nuclear C/EBP-P levels. Macrophages
were incubated under normoxic (N) or hypoxic (H) conditions for up to 30min and
nuclear levels of C/EBP-P determined by EMSA. Hypoxia significantly increased
C/EBP-p nuclear abundance by 15 and 30 min as measured by densitometry. Each value
in 5.2.4 A represents mean ± SEM of n=4 separate experiments (*P<0.02). LPS (1 pg/ml
for 30 min) induces a 160±26% increase compared to normoxic controls.
A representative EMSA is shown in 5.2.4B. The specificity of the observed C/EBP-P
band was addressed by competition assay (5.2.4C). Lane 1 contains 4 pg of protein from
hypoxic macrophages incubated with end-labelled C/EBP-p oligonucleotide probe only.
Lane 2 as Lane 1 with the addition of 100 X excess cold C/EBP non-competitor. Lanes 3.
100 X excess cold C/EBP-P competitor (oligonucleotide with mutated C/EBP-P binding
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Legend for Figure 5.2.5. N-Acetylcysteine inhibits hypoxic upregulation of IL-8
mRNA in association with reduced nuclear AP-1, but not NF-kB expression.
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Legendfor Figure 5.2.5 continued
Hypoxic macrophages were co-incubated with NAC (0.5 or 5 mM) for 30 min, resulting
in marked reduction in IL-8 mRNA expression (5.2.6C and D). Nuclear NF-kB
activation was not significantly effected by NAC at this time point (5.2.5A), but AP-1
activation was inhibited (5.2.5B) The EMSAs shown are representative of n=3
experiments. The IL-8 northern blot and densitometry is one of n=2 experiments.
5.2.6. and 5.2.7. Differential effect of hypoxia on selected chemokine and cytokine
mRNA expression.
Hypoxia has been shown to regulate a large number of genes (Table 1.5.6), Having
shown that acute hypoxia increased steady-state expression of IL-8 mRNA in human
monocyte-derived macrophages, the effects of hypoxia on a number of other chemokines
and cytokines was studied using multi-probe RNase protection assay. Two hours hypoxia
significantly increased IL-8 mRNA expression (130±18%, expressed as a percent
increase over normoxia. P<0.01) and inhibited the expression of RANTES (62+12 %),
IP-10 (100 %), MIP-ip (76+9 %), MlP-la (52+10 %) and MCP-1 (100 %), expressed as
percentage inhibition of normoxic controls (all P<0.02). In contrast to hypoxia, LPS was
able to rapidly upregulate RANTES (590+94 %), 1P-10 (60+38 %), MIP-lp (480+48 %),
MlP-la (396+47 %) and IL-8 (410+60 %) (all P<0.02) (Figure 5.2.6).
Using a different panel of riboprobes, hypoxia was shown to also have a small but
significant inhibitory effect on TNF-a and significantly increased TGF-pi expression.
LPS was a potent inducer of TNF-a and significantly increased TGF-pl expression.
(Figure 5.2.7.)
5.2.8 and 5.2.9. Hypoxia increase nuclear AP-1, but not NF-kB levels, using a
concensus oligonucleotide probes
The observation that hypoxia increased nuclear AP-1 and C/EBP, but not NF-kB
activation was unexpected as most, though not all, inducers of IL-8 gene transcription
activate NF-kB (Roebuck, 1999). Furthermore, several of the genes studied with the
multiprobe RNase protection assay harbour NF-kB and AP-1 binding sites within the
promoter regions (Figure 5.3.1). To further explore a potential activation ofNF-kB and
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AP-1 by hypoxia the experiment was repeated using concensus rather than IL-8-specific
oligonucleotide probes. This was particularly of interest for NF-kB, since the IL-8-
specific sequence differs by several nucleotides from the concensus sequence. In contrast,
the IL-8-specific AP-1 binding harbours the consensus AP-1 footprint sequence (see
Chapter 2.2.7 for sequences). The results for both concensus probes however were
similar to that observed with the IL-8 probes; hypoxia had no effect on basal nuclear NF-
kB levels (Figure 5.2.8), whilst AP-1 nuclear abundance was significantly increased by
























Legend for Figure 5.2.6. Differential effect of hypoxia on selected chemokines.
Macrophages were exposed to normoxia (N), hypoxia (H) or LPS (1 pg/ml) for 2 hours
and RNase protection assay performed with a panel of riboprobes. Note that the
unprotected riboprobes which make up the ladder are larger and hence do not migrate as
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Legendfor Figure 5.2.6 continued
far down the gel as the corresponding protected RNA species. IL-8 mRNA is upregulated
by hypoxia. Expression ofMIP-ip, MEP-la and MCP-1 was significantly reduced by
hypoxia. Expression of RANTES and IP-10 was comparatively low. Prolonged
radiographic exposure however confirmed normoxic RANTES and IP-10 expression and
reduced expression under hypoxic conditions. In contrast, LPS significantly upregulated
the majority of chemokines. Each value in 5.2.6A represents mean ± SEM of n=3
separate experiments (*P<0.02). Densitometry for each chemokine was corrected for L32
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Legend for Figure 5.2.7. Differential effect of hypoxia on selected cytokines.
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Legendfor Figure 5.2.7 continued
Macrophages were exposed to normoxia (N), hypoxia (H) or LPS (1 pg/ml) for 2 hours
and RNase protection assay performed with a panel of riboprobes. Compared to
normoxia, hypoxia inhibited TNF-a mRNA expression, and significantly increased TGF-
Pl. LPS significantly increased TNF-a and TGF-pi expression. TGF-P2 and TGF-P3
were expressed at very low levels in normoxic and hypoxic conditions, although LPS
stimulation did increase expression of both cytokines. Expression of IFN-y and IFN-P
were expressed at low or undetectable levels. Each value in 5.2.7A represents mean ±
SEM of n=3 separate experiments (*P<0.02). Densitometry for each cytokine was
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Legend for Figure 5.2.8. Hypoxia does not activate NF-kB - using a concensus
oligonucleotide probe.
Macrophages were incubated as previously described for up to 60min and nuclear levels
of NF-kB determined by EMSA using a concensus oligonucleotide probe. Hypoxia did
not increase NF-kB activity above basal normoxic levels. LPS (1 pg/ml for 30 min)
strongly induced NF-kB activation. Each value in Figure 5.2.8A represents the mean ±
SEM ofn=4 separate experiments. (*P<0.01). A representative EMSA is shown (5.2.8B),
demonstrating that the concensus probe resolved two distinct NF-kB bands, of which the
upper (arrowed) is inducible by LPS.
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Legend for Figure 5.2.9. Hypoxia does not activate AP-1 - using a consensus
oligonucleotide probe. Macrophages were incubated as previously described for up to 60
min and nuclear levels of AP-1 determined by EMSA using a concensus oligonucleotide
probe. Hypoxia increase AP-1 activity compared to normoxia by 30 min. PMA (100
ng/ml for 30 min) strongly induced AP-1 activation. Each value in Figure 5.2.9A
represents the mean ± SEM of n=4 separate experiments. (*P<0.01 compared to
normoxic controls). A representative EMSA is shown (5.2.9B).
5.2.10. IL-8 expression in hypoxic THP-1 cells
A practical limitation of studying primary monocyte-derived macrophages is the relative
paucity of cells compared to a cell line. To establish if the hypoxic upregulation of IL-8
was reproduced in a human monocyte / macrophage cell line, THP-1 cells (see Chapter 2)
were exposed to hypoxia and IL-8 mNA expression detected by northern blotting. Figure
5.2.10 shows that these cells expressed barely detectable levels of IL-8 mRNA under
normoxic or hypoxic conditons. Secreted IL-8 in the supernatants was below the level of
detection by ELISA. Treatment with LPS induced IL-8 expression, but this was
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Legend for Figure 5.2.10. IL-8 mRNA expression in THP-1 cells.
IL-8 mRNA expression in normoxic and hypoxic THP-1 cells cultured for up to 4 hours
was barely detectable by northern blotting. Treatment with LPS (4 hours) generated
detectable IL-8 expression, but this was considerably less than that observed in primary
monocyte-derived macrophages (MDM) treated with LPS (4 hours). The blot shown
represents one of n=2 separate experiments.
5.2.11. IL-8 expression in human monocytes
Finally, the effect of acute hypoxia in primary human monocytes was studied. It was
anticipated the hypoxic IL-8 response in monocytes would be similar to that observed in
its derivative cell, the mature monocyte-derived macrophage. However, whereas IL-8
gene expression increased in response to hypoxia in the monocyte-derived macrophage
(cultured over 5 days), in the monocyte (cultured over 1 day) hypoxia resulted in a small
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Legend for Figure 5.2.11. Hypoxia inhibits basal IL-8 mRNA expression in cultured
human monocytes.
Human peripheral blood monocytes (aged 18 hr) and macrophages (aged 5 days), both
from the same donor, were cultured in normoxic (N) or hypoxic (H) conditions for 4
hours. Unstimulated monocytes in the culture conditions used expressed significantly
more IL-8 than the matured macrophage, hence a relatively short X-ray exposure time (8
hr) was required to allow densitometry measurement (5.2.1 IB). A more prolonged
exposure (18 hr) was required to allow macrophage IL-8 quantification (5.2.11C).
Hypoxia resulted in a small but significant reduction in basal IL-8 secretion from
monocytes, but increased IL-8 mRNA expression in macrophages. The values in 5.2.1 l.A
represent the mean and SEM from 3 separate donor experiments. IL-8 densitometry was
corrected for 18s house-keeping expression, or ethidium bromide stained ribosomal RNA
(rRNA) as shown in 5.2.1 l.D.
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5.3 DISCUSSION
In this chapter, it was shown that hypoxia increased IL-8 mRNA expression in human
monocyte-derived macrophages. This increase occurred within 30 min of hypxoic
exposure and in association with raised nuclear levels ofAP-1 and C/EBP-P, but not NF-
kB. N-acetylcysteine was shown to attenuate hypoxic IL-8 upregulation in association
with reduced nuclear AP-1 expression. Hypoxia was found to differentially influence
expression of a range of chemokines and cytokines in macrophages. The pattern of
transcription factor activation and the chemokine and cytokine expression induced by
hypoxia was different to that induced by endotoxin.
Hypoxia was found to rapidly increase steady-state IL-8 mRNA expression by 30 min
compared to normoxic controls and To cells. This suggests that hypoxia rapidly increases
IL-8 mRNA expression, at least in part through increased transcription. However, a
nuclear runoff transcription assay, currently the most sensitive method for measuring
specific gene transcription (Greenberg and Bender, 1997), was not performed. It is
possible that hypoxia also increases IL-8 mRNA stability. Kunz et al., (1999) have
recently demonstrated increase IL-8 transcription and enhanced mRNA stability in a
melanoma cell line cultured in anoxic conditions. Whether this also applies to
macrophages requires further study.
In Chapter 3, it was demonstrated that IL-8 protein expression from monocyte-derived
macrophages was significantly raised at 2 hours, but not at other time-points (Figure
3.2.5), Steady-state hypoxia-induced IL-8 mRNA expression was found to be raised up to
the 4 hour time point studied. Macrophages did not have detectable levels of stored IL-8
under hypoxic or normoxic conditions, suggesting inhibition at the level of protein
translation. Hence hypoxia appears to increase IL-8 mRNA expression rapidly and
persistently over 4 hours without parallel increase in protein expression. Studies in
epithelial cells treated with respiratory syncytial virus (RSV) or influenza A virus (Choi
and Jacoby, 1992; Fiedler et al., 1996) and in keratinocytes treated with chemical
'sensitizers' (benzene compounds) (Mohamedzadeh et al., 1994), have demonstrated a
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similar phenomenon, with significant IL-8 gene transcription but comparatively little or
no protein expression. In this context, it has been postulated that the upregulation of IL-8
mRNA may represent an initial response, 'arming' the cell in preparation for a
subsequent potentially injurious stimulus such as secondary bacterial infection or further
chemical insult. This hypothesis may apply to the hypoxic upregulation of IL-8 mRNA in
macrophages, in which a subsequent insult may be reoxygenation or endotoxin.
Increased IL-8 gene expression in macrophages by hypoxia was rapid, occurring within
30 minutes of exposure. Hypoxia has been reported to increase IL-8 expression in several
other cell types, but in none has the increase been reported to occur as rapidly as in
monocyte-derived macrophages reported in the presented study. In primary human
fibroblasts and pulmonary vascular smooth muscle cells, exposure to 3% environmental
oxygen resulted in increased IL-8 mRNA expression by 8 hours exposure, and protein by
48 hours exposure (Tamm et al., 1998). Bovine retinal glial cells in an anaerobic
environment have been shown to increase IL-8 mRNA expression by 3 hours (Yoshida et
al., 1998) but earlier time-points were not reported in this study. Several tumour cell-
lines, including human glioblastoma (Desbaillets et al., 1997) pancreatic adenocarcinoma
(Shi et al., 1999), ovarian (Xu et al., 1999) and malignant melanoma (Kunz et al., 1999)
have been shown to upregulate IL-8 in response to hypoxia or anoxia over several hours
or days.
It is possible that the monocyte-derived macrophage is a comparatively rapid hypoxic
responder. However, apparent differences in response-rate to hypoxia may be entirely
attributable to differences in experimental protocol between studies. In the studies of
different cell lines described, medium was not pre-incubated in the hypoxic environment
and the PO2 of the medium not directly measured. As discussed in Chapter 3, both
factors may be important in determining the hypoxic responses. Karakurum et al., (1994)
has shown increased IL-8 mRNA expression in human umbilical endothelial cells
(HUVECs) exposed to 6 hours hypoxia. The PO2 of the medium was reported to be ~ 2
KPa, although the method used to measure oxygen tension, or the time at which this was
measured, was not described.
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The 5'-regulatory region of the IL-8 gene contains several potential transcription
regulatory elements (Figure 5.1.1). Based principally upon studies of mutated and
restricted reporter-linked IL-8 gene promoter constructs, three transcription factors in
particular, NF-kB, AP-1 and C/EBP-|3 (NF-IL-6) have been implicated in regulating IL-8
gene transcription (Mukaida N et al., 1994; Roebuck et al., 1999). The relative
importance of these transcription factors appears to be dependent upon both the cell type
and the stimulus. In this study, it has been demonstrated that hypoxia rapidly increased
nuclear abundance of both AP-1 and C/EBP-P, within 15 min of exposure. In contrast,
there was no increase in nuclear NF-kB levels compared to normoxic controls at the early
time-points investigated. This pattern of activation differs from that seen with LPS, which
strongly induced NF-kB activation in particular.
These data pertaining to transcription factors are based upon EMSA analysis. This
technique assays nuclear levels or abundance of a given transcription factor. This does
not necessarily provide a measure of transcription factor 'activation' (the signalling
events that generate the final nuclear-translocating transcription factor complex) or
functionality (the subsequent induction of gene transcription). However, based upon
current understanding of AP-1, NF-kB and C/EBP-P regulation and their role in IL-8
transcription, discussed herein, the presence of these transcription factors within the
nucleus implies activation and this term is used as such.
A series of promoter mutation studies indicate that the NF-kB binding site is the
predominant cA-acting element in the IL-8 gene expression (reviewed in Roebuck, 1999).
Hence, IL-8 transcription induced by TNF-a (Lakshminarayanan et al., 1998), respiratory
syncytial virus (Mastronarde et al., 1998) and rhinovirus (Zhu Z et al., 1997) in A549
cells, is critically dependent upon the presence of the NF-kb-binding element. Similar
observations have been made in IL-P stimulated CaCO (colonic cancer) cells (Wu GD et
al., 1997) and HUVECs treated with heavy metal ions (Wagner et al., 1998). However,
in all cases, maximal IL-8 gene induction was only achieved in the presence of non-
mutated AP-1 and / or C/EBP-P binding elements. Furthermore, Roebuck and colleagues
have recently reported NF-kB - independent, AP-1 - dependent IL-8 gene induction in
A549 cells treated with H2O2 (Lakshminarayanan et al., 1998; Roebuck et al., 1999).
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The NF-kB family of transcription factors comprise a group of structurally related Rel
proteins. These include Rel-A (p65), Rel-B, c-Rel, NF-kB- 1 (p50) and NF-kB-2 (p52).
The NF-kB complex is composed of homodimers or heterodimers of the Rel proteins
(Perkins et al., 1992). In 'resting' cells, latent NF-kB is sequestered in the cytoplasm,
complexed to IkB (a family of cytoplasmic retention proteins) (May and Ghosh, 1998).
Upon cell stimulation, protein kinase signalling cascades result in hcB-a phosphorylation,
an event that induces ubiquitination of the cytoplasmic-retaining protein and permits NF-
kB translocation to the nucleus (Ghosh and Baltimore, 1990). Raised nuclear NF-kB
levels therefore infer cytoplasmic transcription factor activation. The signalling events
leading to IkB-cx phosphorylation have recently been reviewed (Silverman and Maniatis,
2001). In the NF-kB EMSA study described in this chapter (Figure 5.2.2), normoxic
monocyte-derived macrophages were found to have basal levels of nuclear NF-kB (and
indeed AP-1 and C/EBP-P). Most studies ofNF-kB activity in monocytes and monocyte-
derived macrophages have revealed constitutive nuclear NF-kB expression (Xu XP et al.,
1999; Blanco-Colio et al., 2000). The extent to which serum factors are responsible for
this is not certain, though Frankenberger et al., (1994) have also demonstrated basal
nuclear NF-kB expression in primary human monocytes in serum-free conditions. In the
studies described in this thesis, monocytes in 10% autologous serum to derive
macrophages. Although serum-free culture protocols have been described for monocyte
culture, in general the yield of mature macrophages is comparatively poor (Dr Ian
Dransfield, personal communication). Actual macrophage experiments were performed in
2% autologous serum and this partial 'serum withdrawal' may be in part responsible for
constitutive transcription factor activation.
The IL-8 NF-kB binding site appears to bind a restricted subset of Rel-family proteins.
Dimers consisting of p65, p50 and c-Rel complexes appear to constitute the IL-8
promoter-binding NF-kB complex in most studies (Kunsch et al., 1994; Roebuck, 1999).
The supershift EMSA study in Figure 5.2.2 was consistent with the conclusion that the
LPS-induced NF-kB species detected in monocyte-derived macrophages comprised both
p50 and p65 subunits. The precise dimeric species can not be identified from this study
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and other Rel protein may be harboured in the DNA-binding NF-kB complex. Acute
hypoxia was found not to influence nuclear NF-kB abundance. At least two previous
studies have implicated NF-kB in the hypoxic upregulation of IL-8. In HUVECs,
Karakurum et al., (1994) demonstrated an enhanced NF-kB - IL-8 promoter binding band
on EMSA, induced by 6 hours hypoxia, that did not supershift with p50 or p65 antibody.
Yoshida et al., (1998) also report increased nuclear NF-kB levels in bovine retinal glial
cells by 1 hour anoxia (without pre-incubation) in association with p65 nuclear
translocation. The data presented in this thesis do not imply that NF-kB is superfluous to
hypoxia-induced IL-8 transcription in monocyte-derived macrophages. Since cells
showed basal nuclear NF-kB expression, it is possible that constitutive activation ofNF-
kB is necessary for subsequent hypoxic upregulation.
Since the IL-8 promoter appears to only bind a subset ofNF-kB proteins, EMSA was also
performed with a consensus NF-kB oligonucleotide harbouring the 'classical' NF-kB
binding element 5'-GGGGACTTTCC-3' (Table 2.2.7). This again showed acute hypoxia
to have no significant effect on nuclear NF-kB abundance. In contrast, using similar
consensus NF-kB probes but more prolonged hypoxia (2 hours), Lepper-Woodford and
Detmer, (1999) demonstrated enhanced nuclear NF-kB levels in rat alveolar macrophages
and Chandel et al., (2000) have shown increased nuclear NF-kB in a murine macrophage
cell line. The different results between these two studies and the current study in human
monocyte-derived macrophages may reflect the different cell phenotypes or the relatively
short exposure (30 min) employed in the studies presented herein.
Several studies, mainly based on evidence from reporter-linked data, have implicated AP-
1 in IL-8 gene regulation (Roger et al., 1998; Lakshminarayanan et al., 1998; Mori et al.,
1998). AP-1 is dimeric complex composed of proteins of the Jun (c-Jun, JunB and JunD),
Fos (c-Fos, FosB, Fra 1 and Fra 2) or ATF (activating transcription factor) family (Karin
et al., 1997). Most frequently, the AP-1 complex comprises Jun-Jun homodimers or Jun-
Fos heterodimers (Smeal et al., 1989). The cytosolic subunits join via leucine zipper
domains and this dimerisation is essential for nuclear translocation and for binding of the
163
functional transcription factor to DNA (Abate et al., 1990). In this respect, measuring
nuclear abundance provides an indication of AP-1 activation.
Nuclear levels of AP-1 were raised within 15 min of hypoxic exposure in macrophages.
Rapid nuclear AP-1 accumulation following hypoxia has previously been demonstrated in
other cell types, including HT29 colonic cancer cells (Yao et al., 1994), HUVECs
(Bandyopadhyay et al., 1995) and HeLa cells (Bandyopadhyay et al., 1995; Rupee and
Baeuerle, 1995). In the AP-1 supershift study described in this chapter, IL-8 DNA
binding AP-1 species was shown to contain c-Jun protein, but no supershift was observed
with c-Fos antibody. In the absence of further superhift studies with alternative AP-1
subunit antibodies, the precise components of the detected AP-1 species cannot be
determined. There have been relatively few studies which have sought to identify the
constituents ofAP-1 protein binding to the IL-8 promoter (Roebuck et al., 1999). In A549
cells (a type 2 alveolar epithelial cell line), supershift analysis of H2O2 or TNF-a -
induced nuclear AP-1 revealed c-Fos and JunD subunits, but not c-Jun
(Lakshminarayanan et al., 1998). Jurkat cells stimulated with PMA expressed increased
IL-8 gene expression in association with increased nuclear c-Fos / JunD complex
accumulation (Mukaida et al., 1990).
In contrast to NF-kB, the IL-8 AP-1 binding element is homologous with the 'classical'
AP-1 binding motif (5'-TGA(c/g)TCA-3\ Table 2.2.7). Results from EMSA studies
performed with a consensus AP-1 oligonucleotide were identical to those with the IL-8
AP-1 probe, revealing increased nuclear AP-1 abundance following acute hypoxia and
PMA.
The basic-leucine zipper dimeric protein C/EBP-P was originally identified as a critical
transcription factor for IL-6 transcription (Poli et al., 1990). Within the IL-8 promoter,
C/EBP-P has been reported to co-operate with NF-kB, such that binding of both
transcription factors increases gene transcription synergistically (Kunsch et al., 1994). In
the absence of NF-kB binding, C/EBP-P binds weakly to the IL-8 promoter. This
cooperativity has been described in A549 cells stimulated with RSV (Mastronarde et al.,
1998), ozone (Jaspers et al., 1997) and asbestos fibres (Simeonova and Luster, 1996) and
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in PMA-treated Jurkat cells (Kunsch et al., 1994). The EMSA studies in this thesis reveal
enhanced nuclear C/EBP-P levels following acute hypoxia. Enhanced C/EBP-P activation
by hypoxia has also previously been reported in cultured endothelial cells (Yan et al.,
1995). In transgenic mice harbouring the C/EBP-P binding element ligated to a lacZ
reporter, hypoxia was found to increase P-galactosidase expression in the vasculature of
lungs, heart and kidneys (Yan et al., 1997).
A proposed model for the regulation of NF-kB, AP-1 and more recently C/EBP-P is
through cellular redox status and reactive oxygen species (ROS) (Li and Karin, 1999 in
FASEB; Gomez-del-Arco et al., 1996; Kastan, 1997; Rahman and MacNee, 2000).
Reactive oxygen species are implicated in the two redox models discussed in Chapter
1.5.5. (Figure 1.5.5), In the NAD(P)H model, ROS are generated by a membrane-bound
NAD(P)H oxidase in direct proportion to environmental oxygen. Hypoxia would
therefore result in decreased ROS. In the mitochondrial electron transport chain (ETC)
model, hypoxia inhibits the activity of cytochrome oxidase (cyt aa3), the terminal electron
receiver, hence increasing downstream generation of ROS. In both cases, the change in
intracellular ROS would be central to subsequent signalling events.
In the presented data, NAC was found to inhibit hypoxia-induced IL-8 gene transcription,
in association with reduced nuclear AP-1 accumulation, but with no effect on basal NF-
kB activity. NAC functions primarily as an anti-oxidant through two distinct
mechanisms; the direct scavenging of ROS and reduction of sulphydryl groups, and also
indirectly as a substrate for the biosynthesis of the cellular redox regulator glutathione (L-
glutamyl-L-cysteinylglycine, GSH) (Gillissen and Nowak, 1998; Kelly, 1998; Rahman
and MacNee, 2000). The attenuation of hypoxia-inducible IL-8 with NAC would support
a model in which hypoxia increased ROS, signalling AP-1 activation and gene
transcription in monocyte derived macrophages. Since basal expression of NF-kB was
unchanged with hypoxia or NAC treatment, the relevance of constitutive NF-kB
activation in subsequent hypoxic activation is unresolved.
The precise regulatory site for hypoxia in the AP-1 activation pathway however is
elusive. AP-1 may be regulated at the transcriptional and post-transcriptional level. At the
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transcriptional level, the immediate early genes c-jun and c-fos are upregulated within a
few minutes of hypoxic exposure in a range of cells and tissues (Webster et al., 1993;
Ausserer et ah, 1994). In pulmonary artery fibroblasts, hypoxia activates p38 mitogen-
activated protein kinase (MAPK) activity and downstream c-Jun expression (Scott et ah,
1998). Pharmacological reduction in intracellular ROS also induces (MAPK) activation,
downstream c-fos and c-jun induction and c-Fos and c-Jun protein expression (Muller et
ah, 1997; Lo, 1996). Post-transcriptionally, reduction and phosphorylation events regulate
transcription factor-DNA binding. Both Fos and Jun proteins bear a redox sensitive
conserved cysteine residue, reduction of which is necessary to allow electrostatic
interaction between protein and DNA (Abate et ah, 1990). This would however infer that
AP-1 -mediated transactivation would increase in the presence of a reducing agent such as
NAC. This is indeed the case in HeLa cells for example, in which unstimulated and
PMA-stimulated AP-1 binding and transactivation is increased in the presence of NAC
(Bergelson et ah, 1994; Meyer et ah, 1993). Finally, phosphorylation of two serine
residues in the transactivation domain of c-Jun is also required for transcriptional
activation (Karin, 1995). Increased ROS following treatment with H2O2 has recently been
shown to activate JNK (Jun N-terminal kinase) through allowing its dissociation from an
inhibitory protein termed GSTp (glutathione S-transferase). Activation of JNK results in
c-Jun phosphorylation and AP-1 transactivation, a process inhibited by NAC (Adler et ah,
1999). Hence, this model may also be consistent with the hypothesis that hypoxia
generates ROS and AP-1 activation.
Several studies have shown that anti-oxidants inhibit NF-kB activation and the
downstream expression of NF-kB responsive genes (reviewed in Li and Karin, 1997).
The antioxidant effect, as with AP-1, appears to be highly cell- and stimulus-specific
(Schreck et ah, 1991; Brennan and O'Neill, 1995; Li and Karin, 1999; Rahman and
MacNee, 2000). Two recent studies that have demonstrated NF-kB activation in response
to hypoxia have also reported attenuation following antioxidant treatment with NAC
(Chandel et ah, 2000; Haddad et ah, 2000), implicating increased ROS in hypoxic
signalling. As with AP-1, the regulatory site within the NF-kB activation pathway is
unknown. Oxidative stress is associated with hcB-a phosphorylation, an event that is
inhibited by antioxidants including NAC in endothelial cells (Cho et ah, 1998) but not
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HeLa cells (Li and Karin, 1999). Although 'classical' IkB-oc phosphorylation occurs at
two conserved serine residues, there is evidence that hypoxia may induced IkB-cx
phosphorylation at tyrosine residues (Koong et al., 1994).
The finding that acute hypoxia increased AP-1 and C/EBP-(3, but not NF-kB, nuclear
expression may have important implications for the selectivity of the hypoxic response in
macrophages. Both putative and functional binding sites for the three transcription factors
studied are present in a large number of gene promoters. The observation that the pattern
of activation with concensus probes was identical to that with IL-8-promoter probes
would suggest the potential for hypoxia to regulate many genes. The presented data
(Figures 5.2.7 and 5.2.8) shows that, in contrast to IL-8, basal steady-state mRNA
expression of several chemokines and cytokines, were clearly down-regulated by 2 hrs
hypoxia. The most striking effects were the reduction in basal expression of the CC
chemokines MlP-la, MIP-1(3 and MCP-1. Low level expression of IP-10, a non-ELR
harbouring CXC chemokine, was attenuated. Of the cytokines studied, basal TNF-a
expression was inhibited and only TGF-(31 expression was significantly increased by
hypoxia. This pattern of expression contrasted starkly with that observed with LPS.
The published promoter regions of a selection of the chemokines and cytokines studied is
shown in Figure 5.3.2. It is apparent that AP-1 and NF-kB binding sites are common to
several of the chemokine genes, ofwhich the most extensively studied is MCP-1. Binding
of Sp-1 to the proximal MCP-1 promoter is known to be critical for assembly of basal
transcriptional machinery following TNF-a stimulation (Ping et al., 2000). However,
both NF-kB and AP-1 sites are required for maximal transcriptional upregulation of
MCP-1 in response to most inflammatory stimuli including TNFa, IL-(3, viral proteins
and H2O2 (Martin et al., 1997; Lim and Garzino-Demo, 2000; Goebeler et al., 2001;
Roebuck et al., 1999; Wung et al., 1997). Therefore, it appears that the transcriptional
regulation of MCP-1 is not unlike that of IL-8. There are several potential explanations
that may explain the observation that in human macrophages, hypoxia increased steady-
state IL-8 mRNA, in association with increased nuclear AP-1 levels and maintained basal
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2000)
Legend for Figure 5.3.1. Schematic representation of the promoter regions of
selected chemokines and TGF-P harbouring AP-1, NF-kB and C/EBP binding
elements. GRE = glucucorticoid responsive element. IRSE = interferon stimulated
response element.
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It is possible that the effect of hypoxia, at least in part, induces differential stability of
mRNA species. This aspect ofmRNA expression was not studied. Hypoxia is known to
increase mRNA stability through induction of cytoplasmic hypoxia-inducible proteins
(HEP) that bind to the AU-rich 3'untranslated region (UTR) of the VEGF, tyrosine
hydroxylase and erythropoeitin mRNA species (Shih and Claffey, 1998; Lewis et al.,
1999). There are no previous reports of hypoxia reducing mRNA stability however.
Furthermore, the acute effect (2 hours) may be too rapid to implicate stability as a factor
in mRNA expression.
Another possibility is that the differential regulation is AP-1 - mediated, with the
transcription factor inducing repression in some genes, such as MCP-1 and activation in
others, such as IL-8 and TGF-p. Hypoxia upregulation of TGF-P 1 has previously been
reported in proximal tubular epithelial cells (Orphanides et al., 1997), retinal cells (Khaliq
et al., 1995, Behzadian et al., 1998) and a choreocarcinoma cell line (Gleadle et al.,
1995). Transcriptional control of TGF-P 1 appears to be largely AP-1 mediated (Figure
5.3.2), and Helfman and Falanga (1993) have demonstrated requirement of AP-1 binding
sites for maximal hypoxic gene induction. With regard to MCP-1 transcription, a
functional repressor transcription factor complex has been reported to regulate MCP-1
gene expression (Jain-Vora et al., 1997; Sridhar et al., 1999). However, there are no
previous reports of AP-1 acting as a gene silencer and indeed within the MCP-1
promoter, AP-1 has been shown to be critical for oxidant (H2O2) induced gene
transcription (Wung et al., 1997). Furthermore, several of the genes studied do not
harbour AP-1 regulatory elements within the known promoter regions. Hence, it is
unlikely that AP-1 acts a central hypoxic regulator within this panel of genes.
This raises the possibility that an alternative transcription factor or factors are responsible
for the differential regulation observed. The most obvious candidate is HEF-1, which has
been termed a master regulator of hypoxic gene responses (Semenza et al., 1999). The
role of HIF-1 in IL-8 gene transcription is explored further in Chapter 6. However, there
is evidence that HIF-1 may play a role in MCP-1 regulation. Negus et al., (1998) have
also demonstrated inhibition of MCP-1 mRNA expression by 2 hours in an ovarian cell
line stimulated with TNF-a and cultured in 0% oxygen. Consistent with the observations
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presented in this chapter, hypoxic inhibition occurred without influencing NF-kB activity
as measured by EMSA. A similar inhibition of MCP-1 mRNA was observed with CoCl
and DFO, pharmacological mimickers of hypoxia. This provides indirect evidence for a
HEF-1 mediated effect. Against this perhaps is the observation that although over 30
individual genes have been shown to be clearly HIF-1 mediated, very few are repressed
through a HIF-1 mechanism (Chapter 1.5; Narravula and Colgan, 2001).
Lastly, it is possible that hypoxia influences an aspect of basal transcriptional machinery
or a higher order of gene regulation such as chromatin modelling. It has been proposed
that the tight interaction between the negatively charged DNA backbone and core
histones creates a 'chromatin barrier', impeding the access of regulatory transcription
factors to target DNA (Struhl, 1998). This mechanism has been implicated in gene
silencing or repression. Acetylation of specific lysine residues, on N-terminal histone
tails, through increased activity of specific histone acetylation transferases (HATs) or
reduced activity of specific histone deactylases (HDACs), is believed to loosen the DNA-
histone interaction and expose previously 'hidden' DNA regions to regulatory
transcription factors. This model is attractive in hypoxic gene regulation since it may
account for differential regulation of multiple genes simultaneously (Van Lint et ah,
1996; Delia Ragione et ah, 2001). That chemokines, and more specifically MCP-1 and
IL-8, may be differentially regulated through histone acetylation / deacetylation, has been
demonstrated recently by Fusunyan et ah, (1999) and Wen and Wu (2001).
The biological relevance of this differential gene response to acute hypoxia in
macrophages is to some extent speculative. The original rationale for studying acute
hypoxic regulation was as a mechanism for rapid IL-8 generation in the lungs of patients
at-risk of ARDS. Since only IL-8 and not a range of other inflammatory mediators was
associated with progression to ARDS, a differential stimulus such as hypoxia may be
more relevant than a pan-inflammatory stimulus such as endotoxin. However, the
differential effect of hypoxia has not been studied in alveolar macrophages and may not
necessarily be relevant in this setting. Monocyte-derived macrophages serve as a
reasonable model of tissue macrophages elsewhere and hypoxia is a relevant stimulus in
injured, inflamed or malignant tissue (Lewis et ah, 1999). Interleukin-8 and TGF-[3 are
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angiogenic, in contrast to IP-10 which is angiostatic, and early induction of IL-8 and
TGF-(3 suggests that tissue repair mechanisms may be initiated even in the acute phase of
injury. The clear difference between the pattern of transcription factor activation and
chemokine and cytokine generation between hypoxia and LPS is of interest. Macrophages
must adapt and respond to a changing environment as they migrate to sites of tissue
injury and inflammation. Differential expression of genes to hypoxia and endotoxin may
represent a switch from initiating wound healing to responding to infection. It is likely
ofcourse that both infection and hypoxia may co-exist, for example in sepsis and the
combined effect needs to be investigated further in in vitro studies. Therapeutically, it
may be possible to attenuate one response, whilst maintaining the other. For example, it
may be advantageous to inhibit the comparatively large IL-8 response to LPS if
accumulating neutrophils cause overwhelming tissue injury, but to maintain the relatively
low-level hypoxic response to aid wound healing.
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Table 5.3.1
Transcription Factor Gene Reference
NF-kB IL-8* Karakurum et ah, 1994; Yoshida
etal., 1998
Cyclo-oxygenase-2 Schmedtje et ah, 1997
TNF-a Leeper-Woodford and Detmer,
1999, Chandel et ah, 2000
AP-1 Tyrosine Hydroxylase Czyzyk-Krzeska et ah, 1994a;
Czyzyk-Krzeska et ah, 1994b;
Norris and Millhorn, 1995
Mishra et ah, 1998
Endothelin-1** Yamashita et ah, 2001
IL-8* Shi et ah, 1999, Xu et ah, 1999
Basic fibroblast growth factor Le et ah, 1999
TGF-pl Helfman and Felanga, 1993
C/EBPP (NF-IL-6) IL-6 Yanetah, 1996; Yan 1997
Table 5.3.1. Hypoxia-induced genes in which NF-kB, AP-1 and C/EBP-P have been
implicated
*Relative importance of NF-kB and AP-1 regulation may be cell-specifc. The studies
from Shi et al., 1999 and Xu et ah, 1999, using IL-8 reporter constructs, report that both
AP-1 and NF-kB sites are necessary for hypoxic induction in pancreatic adenocarcinoma
and ovarian carcinoma cells








In Chapter 5, NF-kB, AP-1 and C/EBP-(3, transcription factors known to be involved in
IL-8 gene regulation, were studied in hypoxic macrophages. Hypoxia-inducible factor-1
(HfF-1) is known to be important in the regulation of a number of hypoxia-regulated
genes (Table 1.5.6). The role of HIF-1 in the hypoxic regulation of IL-8 is unknown. A
computer-assisted search (TFSEARCH version 1.3, Yutaki Akiyama, Kyoto University,
Japan) for the HIF-binding core sequence 5'-CGTG-3' in the published 1.5Kb EL-8
promoter region (Accession no. M28130; Mukaida et al., 1989) revealed a single putative
binding site on the antisense strand located -2 to -6 bp (3'-TCGTGA-5'), immediately
upstream from the transcription initiation site, but down-stream of the TATA box (Figure
5.1.1). Although functional HIF-1 sites within antisense strands have been reported in
other genes (Table 1.5.6), a location downstream of the TATA box would be unusual for
a regulatory transcription factor element. Furthermore, as the number genes found to be
HIF-1 regulated increases, the core binding sequence for the protein has been refined to
5'-RCGTG-3', where R represents a purine (Semenza, 2000). Although these factors
suggest the putative IL-8 HIF-1-binding site is unlikely to be functional, it is recognised
that HIF-1 may exert its effect at enhancer sites, potentially several Kb away from the
TATA box. Recently, novel regulatory cA-acting elements located >6.5 kB upstream and
/ or 3.7 kfi downstream of the IL-8 TATA box have been described (Wen and Wu et al.
2001)




Three approaches were employed to study the potential role of HIF-1 in hypoxic
regulation of IL-8; pharmacological studies using mimickers of hypoxia, transfection
studies in macrophages using a reporter (CAT)-linked IL-8 promoter and studies in HIF-
1-deficient cells.
6.2.1. Cobalt and Desferrioxamine do not increase IL-8mRNA expression
Cobaltous ions and iron chelators, through mechanisms which remain unclear, are able to
mimic hypoxic induction ofHIF-la protein expression and activation of a range ofHIF-
1-mediated target genes (Goldberg, 1988; Wang and Semenza, 1993).
Macrophages were exposed to normoxia, hypoxia, CoCl (lOOpM), desferrioxamine
(DFO) (1 mM) or LPS (1 pg/ml) for 1 hour (Figure 6.2.1). Immunoblotting for HIF-la
revealed expression in hypoxic cells and those treated with CoCl and DFO, with no
expression in normoxic or LPS-treated cells. In contrast to hypoxia and LPS however,
neither CoCl nor DFO increased IL-8 mRNA expression.
These data suggest that HIF-1 may not be implicated in the hypoxic induction of IL-8. To
further explore a possible functional role for HIF-1 in IL-8 gene transcription,
experiments were planned in which a reporter-linked IL-8 promoter, would be transfected
into human monocyte-derived macrophages. By transfecting IL-8 DNA with a mutated
HIF-1 site, the functional nature of this putative site may be established. Indeed, this
methodology would allow studies of the functional roles of the NF-kB, AP-1 and
C/EBP-p sites in hypoxic IL-8 induction.
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Figure 6.2.1
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Legend for Figure 6.2.1. Hypoxia induces HlF-la protein expression in human
macrophages. Macrophages were cultured under normoxic (N) or hypoxic (H)
conditions or with LPS (1 pg/ml) CoCI (100 jiM) or DFO (1 mM) for 2 hrs. Hypoxia,
CoCI and DFO induced HIF-la expression (A). BL-8 mRNA expression from treated
macrophages was assayed by northern blotting, with subsequent verification of equal
RNA loading determined by re-probing with an 18s house-keeping probe (B and C).
Densitometry, corrected for 18s expression, showed that LPS and hypoxia, but not CoCI
and DFO, significantly upregulate IL-8 mRNA expression (D).
Immunoblotting of whole protein lysates with a HIF-la antibody was performed on n=3
separate experiments. The blot shown was performed by Dr Michael Weisener,
Wellcome Trust Centre for Human Genetics, Oxford. The northern analysis was
performed on n=3 separate experiments. Each value in Figure 6.1.2D represents mean ±
SEM. *P<0.02 compared to normoxia.
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6.2.2. Cationic liposome-mediated transfection of human monocyte-derived
macrophages is inefficient.
Human monocyte derived macrophages were transfected with a pSV-(3-Galactosidase
vector using the cationic liposome Tfx-10 (Promega) as described in Chapter 2. Three
different liposome : DNA ratios were used; 2:1, 3:1 and 4:1. Post-transfection, cells were
cultured for 18 hours under normoxic conditions. CHO-K1 cells, known to be readily
transfectable, were used as a positive control. Cell viability, as measured by Trypan blue
exclusion, was >95% in both cell types when transfected at a charge ratio of 2:1 or 3:1. In
macrophages, viability was reduced to 80%, and in C4.5 cells 85%, at a charge ratio of
4:1. The expression of P-GAL protein in the cell lysate was measured by ELISA, and
adjusted for total protein. At all three charge ratios, macrophages expressed markedly less
P-GAL compared to CHO-K1 cells (Figure 6.2.2). At a charge ratio of 2:1, p-GAL
expression in CHO-K1 cells was optimal (0.25pg/pl), and was 20-fold greater than the













Liposome : DNA ratio
Legend for 6.2.2. Liposome mediated transfection in CHO-K1 cells and
macrophages. Cells were transfected at three different charge ratios. Monocyte-derived
macrophages expressed markedly less b-GAL compared to CHO-K1. A liposome ratio of
2:1 was significantly more efficient than 3:1 or 2:1. This experiment was performed once
in triplicate wells. Data is presented as mean ± SD. *P<0.05 compared to all other
transfections.
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Hence, liposome-mediated transfer of DNA to human monocyte-derived macrophages
was comparatively inefficient, and was thought not to be a useful method for
investigating IL-8 gene regulation in these cells.
An alternative approach was employed, using engineered HIF-la - deficient (Kal3) and
HIF-la- expressing (C4.5) CHO-K1 cell-lines (a kind gift from Prof. Peter Ratcliffe,
Oxford). The derivation and characterisation of this cell line is well described (Wood et
al., 1998). Briefly CHO-K1 cells were stably transfected (grown on selective media) with
plasmids bearing HREs linked to genes encoding immunoselectable cell surface markers
(CD2 and E-Selectin). Cells were mutagenised by exposure to 3-chloro-7-methoxy-9-(3-
[chloroethyl]-amino propylamino)-acridine dihydrochloride. Derived cells which
displayed reduced or absent hypoxia-inducible marker expression were further screened
and one clone (Kal3) revealed absent HIF-la expression. A clone which strongly
expressed hypoxia-inducible surface markers (C4.5) was also selected as a control cell
population. Hypoxic Kal3 cells fail to upregulate several endogenous genes in which
HIF-la has been implicated (Wood et al., 1998)
6.2.3 C4.5 cells upregulate CD2 and E-selectin following hypoxia and CoCl
treatment
In order to verify the C4.5 cell phenotype and ensure that the reported effects of hypoxia
in this cell could be reproduced in the conditions used in my experiments, cells were
incubated for 18 hours under normoxic or hypoxic conditions, or with CoCl (100 pM).
Cells were immunostained with mouse anti-human monoclonal antibodies to CD2 and E-
selectin and analysed by FACS. Antibodies to human CD5 (a T cell marker) and MOPC
(a mouse myeloma IgGl marker) were employed as negative controls. Both hypoxia and
CoCl increased CD2 and E-selectin expression in C4.5 cells, compared to normoxic
controls (Table 6.2.3 and Figure 6.2.3),
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Table 6.2.3
Mean log fluorescence with antibody
FB CD5 MOPC CD2 E-selectin
N 4.0 4.0 3.6 47 10.5
4.2 4.1 3.6 50 13
H 4.8 4.6 4.2 277 107
5 4.3 4.4 289 97
CoCl 3.5 3.7 121 48 3.4
3.7 3.7 128 54 3.1
Legend for Table 6.2.3 and Figure
6.2.3. Verification of the C4.5 cell
phenotype. Both hypoxia (H) and CoCl
upregulate surface expression of CD2 and
E-selectin compared to normoxia (N).
(Table 6.2.3). Flow buffer, CD5 and
MOPC were negative controls. A
graphical representation of the data for
CD2 is shown in Figure 6.2.3, a flow-
cytometry histogram of cell count versus
log fluorescence. This experiment was
performed once, in duplicate. Both values
are shown in Table 6.2.3.
6.2.4. Detection of IL-8 and other chemokines in C4.5 and Kal3 cells
It is not known if CHO-KI cells express IL-8 or related homologue. There are no entries
in the GenBank database pertaining to Chinese hamster IL-8. Hence, total RNA from
normoxic, hypoxic and PMA-treated C4.5 cells was 'screened' for IL-8 mRNA by
northern blotting using the human IL-8 cDNA probe, by RT-PCR using both human and
rabbit IL-8 PCR primers. None of these techniques yielded products consistent with IL-8
transcript (data not shown). RNase-protection assay (RPA) using human riboprobes to
selected chemokines (as described in Chapters 2 and 5) was also attempted. Wood et al.,
1999 have used this technique to study expression of several genes using Chinese
Hamster, murine or human RNA probes in C4.5 and Kal3 cells. However, no bands
other than the housekeeping GAPDH and L32 were observed by RPA as shown in Figure
6.2.4.
These data suggested either that CHO cells do not express IL-8, or that Chinese hamster
IL-8 transcript does not bear sufficient cross-species homology to allow detection by the
Figure 6.2.3
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human or rabbit IL-8 reagents used. C4.5 and Kal3 cells were therefore transfected with
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Legend for Figure 6.2.4. . RNase protection assay using multiple human RNA
probes in C4.5 and Kal3 CHO-K1 cells. Human riboprobes failed to detect chemokine
mRNA species from CHO cells. Bands were not visualised even following prolonged
radiographic exposure. This assay was performed on RNA samples obtained from a
single experiment.
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6.2.5 and 6.2.6. IL-8-Reporter-linked expression in C4.5 and Kal3 cells
Cells were co-transfected with the CAT-linked IL-8 promoter and a P-Gal control vector
(vector maps shown in Figure 2.2.12.1) and subsequently incubated under normoxic or
hypoxic conditions, or with DFO, CoCl or PMA, for 18 hours. Cell lysates were assayed
for CAT (and P-Gal) protein. Figure 6.2.5 shows that compared to normoxia (expressed
as 100%), hypoxia, DFO and CoCl all significantly inhibited CAT protein expression
(58±8%, 61+10% and 26±6% respectively; P<0.02). PMA significantly increased CAT
expression (138+10 %; P<0.02). However, an unexpected finding was that hypoxia, DFO
and CoCl also significantly inhibited p-Gal control vector expression (61±10 %, 58±10 %
and 44±5 % respectively; P<0.02). PMA had no significant effect on P-Gal expression
(101±7 %). As an additional control experiment, cells were transfected with pCAT-
Control Vector. This vector contains SV40 promoter and enhancer sequences (vector
maps are shown in Figure 2.2.13), and is designed to induce strong constitutive
expression in eukaryotic cells. Again, hypoxia, DFO and CoCl all inhibited CAT
expression to a similar degree to IL-8 transfected cells (Figure 6.2.5).
The pattern of reporter protein expression from transfected Kal3 cells was similar to that
observed with C4.5 cells; hypoxia, DFO and CoCl all significantly inhibited CAT and p-
Gal expression in cells co-transfected with CAT-linked IL-8 promoter and P-Gal control
vector (Figure 6.2.6). Similarly, Kal3 cells transfected with pCAT-control vector
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Legend for Figure 6.2.5. IL-8 reporter-linked expresion in C4.5 cells. C4.5 (HIF-1
expressing) cells were co-transfected with the CAT-linked IL-8 promoter (A) and a pSV-
P-Galactosidase vector (B). Cells were cultured in normoxic or hypoxic conditions, or
with PMA (100 nM), CoCI (100 pM) or DFO (ImM) for 18 hrs. Results are expressed as
mean SEM. * P<0.02, n=3 experiments performed in duplicate. As a further control (see
text), C4.5 cells were transfected with a pCAT control vector and treated as above for 18






















0 25 50 75 100 125 150
CAT expression (%)
Legend for Figure 6.2.6. IL-8 reporter-linked expresion in Kal3 cells. As with C4.5
cells Kal3 (HIF-1 deficient) cells were co-transfected with the CAT-linked IL-8
promoter (A) and a pSV-(3-Galactosidase vector (B). Cells were cultured in normoxic or
hypoxic conditions, or with PMA (100 nM), CoCl (100 pM) or DFO (ImM) for 18 hrs.
Results are expressed as mean SEM. * P<0.02, n=3 experiments performed in duplicate.
As an additional control, Ka 13 cells were separately transfected with a pCAT control
vector and treated as above for 18 hrs (C). Results represent mean of n=2 experiments,
performed in duplicate
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These experiments clearly show that the inhibitory effects of hypoxia, DFO and CoCl on
reporter protein expression in CAT-linked IL-8 promoter transfected cells cannot be
attributed to an effect on the IL-8 promoter. There are several possibilities that may
explain apparent global reduction in expression of reporter protein as observed in these
studies:
i) Experimental treatment with hypoxia, CoCl and DFO significantly reduced cell
viability
ii) Hypoxia, CoCl and DFO interfere with CAT (and (3-GAL) protein translation,
stability or detection by ELISA.
iii) Hypoxia, CoCl and DFO interfere with basal transcription machinery. In this case,
not only eukaryotic but also prokaryotic transcriptional apparatus must be
repressed by the experimental treatment.
6.2.7 Inhibition of reporter protein expression is not due to reduced cell viability
Cell viability of transfected cells following 18 hours hypoxia, DFO or CoCl treatment
was assessed by trypan blue exclusion, which consistently revealed >95% viability.
However to further explore the possibility that hypoxia, CoCl and DFO were reducing
reporter protein expression as a result of cell death, LDH levels were was assayed in the
supernatant following 18 hours culture. There was no increase in supernatant LDH levels
under experimental conditions (Figure 6.2.7).
6.2.8. Hypoxia increases intracellular LDH expression in C4.5, but not Kal3 cells
LDH is a glycolytic enzyme known to be upregulated by hypoxia. Previous
pharmacological studies have shown that HIF-1 is likely to be involved in hypoxic-
induction of LDH (Firth et al., 1994). Intracellular LDH levels were assayed in lysates
from C4.5 and Kal3 cells cultured in normoxic or hypoxic conditions. This showed that
in C4.5 cells, hypoxia significantly increased intracellular LDH protein levels compared
to normoxic controls (1585+202 v 908+191 U/ml; P<0.02). In Kal3 cells LDH levels in
hypoxic and normoxic cells were identical (605+197 v 594+54 U/ml), evidence that
hypoxic upregulation of LDH is HIF-1a - dependent.
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Figure 6.2.7
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Legend for Figure 6.2.7. Viablity of CHO cells assessed by LDH assay in cell
supernatants. Supernatants from transfected C4.5 and Kal3 cells incubated in normoxia
(N), hypoxia (H) or with PMA (100 nM), CoCI (100 pM) or DFO (100 mM) for 18 hours
in 10% FCS were assayed for LDH content. Medium with 10% FCS was also assayed for
background LDH levels. No significant increase over background levels was detected.
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Legend for Figure 6.2.8. Upregulation of intracellular LDH by hypoxia in C4.5 and
Kal3 cells. C4.5 and Kal3 cells were incubated in normoxic (N) or hypoxia (H) for 18
hours and lysed in 0.1% Triton-XlOO. Intracellular LDH was significantly increased in
C4.5 cells but not in Kal3 cells. Data is presented as mean ± SEM. n=3 experiments,
performed in triplicate wells. P<0.002.
185
6.2.9. Inhibition of reporter protein expression is not due to reduced protein stability
or impaired detection.
The reporter assays for both CAT and P-Gal depend upon measurement of reporter
protein levels by ELISA. Recombinant CAT and (3-Gal protein from E.Coli (Boehringer
Mannheim) was reconstituted at 0.5 ng/ml in 1ml of medium with 10% FCS. The
medium was then incubated under normoxic or hypoxic conditions, or with 100 pM CoCl
or 1 mM DFO for 18 hours. Measured levels ofboth recombinant CAT and (3-Gal protein
following hypoxic exposure or spiking with CoCl or DFO were similar to normoxic
controls (Figure 6.2.9), This suggests that neither protein stability nor detection by
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Legend for Figure 6.2.9. Effect of Hypoxia, CoCl and recombinant CAT and P-Gal
protein detection by ELISA. Recombinant CAT and P-Gal protein (0.5 ng/ml) was
incubated under normoxic or hypoxic conditions, or with 100 pM CoCl or 1 mM DFO,
for 18 hours. Standard ELISA was performed, and absorbance measured at 405 nm. For
comparison, absorbance from an aliquot of freshly reconstituted protein (0.5 ng/ml) is
also shown (X). Incubation of protein with the various treatments did not affect detection
by ELISA. Data is presented as mean ± SD. n=l experiment performed in triplicate
In the absence of evidence for reduced cell viability, reduced protein stability or impaired
detection, it is possible that hypoxia, DFO and CoCl influence basal eukaryotic and
prokaryotic transcriptional machinery. This is discussed further in the Discussion.
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6.3 DISCUSSION
In these experiments the potential role of HIF-1 in the hypoxic regulation of IL-8 in
macrophages was explored. Human macrophages were shown to express HIF-1a under
hypoxic conditions, and following treatment with coboltous ions and DFO. However
neither CoCl nor DFO significantly upregulated IL-8 mRNA expression. In HIF-1 -
deficient CHO cells transfected with a CAT-linked IL-8 promoter, hypoxia, CoCl and
DFO all significantly inhibited CAT expression compared to normoxia. However,
identical results were seen with the control P-Gal vector and with a pCAT vector
harbouring SV40 promotor and enhancer sequences. The inhibited protein expression was
not a result of reduced cell viabilty as determined by trypan blue exclusion and LDH
assay of cell supernatants.
Pharmacological manipulation of HIF-1 expression has provided a useful tool for
studying the potential role ofHIF-1 in gene regulation. Coboltous ions and iron chelators
such as DFO mimic hypoxia in both induction ofHEF-la protein and activation ofHIF-1
mediated target genes such as erythropoietin (Goldberg et al., 1988; Wang and Semenza,
1993), VEGF (Goldberg et al., 1994) transferrin receptor (Lok et al., 1999) LDH-A (Firth
et al., 1994), PDGF-P (Gleadle et al., 1995) endothelin-1 (Hu et al., 1998) and NO
synthase (Melillo et al., 1997).
The mechanisms by which cobaltous (and other divalent transition metal) ions and the
iron chelator DFO induce HIF-1 are unclear (Chapter 1.5.5). To date however, there are
no reported examples of hypoxia inducible genes in which HIF-1 is clearly implicated (as
determined by transfection of mutated or deleted reporter-linked promoter sequences),
but in which neither divalent cations nor iron chelators mimic the hypoxic effect.
Conversely, both CoCl and DFO may influence gene regulation via pathways
independent ofHIF-1 (Wenger, 2000). In CHO cells, CoCl upregulates haemoxygenase-1
(HO-1) in a HIF-1 independent manner, in association with increased DNA binding of
Nrf2, a recently characterised member of the AP-1 family of bZEP transcription factors
(Gong et al., 2001). The finding that neither CoCl nor DFO increased IL-8 mRNA, at a
dose widely used in studies of hypoxic signalling, suggests that HIF-1 is unlikely to play
a role in IL-8 synthesis in human macrophages.
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Recently inflammatory stimuli such as TNF-a, and IL-ip have been shown to induce
HIF-la expression (Haddad and Land, 2001) and increases DNA-binding activity
(Hellwig-Burgel et al., 1999) in epithelial and endothelial cell lines. In the macrophages
studied herein, HIF-la expression was not induced by LPS. Whether other inflammatory
stimuli such as cytokines induce HIF-1 expression in macrophages is not known.
However, it could be hypothesised that for macrophages, which must adapt to
miroenvironmental changes during migration to the inflammatory site, it may be
advantageous to differentiate hypoxic from infective stimuli.
To further explore a role for HIF-1 in IL-8 transcription, experiments were performed in a
HIF-1a deficient cell line. The C4.5 (HIF-la expressing) cell line has been stably
transfected with a plasmid bearing multiple HREs linked to genes encoding CD2 and E-
selectin. A mutagenised clone of this cell line, the Kal3 cell line, does not express HIF-
la and hence does not express CD2 or E-selectin following hypoxia (Wood et al., 1998).
These cells have proved to be a useful tool for studying the role ofHIF-1 in the hypoxic
regulation of genes including HO-1, Glucose transporter-1 (Glut-1) and VEGF (Wood et
al., 1998). CHO cells did not appear to express IL-8 mRNA as detectable by human and
rabbit PCR primers, cDNA probes and riboprobes The cells were therefore transfected
with a CAT-linked IL-8 promoter.
The results demonstrate that in C4.5 transfected with a CAT-linked IL-8 promoter,
hypoxia, DFO and CoCl all significantly inhibited CAT expression compared to
normoxic controls. This phenomenon however cannot be attributed to a specific effect on
the IL-8 promoter. Expression of the co-transfected (5-Gal vector, which is under the
control of the constitutively driven SV40 early promoter and enhancer, was similarly
inhibited by hypoxia, CoCl and DFO. Similarly, transfection of a pCAT control vector
under the control of the SV40 early promoter and enhancer resulted in reduced CAT
expression following hypoxia, CoCl and DFO. Furthermore, this effect cannot be
attributed to HIF-1-mediated hypoxic signal, since Kal3 (non HIF-1 - expressing) cells
responded identically. Treatment with PMA, a C-kinase activator and known IL-8
activator (Schondorf et al., 1993; Okamoto et al., 1994; Smyth et al., 1991) did induce
increased CAT expression in IL-8 promoter transfected cells, with no effect on (3-GAL or
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pCAT control vector transfected cells. This demonstrated that CHO cells possess the
capacity to induce the IL-8 promoter if appropriately stimulated. Furthermore, the
observation that intracellular LDH was upregulated in a HIF-1 dependent manner, as has
previously been described (Semenza et al., 1994; Firth et al., 1995), suggests an
appropriate cellular response to hypoxia.
A number of possible explanations for these unexpected findings were explored. Reporter
assays measure expression at the protein level. Hence in addition to factors that influence
gene promoter or enhancer elements, cell viability, reporter protein stability and
detection, protein translation, reporter mRNA stability and the general transcriptional
machinery may all influence the assay result. Experiments were performed to address
some of these possibilities. The inhibitory effects of hypoxia, CoCl and DFO would be
accounted for if these treatments reduced cell viability. This however was not the case,
since cell viability as measured by both trypan blue exclusion and LDH activity in cell
supernatants was unaffected. Similarly experiments in which recombinant CAT and (3-
GAL protein was co-incubated with CoCl and DFO prior to ELISA suggested that the
effect was not due to reduced CAT or P-GAL protein stability or impaired protein
detection.
The inhibitory effects of hypoxia, CoCl and DFO may therefore occur at the mRNA
level, either through impaired reporter mRNA translation to protein, impaired mRNA
stability, or through inhibition of general transcriptional machinery. Experiments that
address these specific issues have not been performed. The transcription of transfected
reporter-linked genes, as with transcription of all native genes in eukaryocytic cells, is
dependent upon the activation of basal transcriptional apparatus. This process consists of
the binding of general transcription factors (starting with TFIID) to the TATA sequence.
This results in recruitment of RNA polymerase II to the DNA promoter, an essential
event in gene transcription. Inhibition of general transcriptional machinery would
therefore be a possible mechanism for the inhibition of reporter expression.
Prokaryotic promoters are commonly used in as 'control' in transfection experiments, on
the basis that prokaryotic transcriptional machinery should function constitutively and
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independently of eukaryotic regulation. Previous studies have demonstrated that
prokaryotic vector DNA can alter eukaryotic transgene expression in vivo. In a transgenic
alpha-fetoprotein mouse model, plasmid prokaryotic DNA elements were found to be
responsible for inhibiting expression of the eukaryotic transgene in vivo (Hammer et ah,
1987). Whilst these in vivo findings support the notion that prokaryotic and eukaryotic
transcriptional control is not mutually exclusive, the fact remains that viral promoters are
used extensively in vitro, including hypoxia experiments, without reports of eukaryotic
interference (Semenza et al., 2000B and references therein).
The effects of hypoxia, CoCl and DFO on reporter expression in transfected cells are not
easily explained and require further study. For example, it would be of interest to
investigate the effect of hypoxia on PMA-stimulated cells, to observe if the inhibitory
effects on reporter expression will over-ride a positive stimulus. Furthermore, CHO cells
transfected with alternative viral-controlled expression vectors, such as cytomegalovirus
(CMV) or adenoviral vectors would provide information on the specificity of the
observed effects to the SV-40 constmct.
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SUMMARY
The original catalyst for much of the work presented herein has come from clinical
studies of patients at-risk of developing ARDS, in which it has been shown that
raised intrapulmonary levels of IL-8 following multiple trauma are associated with
progression to this catastrophic form of lung injury. The mechanisms by which
intrapulmonary IL-8 may be raised in this context are unknown but the observation
that the high levels of IL-8 were detected within a few hours (range 0.75 - 4 hr) of
trauma suggest that events occurring in the immediate aftermath of the acute insult
play a role in stimulating IL-8 generation. I hypothesised that clinically relevant
potential stimuli in this scenario included acute stress mediators such as
catecholamines and neuropeptides and acute physiological events, principally tissue
hypoxia and resuscitation-associated hyperoxia.
In in vitro studies of human monocyte-derived macrophages, adrenalin, substance P
and MIF had no effect on IL-8 protein release at 2 hours, an early time point chosen
to reflect the timing of clinical samples taken from trauma patients. Acute hypoxia
(PO2 ~ 3.5 KPa) increased IL-8 protein release by 1.8-fold by 2 hours and steady-
state IL-8 mRNA expression by 30 min compared to normoxic controls. The
introduction of hyperoxia, as a second stimulus or 'hit' following hypoxia was a
more potent stimulus for IL-8 protein generation than hypoxia or hyperoxia alone.
The effects of hypoxia / hyperoxia on IL-8 generation were further studied in a
rabbit model of acute lung injury. Localised bronchoscopic instillation of HC1 into
the left lower lobe of an anaesthetised ventilated rabbit resulted in significantly
increased i) IL-8 mRNA and protein expression, ii) neutrophil infiltration into
alveolar airspaces and iii) lung leak as measured by Evans blue labelled-albumin in
the directly injured lung compared to the contralateral 'indirectly' injured lung.
Systemic hypoxaemia was induced by reducing in the inspiratory oxygen fraction.
Compared to normoxic controls (arterial PaC>2 ~ 11 KPa), acute hypoxia (Pa02 ~ 5
KPa) for up to 2 hours increased intrapulmonary IL-8 mRNA but not protein
expression in the acid-injured lung. Delivery of 100% oxygen for 2 hours (PaC>2 ~ 60
KPa) following acute hypoxia (a multiple-hit), increased both intrapulmonary IL-8
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mRNA and IL-8 protein levels. The increase in IL-8 protein was attenuated if the
reoxygenation phase was controlled to return arterial PO2 to normoxic levels (~ 11
KPa). These data support the hypothesis that acute hypoxia / hyperoxia are
clinically relevant stimuli that can generate raised levels of intrapulmonary IL-8.
The mechanisms by which hypoxia may rapidly increase IL-8 mRNA expression in
monocyte-derived macrophages was further studied in vitro. The rapidity of the
response (30 mins) suggested an increase in gene transcription. Electromobility gel-
shift assay revealed that hypoxia increased nuclear levels of the IL-8 promoter-
binding transcription factors AP-1 and CEBP-P, but not NF-kB, by 15 min
exposure. Hypoxia induced macrophage expression of HIF-la, a critical regulator of
hypoxic adaptive responses. However cobalt chloride and desferrioxamine (DFO),
HIF-la-inducing hypoxia mimics, did not upregulate IL-8 suggesting that IL-8
transcription may be HIF-1 independent. Finally it was demonstrated that in
contrast to IL-8, hypoxia inhibited expression of a panel of chemokines and
cytokines including MCP-1, MlP-la, MIP-lp and TNF-a. Both the pattern of
chemokine expression and transcription factor activation observed with hypoxia
differed from that induced by bacterial lipopolysaccharide (LPS), which potently
activated NF-kB and upregulated several chemokine genes. This implies potentially
distinct adaptive responses to hypoxia and infection in the macrophage.
Future studies
Several observations made in the course of this thesis are worthy of further study.
The majority of the in vitro studies were performed in monocyte-derived
macrophages, serving as model of the resident alveolar macrophage. There may
however be significant differences in functional response between the cell
phenotypes and complementary studies in alveolar macrophages from healthy
human donors would address this issue. The observation that hypoxia rapidly
increased steady-state IL-8 mRNA expression in association with increased nuclear
expression of regulatory transcription factors strongly suggests an increase in gene
transcription. However this requires confirmation by nuclear run-off assay. The
effect of hypoxia on IL-8 mRNA stability may also be tested in studies with the
transcriptional inhibitor actinomycin-D.
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The observations from EMSA studies implicated AP-1 and C/EBP-P, but not NF-kB
or HIF-1 in the hypoxic regulation of IL-8. Reporter-linked transfection studies
were hampered through difficulty transfecting primary macrophages using
standard liposome-mediated transfer. A different approach may be to employ
adenovirus infection to deliver the IL-8 promoter to macrophages. Alternatively,
although THP-1 cells appeared not to respond to hypoxia, other human
monocyte/macrophage cell lines such as U937 or Mono-Mac-6 could be 'screened'
for hypoxic-induction of IL-8. Such cell lines are generally more amenable to
transfection through standard techniques. However, the differential regulation of a
number of chemokines and cytokines, several of which have in common
transcription factor binding sites for AP-1, C/EBP-P and NF-kB, suggests the
involvement of other regulatory factors. The most obvious candidate would be HIF-
1. However the finding that neither cobalt chloride nor desferrioxamine induced IL-
8 transcription is evidence against a role for HIF-1 in IL-8 gene regulation. This
raises the possibility of a regulatory mechanism that overrides, or more likely
complements transcription-factor control in selective gene transcription in response
to hypoxia. Histone modification represents one potential mechanism and in
particular there is evidence that histone acetylation may differentially regulate
chemokines (Fusunyan et al., 1999; Wen and Wu, 2001). The effect of hypoxia on
histone acetylation status in macrophages would represent an exciting area for
MtHst sthdyobservations reported demonstrate that hypoxia and hyperoxia generate
IL-8 synthesis in macrophages and in lung tissue in vivo, the direct relevance of these
findings to the clinical setting of multiple trauma is debatable. Firstly, although
hypoventilation, atelectasis, and contusion are all likely to feature acutely in trauma
victims, the presence of associated widespread alveolar hypoxia is not certain.
Alveolar hyperoxia in contrast would be very likely to occur in the resuscitation
phase following trauma and is therefore of direct clinical relevance. Direct
measurement of tissue oxygenation in the acute clinical setting is feasible but
presents significant practical obstacles. Animal models of trauma present logistical
and ethical constraints, hence our use of a direct acid-injury model. However, some
aspects of the trauma clinical scenario, such as haemorrhage, hypoventilation,
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atelectasis and hyperoxic resuscitation may be reproduced in an animal model. This
would present the opportunity to study the effects of tissue hypoxia and hyperoxia
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APPENDICES
Appendix 1A. American College of Chest Physicians and Society of Critical Care Medicine
(ACCP/SCCM) definition for SIRS. Bone et al„ 1992.
Systemic Inflammatory Response Syndrome (SIRS)
A severe clinical illness with the presence of two or more of the following criteria :
Temperature >38°C or <36°C
Tachycardia >90 beats / min
Tachypnoea >20 breaths / min or PaCO-> < 4.25 KPa
Altered white blood cell count >12x109/L or <4 x 109/L or > 10% band forms on
peripheral blood film
Appendix IB. The North American / European Concensus Criteria for ALI and ARDS. Bernard et
al., 1994
Acute lung injury (ALI) ARDS
Timing Acute onset
Oxygenation PaO2/ Fi02 < 40 KPa regardless of
PEEP
Pa02/ Fi02 < 26.6 KPa
Regardless of PEEP
Radiography Bilateral infiltrates on chest X-ray
Pulmonary artery wedge pressure < 18 mmHg with no evidence of left atrial hypertension
lxii
Appendix 1C
Mediators assayed in blood and airspaces of patients at-risk of ARDS
(heterogenous risk factors)
Biological Mediator References
Cytokines TNF-a Marks et al., 1990; Parsons et ah, 1992; Raponi et al.,
1992;Hyers et al., 1991,Roten etal., 1991
IL-lp Sileretal., 1989; Pugin, 1996
IL-8 Jorens et al., 1992; Donnelly et al., 1993; Torre et al.,
1993; Hirani etal., 2001
IL-lra Parsons et al., 1997
IL-10 Parsons et al., 1997
Bacterial Endotoxin Parsons et al., 1989; Donnelly et al., 1994A; Goldie et al.,
products 1995;
Lipids and ltb4 Stephenson et al., 1988; Davis et al., 1990; Antonelli et
metabolites of al., 1994; Amat et al., 2000




Bursten et al., 1996
Complement C5a Weinberg et al., 1984; Duchateau et al., 1984
C5b-9 terminal Langlois and Gowry, 1988
complex
Markers of Elastase Donnelly et al., 1995;
neutrophil / E / P- selectins Donnelly et al., 1994; Sakamaki et al., 1995
endothelial L-selectin Stegel et al., 2001
activation vWf-Ag Rubin et al., 1990; Moss et al., 1995; Bajaj et al., 1999





Armstrong et al., 1999
products VEGF Thicket et al., 2001
Surfactant SP-A Pison et al., 1992; Green et al., 1999
proteins
Iron metabolism Ferritin Connelly et al., 1997, Sharkey et al., 1999
Markers of Hydrogen Baldwin et al., 1986
oxidative stress peroxide
Catalase Leff et al., 1993
MnSOD
Ixiii
